RNA molecules used to treat fungi
By designing asymmetric precursor RNA molecules and utilizing double-stranded RNA regions with specific structures and atypical base pairs, the inefficiency of existing RNA silencing technologies in plants has been solved, enabling efficient and specific regulation of gene expression and improved crop quality.
Patent Information
- Application Number
- CN202480088500.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2024-06-28
- Filing Date
- 2024-12-20
- Publication Date
- 2026-11-17
AI Technical Summary
Existing RNA silencing technology is inefficient and has limited application in plants, especially when using hairpin RNA (hpRNA) transgenic constructs with long dsRNA stems, which are difficult to effectively regulate gene expression and improve crop quality and disease and pest resistance.
Asymmetric precursor RNA molecules, containing double-stranded RNA regions with specific structures, can be designed and cleaved by ribonucleases in eukaryotic cells into double-stranded product RNA molecules with protrusions through asymmetric design of ribonucleotides and atypical base pairs. These molecules can then be used to sequence-specifically downregulate the expression of target RNA molecules.
It enables efficient and specific regulation of gene expression in eukaryotic cells, reducing the amount or activity of target RNA molecules. It is applicable to organisms such as plants, fungi, pests, and nematodes, improving the effect of gene silencing and the efficiency of crop improvement.
Smart Images

Figure FT_1 
Figure FT_2 
Figure FT_3
Abstract
Description
Technical Field
[0001] This invention relates to asymmetric RNA molecules, their precursors, and their use in gene silencing. Background Technology
[0002] RNA silencing is an evolutionarily conserved gene silencing mechanism induced by double-stranded RNA (dsRNA) in eukaryotes. dsRNA can take the form of a specific hairpin RNA (hpRNA). In the basic RNA silencing pathway, dsRNA is processed by the Dicer protein into a short 20-25 nucleotide (nt) small RNA duplex, one strand of which binds to the Argonaute (AGO) protein to form an RNA-induced silencing complex (RISC). This silencing complex uses the small RNA as a guide to find and bind to complementary single-stranded RNA, where the AGO protein cleaves the RNA, leading to its degradation, or reduces the translation of the target RNA in the absence of target RNA cleavage.
[0003] In plants, multiple RNA silencing pathways exist, including microRNA (miRNA), trans-acting small interfering RNA (tasiRNA), repetition-associated siRNA (rasiRNA), and exogenous (viral and transgenic) siRNA (exosiRNA) pathways. miRNAs are small RNAs of 20-24 nts, derived from short stem-loop precursor RNA, processed in the nucleus by Dicer-like 1 (DCL1), which is transcribed from MIR genes by RNA polymerase II. TasiRNAs are phased siRNAs of approximately 21 nts, primarily produced by DCL4 from long dsRNA synthesized from miRNA-cleaved TAS RNA fragments via RNA-dependent RNA polymerase 6 (RDR6). RasiRNAs of 24 nts are produced by DCL3, and the precursor dsRNA is produced by the combined function of plant-specific DNA-dependent RNA polymerase IV (PolIV) and RDR2 from repetitive DNA in the genome. The exosiRNA pathway overlaps with the tasiRNA and rasiRNA pathways, and both DCL4 and DCL3 are involved in exosiRNA processing. In addition to DCL1, DCL3, and DCL4, the model plant Arabidopsis thaliana and other higher plants encode DCL2 or its equivalent, which produces 22-nt siRNAs, including exosiRNAs, and plays a crucial role in systemic and transmissive gene silencing in plants. All these plant small RNAs are methylated at the 2'-hydroxyl position of their 3'-terminal nucleotide by HUA enhancer 1 (HEN1), and this 3'-terminal 2'-O-methylation is considered to stabilize small RNAs in plant cells. miRNAs, tasiRNAs, and exosiRNAs are functionally similar to small RNAs in animal cells that participate in post-transcriptional gene silencing or sequence-specific degradation of RNA in animals. However, rasiRNA is plant-specific and its function is to guide de novo cytosine methylation at homologous DNA sites, a transcriptional gene silencing mechanism called RNA-guided DNA methylation (RdDM).
[0004] RNA silencing induced by dsRNA has been widely used to reduce gene activity in various eukaryotic systems, and numerous gene silencing techniques have been developed. Different organisms are generally suited to different gene silencing methods. For example, long dsRNAs (at least 100 base pairs in length) are less suitable for inducing RNA silencing in mammalian cells due to dsRNA-induced interferon responses, and therefore shorter dsRNAs (less than 30 base pairs) are generally used in mammalian cells, while in plants, hairpin RNAs (hpRNAs) with long dsRNA stems are very effective. In plants, different RNA silencing pathways have led to different gene silencing techniques, such as artificial miRNAs, artificial tasiRNAs, and virus-induced gene silencing techniques. However, to date, the successful application of RNA silencing in plants has primarily been achieved through the use of long hpRNA transgenes. hpRNA transgenic constructs typically consist of inverted repeat sequences comprised of perfectly complementary sense and antisense sequences of a target gene sequence (which forms the dsRNA stem of the hpRNA during transcription). The target gene sequence is separated by spacer sequences (circles forming the hpRNA), which are inserted between promoters and transcription terminators for expression in plant cells. The spacer sequences function to stabilize the inverted repeat DNA in bacteria during construct preparation. The dsRNA stem of the resulting hpRNA transcript is processed by DCL proteins into siRNA that guides the silencing of the target gene. hpRNA transgenes have been widely used for crop improvement by knocking down gene expression, modifying metabolic pathways, and enhancing plant resistance to pests and diseases, and many successful applications of this technology in crop improvement have been reported (Guo et al., 2016; Kim et al., 2019).
[0005] WO2019 / 051563 discloses a double-stranded RNA molecule and its use in gene silencing, said RNA molecule including a double hairpin structure. WO2020 / 024019 discloses a double-stranded RNA structure with atypical base pairs in the double-stranded RNA region and its use in gene silencing. WO2021 / 022325 discloses a double-stranded RNA molecule for regulating plant flowering.
[0006] Although dsRNA-induced gene silencing has proven to be a valuable tool for altering an organism's phenotype, there is still a need for alternative, preferably improved, dsRNA molecules that can be used for RNA interference (RNAi). Summary of the Invention
[0007] The inventors have identified double-stranded product RNA molecules with desired properties and precursor RNA molecules encoding these double-stranded product RNA molecules. These are particularly useful for downregulating gene expression or reducing the amount or activity of one or more target RNA molecules in eukaryotic cells in a sequence-specific manner. Specifically, the precursor RNA molecules and therefore the double-stranded product RNA molecules have asymmetric design features providing one or more raised ribonucleotides in the precursor and product RNA molecules, preferably also having an ledRNA structure or containing multiple atypical base pairs, preferably G:U base pairs, in the double-stranded region of the RNA molecule. The precursor RNA molecules can be locally applied to eukaryotic cells, tissues, organs, or organisms, or taken up by organisms (such as pests), or expressed by polynucleotides encoding the precursor RNA molecules. Thus, the precursor RNA molecules provide an improved means of controlling harmful organisms and pathogens (such as pests, nematodes) and fungal and viral pathogens, or reducing the incidence of diseases in eukaryotic organisms or treating diseases in eukaryotic organisms.
[0008] Examples of precursor RNA molecules and product RNA molecules in the following aspects and embodiments are described herein. Figure 53 The illustrations are schematic, and the reader is encouraged to view them in conjunction with the descriptions of the following aspects and embodiments. Figure 53 .
[0009] In a first aspect, the present invention provides an asymmetric precursor RNA molecule processed to produce a siRNA molecule, said siRNA molecule consisting of a sense RNA sequence of 21 nts hybridized with an antisense RNA sequence of 22 nts. Therefore, the present invention provides a precursor RNA molecule (A) comprising at least one double-stranded RNA region (B), wherein:
[0010] (i) The double-stranded RNA region (B) comprises:
[0011] (a) A first RNA strand (D) of at least 23 consecutive ribonucleotides, the first RNA strand (D) comprising a first RNA sequence (E) of at least 21 consecutive ribonucleotides, and
[0012] (b) A second RNA strand (F) of at least 24 consecutive ribonucleotides, wherein the second RNA strand (F) contains a second RNA sequence (G) of at least 22 consecutive ribonucleotides.
[0013] The first RNA chain (D) and the second RNA chain (F) are covalently linked by a linker RNA sequence (L).
[0014] The first RNA sequence (E) hybridizes with the second RNA sequence (G) through base pairing between at least 20 of the at least 21 consecutive ribonucleotides of the first RNA sequence (E) and at least 20 of the at least 22 consecutive ribonucleotides of the second RNA sequence (G), thereby forming at least a portion (C) of the double-stranded RNA region (B).
[0015] In the portion (C) of the double-stranded RNA region (B), one or two of the at least 22 ribonucleotides in (G) are non-base-paired, and zero or one of the at least 21 ribonucleotides in (E) are non-base-paired, thereby forming one, two, or three protrusions in the portion (C) of the double-stranded RNA region (B).
[0016] Each of the one, two, or three protrusions is immediately followed by a ribonucleotide, which is base-paired in the portion (C) of the double-stranded RNA region (B); and
[0017] (ii) The precursor RNA molecule (A) can be cleaved in eukaryotic cells by one or more ribonucleases (RNases) to produce one or more double-stranded product RNA molecules (P), said one or more double-stranded product RNA molecules (P) consisting of a sense RNA sequence (H) of 21 consecutive ribonucleotides from the first RNA sequence (E) and an antisense RNA sequence (J) of 22 consecutive ribonucleotides from the second RNA strand (F), including at least 20 consecutive ribonucleotides from (G).
[0018] The one or more double-stranded RNA molecules (P) contain the one, two, or three protrusions.
[0019] In one or more of the double-stranded RNA molecules (P), 18 or 19 of the ribonucleotides 1 to 19 of the sense RNA sequence (H) are each paired with ribonucleotide bases 1 to 20 of the antisense RNA sequence (J).
[0020] In the one or more double-stranded RNA molecules (P), ribonucleotides 20 and 21 of the sense RNA sequence (H) form an unpaired 3' overhang consisting of two ribonucleotides, and ribonucleotides 21 and 22 of the antisense RNA sequence (J) form an unpaired 3' overhang consisting of two ribonucleotides.
[0021] In one or more of the double-stranded RNA molecules (P), ribonucleotides 1 and 2 of the sense RNA sequence (H) are paired with ribonucleotides 19 and 20 of the antisense RNA sequence (J), respectively.
[0022] In one or more of the double-stranded RNA molecules (P), ribonucleotides 18 and 19 of the sense RNA sequence (H) are paired with ribonucleotides 1 and 2 of the antisense RNA sequence (J), respectively. An exemplary RNA molecule in this respect is... Figure 53 The small diagrams A through H are shown schematically.
[0023] In one embodiment of the first aspect, one or two ribonucleotides of ribonucleotides 1 and 2 in the at least 23 consecutive ribonucleotides of the first RNA chain (D) do not pair with one or two ribonucleotide bases of ribonucleotides 23 and 24 in the at least 24 consecutive ribonucleotides of the second RNA chain (F). The exemplary RNA molecule of this embodiment... Figure 53 The small diagrams F to H are shown schematically.
[0024] In one embodiment of the first aspect, the first RNA sequence (E) hybridizes with the second RNA sequence (G) through base pairing between at least 20 consecutive ribonucleotides of the at least 21 consecutive ribonucleotides of the first RNA sequence (E) and at least 20 consecutive ribonucleotides of the at least 22 consecutive ribonucleotides of the second RNA sequence (G).
[0025] In the portion (C) of the double-stranded RNA region (B), two ribonucleotides of the at least 22 consecutive ribonucleotides in (G) are non-base-paired, and one ribonucleotide of the at least 21 consecutive ribonucleotides in the first RNA sequence (E) is non-base-paired. These non-base-paired ribonucleotides form two protrusions in the portion (C) of the double-stranded RNA region (B).
[0026] Each protrusion is immediately followed by a ribonucleotide, which is base-paired in the portion (C) of the double-stranded RNA region (B).
[0027] The one or more double-stranded RNA molecules (P) contain the protrusions.
[0028] One of the protrusions is formed by a mismatched ribonucleotide pair between the first RNA sequence (E) and the second RNA sequence (G), and the second protrusion is a mononucleotide protrusion.
[0029] In one or more of the double-stranded RNA molecules (P), all but one of the ribonucleotides in ribonucleotides 1 to 19 of the sense RNA sequence (H) are each paired with ribonucleotide bases in ribonucleotides 1 to 20 of the antisense RNA sequence (J). The exemplary RNA molecule of this embodiment... Figure 53 The small diagrams A and F are shown schematically.
[0030] In one embodiment of the first aspect, the first RNA sequence (E) hybridizes with the second RNA sequence (G) through base pairing between at least 20 consecutive ribonucleotides of the at least 21 consecutive ribonucleotides of the first RNA sequence (E) and at least 20 consecutive ribonucleotides of the at least 22 consecutive ribonucleotides of the second RNA sequence (G).
[0031] In the portion (C) of the double-stranded RNA region (B), two consecutive ribonucleotides of the at least 22 ribonucleotides in (G) are non-base-paired, and one ribonucleotide of the at least 21 ribonucleotides in (E) is non-base-paired, the non-base-paired ribonucleotide forming a protrusion in the portion (C) of the double-stranded RNA region (B).
[0032] The protrusion is immediately followed by a ribonucleotide, which is base-paired in the portion (C) of the double-stranded RNA region (B).
[0033] The one or more double-stranded RNA molecules (P) contain the protrusions, and
[0034] In the one or more double-stranded RNA molecules, all but one of the ribonucleotides 1 to 19 of the sense RNA sequence (H) are each paired with ribonucleotide bases 1 to 20 of the antisense RNA sequence (J). The exemplary RNA molecule of this embodiment... Figure 53 The small image B illustrates this schematically.
[0035] In one embodiment of the first aspect, the first RNA sequence (E) hybridizes with the second RNA sequence (G) through base pairing between at least 20 consecutive ribonucleotides of the at least 21 consecutive ribonucleotides of the first RNA sequence (E) and at least 20 consecutive ribonucleotides of the at least 22 consecutive ribonucleotides of the second RNA sequence (G).
[0036] In the portion (C) of the double-stranded RNA region (B), two of the at least 22 ribonucleotides in (G) are non-base-paired, and one of the at least 21 ribonucleotides in (E) is non-base-paired, the non-base-paired ribonucleotides forming three protrusions in the portion (C) of the double-stranded RNA region (B).
[0037] Each protrusion is immediately followed by a ribonucleotide, which is base-paired in the portion (C) of the double-stranded RNA region (B).
[0038] Each of these protrusions is a mononucleotide protrusion.
[0039] The one or more double-stranded RNA product molecules (P) include the protrusion, wherein in the one or more double-stranded RNA product molecules, all but one of the ribonucleotides 1 to 19 of the sense RNA sequence (H) are each paired with ribonucleotide bases 1 to 20 of the antisense RNA sequence (J). The exemplary RNA molecule of this embodiment... Figure 53 The small diagrams C and G are shown schematically.
[0040] In one embodiment of the first aspect, the first RNA sequence (E) hybridizes with the second RNA sequence (G) through base pairing between at least 21 consecutive ribonucleotides of the at least 21 consecutive ribonucleotides of the first RNA sequence (E) and at least 21 consecutive ribonucleotides of the at least 22 consecutive ribonucleotides of the second RNA sequence (G).
[0041] In the portion (C) of the double-stranded RNA region (B), one of the at least 22 ribonucleotides in (G) is non-base-paired, and all of the at least 21 ribonucleotides in (E) are base-paired. The one non-base-paired ribonucleotide forms a single nucleotide protrusion in the portion (C) of the double-stranded RNA region (B).
[0042] The protrusion is immediately followed by a ribonucleotide, which is base-paired in the portion (C) of the double-stranded RNA region (B).
[0043] The one or more double-stranded RNA molecules (P) contain the protrusions, and
[0044] In one or more of the double-stranded RNA molecules (P), ribonucleotides 1 to 19 of the sense RNA sequence (H) are each paired with ribonucleotide bases in ribonucleotides 1 to 20 of the antisense RNA sequence (J). The exemplary RNA molecule of this embodiment... Figure 53 The small diagrams D, E, and H are shown schematically.
[0045] In one embodiment of the first aspect, the double-stranded RNA region (B) comprises:
[0046] (a) A first RNA strand (D), the first RNA strand (D) comprising a first RNA sequence (E) of at least 23 consecutive ribonucleotides, and
[0047] (b) A second RNA strand (F), wherein the second RNA strand (F) contains a second RNA sequence (G) of at least 24 consecutive ribonucleotides.
[0048] The first RNA sequence (E) hybridizes with the second RNA sequence (G) through base pairing between at least 22 of the at least 23 consecutive ribonucleotides of the first RNA sequence (E) and at least 22 of the at least 24 consecutive ribonucleotides of the second RNA sequence (G), thereby forming at least a portion (C) of the double-stranded RNA region (B).
[0049] In the portion (C) of the double-stranded RNA region (B), one or two of the at least 24 ribonucleotides in (G) are non-base-paired, and zero or one of the at least 23 ribonucleotides in (E) are non-base-paired, thereby forming one, two, or three protrusions in the portion (C) of the double-stranded RNA region (B). The exemplary RNA molecule of this embodiment... Figure 53 The small diagrams A through E are shown schematically.
[0050] Therefore, in one embodiment, the present invention provides a precursor RNA molecule (A) comprising at least one double-stranded RNA region (B), wherein:
[0051] (i) The double-stranded RNA region (B) comprises:
[0052] (a) A first RNA strand (D), the first RNA strand (D) comprising a first RNA sequence (E) of at least 23 consecutive ribonucleotides, and
[0053] (b) A second RNA strand (F), wherein the second RNA strand (F) contains a second RNA sequence (G) of at least 24 consecutive ribonucleotides.
[0054] The first RNA chain (D) and the second RNA chain (F) are covalently linked by a linker RNA sequence (L).
[0055] The first RNA sequence (E) hybridizes with the second RNA sequence (G) through base pairing between at least 22 of the at least 23 consecutive ribonucleotides of the first RNA sequence (E) and at least 22 of the at least 24 consecutive ribonucleotides of the second RNA sequence (G), thereby forming at least a portion (C) of the double-stranded RNA region (B).
[0056] In the portion (C) of the double-stranded RNA region (B), one or two of the at least 24 ribonucleotides in (G) are non-base-paired, and zero or one of the at least 23 ribonucleotides in (E) are non-base-paired, thereby forming one, two, or three protrusions in the portion (C) of the double-stranded RNA region (B).
[0057] Each of the one, two, or three protrusions is immediately followed by a ribonucleotide, which is base-paired in the portion (C) of the double-stranded RNA region (B); and
[0058] (ii) The precursor RNA molecule (A) can be cleaved in eukaryotic cells by one or more ribonucleases (RNases) to produce one or more double-stranded product RNA molecules (P), said one or more double-stranded product RNA molecules (P) consisting of a sense RNA sequence (H) of 21 consecutive ribonucleotides from the first RNA sequence (E) and an antisense RNA sequence (J) of 22 consecutive ribonucleotides from the second RNA sequence (G).
[0059] The one or more double-stranded RNA molecules (P) contain the one, two, or three protrusions.
[0060] In one or more of the double-stranded RNA molecules (P), 18 or 19 of the ribonucleotides 1 to 19 of the sense RNA sequence (H) are each paired with ribonucleotide bases 1 to 20 of the antisense RNA sequence (J).
[0061] In the one or more double-stranded RNA molecules (P), ribonucleotides 20 and 21 of the sense RNA sequence (H) form an unpaired 3' overhang consisting of two ribonucleotides, and ribonucleotides 21 and 22 of the antisense RNA sequence (J) form an unpaired 3' overhang consisting of two ribonucleotides.
[0062] In one or more of the double-stranded RNA molecules (P), ribonucleotides 1 and 2 of the sense RNA sequence (H) are paired with ribonucleotides 19 and 20 of the antisense RNA sequence (J), respectively.
[0063] In one or more of the double-stranded RNA molecules (P), ribonucleotides 18 and 19 of the sense RNA sequence (H) are paired with ribonucleotides 1 and 2 of the antisense RNA sequence (J), respectively. The exemplary RNA molecule of this embodiment... Figure 53 The small diagrams A through E are shown schematically.
[0064] In one embodiment of the first aspect, the first RNA sequence (E) hybridizes with the second RNA sequence (G) through base pairing between at least 22 of the at least 23 consecutive ribonucleotides of the first RNA sequence (E) and at least 22 of the at least 24 consecutive ribonucleotides of the second RNA sequence (G).
[0065] In the portion (C) of the double-stranded RNA region (B), two of the at least 24 ribonucleotides in (G) are non-base-paired, and one of the at least 23 ribonucleotides in (E) is non-base-paired, the non-base-paired ribonucleotides forming two protrusions in the portion (C) of the double-stranded RNA region (B).
[0066] Each protrusion is immediately followed by a ribonucleotide, which is base-paired in the portion (C) of the double-stranded RNA region (B).
[0067] The one or more double-stranded RNA molecules (P) contain the protrusions.
[0068] One of the protrusions is formed by a mismatched ribonucleotide pair between the first RNA sequence (E) and the second RNA sequence (G), and the second protrusion is a mononucleotide protrusion.
[0069] In one or more of the double-stranded RNA molecules (P), all but one of the ribonucleotides in ribonucleotides 1 to 19 of the sense RNA sequence (H) are each paired with ribonucleotide bases in ribonucleotides 1 to 20 of the antisense RNA sequence (J). The exemplary RNA molecule of this embodiment... Figure 53 The small diagram A illustrates this schematically.
[0070] In one embodiment of the first aspect, the first RNA sequence (E) hybridizes with the second RNA sequence (G) through base pairing between at least 22 of the at least 23 consecutive ribonucleotides of the first RNA sequence (E) and at least 22 of the at least 24 consecutive ribonucleotides of the second RNA sequence (G).
[0071] In the portion (C) of the double-stranded RNA region (B), two consecutive ribonucleotides of the at least 24 ribonucleotides in (G) are non-base-paired, and one ribonucleotide of the at least 23 ribonucleotides in (E) is non-base-paired, the non-base-paired ribonucleotide forming a protrusion in the portion (C) of the double-stranded RNA region (B).
[0072] The protrusion is immediately followed by a ribonucleotide, which is base-paired in the portion (C) of the double-stranded RNA region (B).
[0073] The one or more double-stranded RNA molecules (P) contain the protrusions, and
[0074] In the one or more double-stranded RNA molecules, all but one of the ribonucleotides 1 to 19 of the sense RNA sequence (H) are each paired with ribonucleotide bases 1 to 20 of the antisense RNA sequence (J). The exemplary RNA molecule of this embodiment... Figure 53 The small image B illustrates this schematically.
[0075] In one embodiment of the first aspect, the first RNA sequence (E) hybridizes with the second RNA sequence (G) through base pairing between at least 22 of the at least 23 consecutive ribonucleotides of the first RNA sequence (E) and at least 22 of the at least 24 consecutive ribonucleotides of the second RNA sequence (G).
[0076] In the portion (C) of the double-stranded RNA region (B), two of the at least 24 ribonucleotides in (G) are non-base-paired, and one of the at least 23 ribonucleotides in (E) is non-base-paired, the non-base-paired ribonucleotides forming three protrusions in the portion (C) of the double-stranded RNA region (B).
[0077] Each protrusion is immediately followed by a ribonucleotide, which is base-paired in the portion (C) of the double-stranded RNA region (B).
[0078] Each of these protrusions is a mononucleotide protrusion.
[0079] The one or more double-stranded RNA product molecules (P) include the protrusion, wherein in the one or more double-stranded RNA product molecules, all but one of the ribonucleotides 1 to 19 of the sense RNA sequence (H) are each paired with ribonucleotide bases 1 to 20 of the antisense RNA sequence (J). The exemplary RNA molecule of this embodiment... Figure 53 The small diagram C is shown schematically.
[0080] In one embodiment of the first aspect, the first RNA sequence (E) hybridizes with the second RNA sequence (G) through base pairing between at least 23 consecutive ribonucleotides of the at least 23 consecutive ribonucleotides of the first RNA sequence (E) and at least 23 consecutive ribonucleotides of the at least 24 consecutive ribonucleotides of the second RNA sequence (G).
[0081] In the portion (C) of the double-stranded RNA region (B), one of the at least 24 ribonucleotides in (G) is non-base-paired, and all of the at least 23 ribonucleotides in (E) are base-paired. The one non-base-paired ribonucleotide forms a single nucleotide protrusion in the portion (C) of the double-stranded RNA region (B).
[0082] The protrusion is immediately followed by a ribonucleotide, which is base-paired in the portion (C) of the double-stranded RNA region (B).
[0083] The one or more double-stranded RNA molecules (P) contain the protrusions, and
[0084] In one or more of the double-stranded RNA molecules (P), ribonucleotides 1 to 19 of the sense RNA sequence (H) are each paired with ribonucleotide bases in ribonucleotides 1 to 20 of the antisense RNA sequence (J). The exemplary RNA molecule of this embodiment... Figure 53 The small diagrams D and E illustrate this schematically.
[0085] The design principles of the asymmetric precursor RNA molecules described in the first aspect can be applied in an extended manner to longer double-stranded regions. For example, the non-base-paired ribonucleotides in the second RNA sequence (G) (antisense sequence) can be arranged in a periodic manner to provide a population of product RNA molecules (P) having multiple 22 nt non-overlapping antisense RNA sequences (J). Such precursor RNA molecules are particularly useful for reducing the expression of target RNA molecules in plant cells, fungal cells, or nematode cells. They can also be used in other invertebrate cells such as arthropod cells or insect cells, or in non-mammalian vertebrate cells. They can be produced in plant cells to reduce insect target RNA molecules or fungal pathogen or nematode target RNA molecules, or applied locally to plants or insects to reduce target RNA molecules. For example, in one embodiment of the first aspect, the first RNA sequence (E) contains at least 44 consecutive ribonucleotides, and the second RNA sequence (G) contains at least 46 consecutive ribonucleotides.
[0086] The first RNA sequence (E) hybridizes with the second RNA sequence (G) through base pairing between at least 42, preferably at least 43, or at least 44 consecutive ribonucleotides of the first RNA sequence (E) and at least 42, preferably at least 43, or at least 44 consecutive ribonucleotides of the second RNA sequence (G) from at least 46 consecutive ribonucleotides.
[0087] In the portion (C) of the double-stranded RNA region (B), two, three, or four of the at least 46 consecutive ribonucleotides in (G) are non-base-paired, and zero, one, or two of the at least 44 consecutive ribonucleotides in (E) are non-base-paired, thereby forming a protrusion in the portion (C) of the double-stranded RNA region (B).
[0088] Each of the protrusions is immediately followed by a ribonucleotide, which is base-paired in the portion (C) of the double-stranded RNA region (B).
[0089] The precursor RNA molecule can be cleaved in eukaryotic cells by one or more ribonucleases (RNases) to produce multiple different double-stranded RNA molecules (P). Each of the multiple different double-stranded RNA molecules (P) consists of a sense RNA sequence (H) of 21 consecutive ribonucleotides and an antisense RNA sequence (J) of 22 consecutive ribonucleotides.
[0090] Each of the plurality of different double-stranded RNA molecules (P) contains at least one of the protrusions, and
[0091] At least some of the different double-stranded RNA molecules (P) have non-overlapping antisense RNA sequences (J), preferably adjacent to non-overlapping antisense RNA sequences (J).
[0092] In another embodiment of the first aspect, the first RNA chain (D) comprises a first RNA sequence (E) of at least 44 consecutive ribonucleotides, and the second RNA chain (F) comprises a second RNA sequence (G) of at least 46 consecutive ribonucleotides.
[0093] The first RNA sequence (E) hybridizes with the second RNA sequence (G) through base pairing between all 44 consecutive ribonucleotides of the first RNA sequence (E) and 44 consecutive ribonucleotides of the second RNA sequence (G) out of 46 consecutive ribonucleotides, thereby forming a portion (C) of the double-stranded RNA region (B).
[0094] In the portion (C) of the double-stranded RNA region (B), two of the 46 consecutive ribonucleotides in (G) are non-base-paired, thereby forming a single ribonucleotide protrusion in the portion (C) of the double-stranded RNA region (B).
[0095] Each of the protrusions is immediately followed by a ribonucleotide, which is base-paired in the portion (C) of the double-stranded RNA region (B).
[0096] The precursor RNA molecule can be cleaved in eukaryotic cells by one or more ribonucleases (RNases) to produce multiple different double-stranded RNA molecules (P). Each of the multiple different double-stranded RNA molecules (P) consists of a sense RNA sequence (H) of 21 consecutive ribonucleotides and an antisense RNA sequence (J) of 22 consecutive ribonucleotides.
[0097] Each of the plurality of different double-stranded RNA molecules (P) contains at least one of the protrusions, and
[0098] At least some of the different double-stranded RNA molecules (P) have non-overlapping antisense RNA sequences (J), preferably adjacent to the non-overlapping antisense RNA sequence (J). In this embodiment and the foregoing embodiments, the mononucleotide protrusions are preferably separated by 16-26 consecutive base pairs, more preferably by 17-24 or 18-23 consecutive base pairs, even more preferably by 19-22 consecutive base pairs, and most preferably by 20 or 21 consecutive base pairs. In a specific example, the mononucleotide protrusions are separated by 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, or 26 consecutive base pairs. In one example, all these base pairs are typical base pairs. Alternatively, one, two, three, four, five, or six base pairs between the protrusions are G:U base pairs. The precursor RNA molecule may contain two or more such double-stranded RNA regions, for example, containing ledRNA structures. In these embodiments, the eukaryotic cell cleaving the precursor RNA molecule (A) is preferably a plant cell, or a fungal cell, or a nematode cell, or an arthropod cell such as an insect cell, arachnid, or decapod, or the target RNA molecule is preferably in a plant cell, or a fungal cell, or a nematode cell, or an arthropod cell such as an insect cell, arachnid, or decapod. The precursor RNA molecule may be produced in a cell-free system or in microbial cells such as bacterial or yeast cells, and such cells may be locally applied to the plant or the insect or taken up by the insect.
[0099] In one embodiment of a longer dsRNA region having at least 44 base pairs, the precursor RNA molecule lacks the linker RNA sequence (L), and the first RNA strand (D) and the second RNA strand (F) hybridize to form the double-stranded RNA region (B). Such precursor RNA molecules can be readily produced in cell-free systems, for example, in vitro. In one embodiment, the first RNA strand (D) comprises a first RNA sequence (E) of at least 44 consecutive ribonucleotides, and the second RNA strand (F) comprises a second RNA sequence (G) of at least 46 consecutive ribonucleotides.
[0100] The first RNA sequence (E) hybridizes with the second RNA sequence (G) through base pairing between all 44 consecutive ribonucleotides of the first RNA sequence (E) and 44 consecutive ribonucleotides of the second RNA sequence (G) out of 46 consecutive ribonucleotides, thereby forming a portion (C) of the double-stranded RNA region (B).
[0101] In the portion (C) of the double-stranded RNA region (B), two of the 46 consecutive ribonucleotides in (G) are non-base-paired, thereby forming a single ribonucleotide protrusion in the portion (C) of the double-stranded RNA region (B).
[0102] Each of the protrusions is immediately followed by a ribonucleotide, which is base-paired in the portion (C) of the double-stranded RNA region (B).
[0103] The precursor RNA molecule can be cleaved in eukaryotic cells by one or more ribonucleases (RNases) to produce multiple different double-stranded RNA molecules (P). Each of the multiple different double-stranded RNA molecules (P) consists of a sense RNA sequence (H) of 21 consecutive ribonucleotides and an antisense RNA sequence (J) of 22 consecutive ribonucleotides.
[0104] Each of the plurality of different double-stranded RNA molecules (P) contains at least one of the protrusions, and
[0105] At least some of the different double-stranded RNA molecules (P) have non-overlapping antisense RNA sequences (J), preferably adjacent to the non-overlapping antisense RNA sequence (J). In this embodiment, the mononucleotide protrusions are preferably separated by 16-26 consecutive base pairs, more preferably by 17-24 or 18-23 consecutive base pairs, even more preferably by 19-22 consecutive base pairs, and most preferably by 20 or 21 consecutive base pairs. In specific examples, the mononucleotide protrusions are separated by 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, or 26 consecutive base pairs. In a preferred example, all these base pairs are typical base pairs. Alternatively, one, two, three, four, five, or six base pairs between the protrusions may be G:U base pairs.
[0106] In the three embodiments described above, the first RNA sequence (E) and the second RNA sequence (G) can be extended to more than 44 and 46 ribonucleotides, respectively. In another embodiment of the first aspect, for even longer dsRNA regions, the first RNA sequence (E) comprises at least 65 consecutive ribonucleotides, and the second RNA sequence (G) comprises at least 68 consecutive ribonucleotides, wherein the first RNA sequence (E) hybridizes with the second RNA sequence (G) through base pairing between at least 62, preferably at least 63, at least 64, or at least 65 consecutive ribonucleotides of the at least 65 consecutive ribonucleotides of the first RNA sequence (E) and at least 62, preferably at least 63, at least 64, or at least 65 consecutive ribonucleotides of the at least 68 consecutive ribonucleotides of the second RNA sequence (G).
[0107] In another embodiment of the first aspect, the first RNA chain (D) comprises a first RNA sequence (E) of at least 65 consecutive ribonucleotides, and the second RNA chain (F) comprises a second RNA sequence (G) of at least 68 consecutive ribonucleotides.
[0108] The first RNA sequence (E) hybridizes with the second RNA sequence (G) through base pairing between all 65 consecutive ribonucleotides of the first RNA sequence (E) and 65 consecutive ribonucleotides of the second RNA sequence (G) out of 68 consecutive ribonucleotides, thereby forming a portion (C) of the double-stranded RNA region (B).
[0109] In the portion (C) of the double-stranded RNA region (B), three of the 68 consecutive ribonucleotides in (G) are non-base-paired, thereby forming a single ribonucleotide protrusion in the portion (C) of the double-stranded RNA region (B).
[0110] Each of the protrusions is immediately followed by a ribonucleotide, which is base-paired in the portion (C) of the double-stranded RNA region (B).
[0111] The precursor RNA molecule can be cleaved in eukaryotic cells by one or more ribonucleases (RNases) to produce multiple different double-stranded RNA molecules (P). Each of the multiple different double-stranded RNA molecules (P) consists of a sense RNA sequence (H) of 21 consecutive ribonucleotides and an antisense RNA sequence (J) of 22 consecutive ribonucleotides.
[0112] Each of the plurality of different double-stranded RNA molecules (P) contains at least one of the protrusions, and
[0113] At least some of the different double-stranded RNA molecules (P) have non-overlapping antisense RNA sequences (J), preferably adjacent to the non-overlapping antisense RNA sequence (J). In this embodiment and the foregoing embodiments, the mononucleotide protrusions are preferably periodically spaced, for example, by 16-26 consecutive base pairs, more preferably by 17-24 or 18-23 consecutive base pairs, even more preferably by 19-22 consecutive base pairs, and most preferably by 20 or 21 consecutive base pairs. In a specific example, the mononucleotide protrusions are spaced by 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, or 26 consecutive base pairs. In one example, all these base pairs are typical base pairs. Alternatively, one, two, three, four, five, or six base pairs between the protrusions may be G:U base pairs. The precursor RNA molecule may contain two or more such double-stranded RNA regions, for example, leading RNA structures.
[0114] In one embodiment of a longer dsRNA region having at least 65 base pairs, the precursor RNA molecule lacks the linker RNA sequence (L), and the first RNA strand (D) and the second RNA strand (F) hybridize to form the double-stranded RNA region (B). Such precursor RNA molecules can be readily produced in cell-free systems, for example, in vitro. In one embodiment, the first RNA strand (D) comprises a first RNA sequence (E) of at least 65 consecutive ribonucleotides, and the second RNA strand (F) comprises a second RNA sequence (G) of at least 68 consecutive ribonucleotides.
[0115] The first RNA sequence (E) hybridizes with the second RNA sequence (G) through base pairing between all 65 consecutive ribonucleotides of the first RNA sequence (E) and 65 consecutive ribonucleotides of the second RNA sequence (G) out of 68 consecutive ribonucleotides, thereby forming a portion (C) of the double-stranded RNA region (B).
[0116] In the portion (C) of the double-stranded RNA region (B), three of the 68 consecutive ribonucleotides in (G) are non-base-paired, thereby forming a single ribonucleotide protrusion in the portion (C) of the double-stranded RNA region (B).
[0117] Each of the protrusions is immediately followed by a ribonucleotide, which is base-paired in the portion (C) of the double-stranded RNA region (B).
[0118] The precursor RNA molecule can be cleaved in eukaryotic cells by one or more ribonucleases (RNases) to produce multiple different double-stranded RNA molecules (P). Each of the multiple different double-stranded RNA molecules (P) consists of a sense RNA sequence (H) of 21 consecutive ribonucleotides and an antisense RNA sequence (J) of 22 consecutive ribonucleotides.
[0119] Each of the plurality of different double-stranded RNA molecules (P) contains at least one of the protrusions, and
[0120] At least some of the different double-stranded RNA molecules (P) have non-overlapping antisense RNA sequences (J), preferably adjacent to the non-overlapping antisense RNA sequence (J). In this embodiment, the mononucleotide protrusions are preferably separated by 16-26 consecutive base pairs, more preferably by 17-24 or 18-23 consecutive base pairs, even more preferably by 19-22 consecutive base pairs, and most preferably by 20 or 21 consecutive base pairs. In specific examples, the mononucleotide protrusions are separated by 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, or 26 consecutive base pairs. In a preferred example, all these base pairs are typical base pairs. Alternatively, one, two, three, four, five, or six base pairs between the protrusions may be G:U base pairs.
[0121] In the three embodiments described above, the first RNA sequence (E) and the second RNA sequence (G) may be extended to more than 65 and 68 ribonucleotides, respectively. In another embodiment of the first aspect, the first RNA sequence (E) comprises at least 86 consecutive ribonucleotides, and the second RNA sequence (G) comprises at least 90 consecutive ribonucleotides, wherein the first RNA sequence (E) hybridizes with the second RNA sequence (G) through base pairing between at least 82, preferably at least 83, at least 84, at least 85, or at least 86 of the at least 86 consecutive ribonucleotides of the first RNA sequence (E) and at least 82, preferably at least 83, at least 84, at least 85, or at least 86 of the at least 90 consecutive ribonucleotides of the second RNA sequence (G).
[0122] In another embodiment of the first aspect, the first RNA chain (D) comprises a first RNA sequence (E) of at least 86 consecutive ribonucleotides, and the second RNA chain (F) comprises a second RNA sequence (G) of at least 90 consecutive ribonucleotides.
[0123] The first RNA sequence (E) hybridizes with the second RNA sequence (G) through base pairing between all 86 consecutive ribonucleotides of the first RNA sequence (E) and 86 consecutive ribonucleotides of the 90 consecutive ribonucleotides of the second RNA sequence (G), thereby forming a portion (C) of the double-stranded RNA region (B).
[0124] In the portion (C) of the double-stranded RNA region (B), four of the 90 consecutive ribonucleotides in (G) are non-base-paired, thereby forming a single ribonucleotide protrusion in the portion (C) of the double-stranded RNA region (B).
[0125] Each of the protrusions is immediately followed by a ribonucleotide, which is base-paired in the portion (C) of the double-stranded RNA region (B).
[0126] The precursor RNA molecule can be cleaved in eukaryotic cells by one or more ribonucleases (RNases) to produce multiple different double-stranded RNA molecules (P). Each of the multiple different double-stranded RNA molecules (P) consists of a sense RNA sequence (H) of 21 consecutive ribonucleotides and an antisense RNA sequence (J) of 22 consecutive ribonucleotides.
[0127] Each of the plurality of different double-stranded RNA molecules (P) contains at least one of the protrusions, and
[0128] At least some of the different double-stranded RNA molecules (P) have non-overlapping antisense RNA sequences (J), preferably adjacent to the non-overlapping antisense RNA sequence (J). In this embodiment and the foregoing embodiments, the mononucleotide protrusions are preferably periodically spaced, for example, by 16-26 consecutive base pairs, more preferably by 17-24 or 18-23 consecutive base pairs, even more preferably by 19-22 consecutive base pairs, most preferably by 20 or 21 consecutive base pairs, or on average by about 21 base pairs. In a specific example, the mononucleotide protrusions are independently spaced by 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, or 26 consecutive base pairs. In one example, all these base pairs are typical base pairs. Alternatively, one, two, three, four, five, or six base pairs between the protrusions may be G:U base pairs. The precursor RNA molecule may contain two or more such double-stranded RNA regions, for example, leading RNA structures.
[0129] In one embodiment of a longer dsRNA region having at least 86 base pairs, the precursor RNA molecule lacks the linker RNA sequence (L), and the first RNA strand (D) and the second RNA strand (F) hybridize to form the double-stranded RNA region (B). Such precursor RNA molecules can be readily produced in cell-free systems, for example, in vitro. In one embodiment, the first RNA strand (D) comprises a first RNA sequence (E) of at least 86 consecutive ribonucleotides, and the second RNA strand (F) comprises a second RNA sequence (G) of at least 90 consecutive ribonucleotides.
[0130] The first RNA sequence (E) hybridizes with the second RNA sequence (G) through base pairing between all 86 consecutive ribonucleotides of the first RNA sequence (E) and 86 consecutive ribonucleotides of the 90 consecutive ribonucleotides of the second RNA sequence (G), thereby forming a portion (C) of the double-stranded RNA region (B).
[0131] In the portion (C) of the double-stranded RNA region (B), four of the 86 consecutive ribonucleotides in (G) are non-base-paired, thereby forming a single ribonucleotide protrusion in the portion (C) of the double-stranded RNA region (B).
[0132] Each of the protrusions is immediately followed by a ribonucleotide, which is base-paired in the portion (C) of the double-stranded RNA region (B).
[0133] The precursor RNA molecule can be cleaved in eukaryotic cells by one or more ribonucleases (RNases) to produce multiple different double-stranded RNA molecules (P). Each of the multiple different double-stranded RNA molecules (P) consists of a sense RNA sequence (H) of 21 consecutive ribonucleotides and an antisense RNA sequence (J) of 22 consecutive ribonucleotides.
[0134] Each of the plurality of different double-stranded RNA molecules (P) contains at least one of the protrusions, and
[0135] At least some of the different double-stranded RNA molecules (P) have non-overlapping antisense RNA sequences (J), preferably adjacent to the non-overlapping antisense RNA sequence (J). In this embodiment, the mononucleotide protrusions are preferably separated by 16-26 consecutive base pairs, more preferably by 17-24 or 18-23 consecutive base pairs, even more preferably by 19-22 consecutive base pairs, most preferably by 20 or 21 consecutive base pairs, or on average by about 21 base pairs. In specific examples, the mononucleotide protrusions are independently separated by 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, or 26 consecutive base pairs. In a preferred example, all these base pairs are typical base pairs. Alternatively, one, two, three, four, five, or six base pairs between the protrusions may be G:U base pairs.
[0136] In the three embodiments described above, the first RNA sequence (E) and the second RNA sequence (G) may be extended to lengths of 86 and 90 ribonucleotides, respectively. In another embodiment of the first aspect, the first RNA sequence (E) comprises at least 107 consecutive ribonucleotides, and the second RNA sequence (G) comprises at least 112 consecutive ribonucleotides, wherein the first RNA sequence (E) hybridizes with the second RNA sequence (G) through base pairing between at least 102, preferably at least 103, at least 104, at least 105, at least 106, or at least 107 consecutive ribonucleotides of the first RNA sequence (E) and at least 102, preferably at least 103, at least 104, at least 105, at least 106, or at least 107 consecutive ribonucleotides of the second RNA sequence (G) from the at least 112 consecutive ribonucleotides. In this embodiment, at least 5 and at most 10 ribonucleotides of the second RNA sequence are non-base-paired and form protrusions, preferably mononucleotide protrusions.
[0137] In another embodiment of the first aspect, the first RNA chain (D) comprises a first RNA sequence (E) of at least 107 consecutive ribonucleotides, and the second RNA chain (F) comprises a second RNA sequence (G) of at least 112 consecutive ribonucleotides.
[0138] The first RNA sequence (E) hybridizes with the second RNA sequence (G) through base pairing between all 107 consecutive ribonucleotides of the first RNA sequence (E) and 107 consecutive ribonucleotides of the 112 consecutive ribonucleotides of the second RNA sequence (G), thereby forming a portion (C) of the double-stranded RNA region (B).
[0139] In the portion (C) of the double-stranded RNA region (B), five of the 112 consecutive ribonucleotides in (G) are non-base-paired, thereby forming a single ribonucleotide protrusion in the portion (C) of the double-stranded RNA region (B).
[0140] Each of the protrusions is immediately followed by a ribonucleotide, which is base-paired in the portion (C) of the double-stranded RNA region (B).
[0141] The precursor RNA molecule can be cleaved in eukaryotic cells by one or more ribonucleases (RNases) to produce multiple different double-stranded RNA molecules (P). Each of the multiple different double-stranded RNA molecules (P) consists of a sense RNA sequence (H) of 21 consecutive ribonucleotides and an antisense RNA sequence (J) of 22 consecutive ribonucleotides.
[0142] Each of the plurality of different double-stranded RNA molecules (P) contains at least one of the protrusions, and
[0143] At least some of the different double-stranded RNA molecules (P) have non-overlapping antisense RNA sequences (J), preferably adjacent to the non-overlapping antisense RNA sequence (J). In this embodiment and the foregoing embodiments, the mononucleotide protrusions are preferably periodically spaced, for example, by 16-26 consecutive base pairs, more preferably by 17-24 or 18-23 consecutive base pairs, even more preferably by 19-22 consecutive base pairs, most preferably by 20 or 21 consecutive base pairs, or on average by about 21 base pairs. In a specific example, the mononucleotide protrusions are independently spaced by 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, or 26 consecutive base pairs. In one example, all these base pairs are typical base pairs. Alternatively, one, two, three, four, five, or six base pairs between the protrusions may be G:U base pairs. The precursor RNA molecule may contain two or more such double-stranded RNA regions, for example, leading RNA structures.
[0144] In one embodiment of a longer dsRNA region having at least 107 base pairs, the precursor RNA molecule lacks the linker RNA sequence (L), and the first RNA strand (D) and the second RNA strand (F) hybridize to form the double-stranded RNA region (B). Such precursor RNA molecules can be readily produced in cell-free systems, for example, in vitro. In one embodiment, the first RNA strand (D) comprises a first RNA sequence (E) of at least 107 consecutive ribonucleotides, and the second RNA strand (F) comprises a second RNA sequence (G) of at least 112 consecutive ribonucleotides.
[0145] The first RNA sequence (E) hybridizes with the second RNA sequence (G) through base pairing between all 107 consecutive ribonucleotides of the first RNA sequence (E) and 107 consecutive ribonucleotides of the 112 consecutive ribonucleotides of the second RNA sequence (G), thereby forming a portion (C) of the double-stranded RNA region (B).
[0146] In the portion (C) of the double-stranded RNA region (B), five of the 112 consecutive ribonucleotides in (G) are non-base-paired, thereby forming a single ribonucleotide protrusion in the portion (C) of the double-stranded RNA region (B).
[0147] Each of the protrusions is immediately followed by a ribonucleotide, which is base-paired in the portion (C) of the double-stranded RNA region (B).
[0148] The precursor RNA molecule can be cleaved in eukaryotic cells by one or more ribonucleases (RNases) to produce multiple different double-stranded RNA molecules (P). Each of the multiple different double-stranded RNA molecules (P) consists of a sense RNA sequence (H) of 21 consecutive ribonucleotides and an antisense RNA sequence (J) of 22 consecutive ribonucleotides.
[0149] Each of the plurality of different double-stranded RNA molecules (P) contains at least one of the protrusions, and
[0150] At least some of the different double-stranded RNA molecules (P) have non-overlapping antisense RNA sequences (J), preferably adjacent to the non-overlapping antisense RNA sequence (J). In this embodiment, the mononucleotide protrusions are preferably separated by 16-26 consecutive base pairs, more preferably by 17-24 or 18-23 consecutive base pairs, even more preferably by 19-22 consecutive base pairs, most preferably by 20 or 21 consecutive base pairs, or on average by about 21 base pairs. In specific examples, the mononucleotide protrusions are independently separated by 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, or 26 consecutive base pairs. In a preferred example, all these base pairs are typical base pairs. Alternatively, one, two, three, four, five, or six base pairs between the protrusions may be G:U base pairs.
[0151] In each of the above embodiments, the second RNA sequence (G) is longer than the first RNA sequence (E) because the non-base-paired ribonucleotides protrude from (G). Preferably, the length of the first RNA sequence (E) is 94%-97% or 94%-96% of the length of the second RNA sequence (G). These features can also be applied across the full length of the double-stranded region (B), wherein the portion (C) of the double-stranded region is the full length of (B).
[0152] As those skilled in the art will understand, additional embodiments include a first RNA sequence (E) that hybridizes with a second RNA sequence (G) having a longer continuous ribonucleotide, following the same principles described in the embodiments above.
[0153] In one embodiment, both the first RNA sequence (E) and the second RNA sequence (G) contain at least 100, or at least 150, or at least 200, or at least 250, or at least 300 consecutive ribonucleotides, preferably up to 1000 consecutive ribonucleotides, more preferably up to 800 consecutive ribonucleotides, or even more preferably up to 600 consecutive ribonucleotides. For example, both the first RNA sequence (E) and the second RNA sequence (G) contain consecutive ribonucleotides in the range of 100-1000, 100-800, or 100-600, or in the range of 150-1000, 150-800, or 150-600. In a preferred embodiment, the length of the sense RNA sequence in the dsRNA region is 94%-97% or 94%-96% of the length of the antisense sequence. These features apply to hairpin RNAs and dsRNAs formed by the annealing of two RNA strands, i.e., without a linker loop sequence. Each of these features can also be applied to the second dsRNA region in the precursor RNA molecule (e.g., in ledRNA molecules). In these embodiments, the eukaryotic cell cleaving the precursor RNA molecule (A) is preferably a plant cell, fungal cell, nematode cell, or arthropod cell such as an insect cell, arachnid cell, or decapod cell, or the target RNA molecule is preferably in a plant cell, fungal cell, nematode cell, or arthropod cell such as an insect cell, arachnid cell, or decapod cell.
[0154] Each embodiment in the first aspect may have the following features:
[0155] (i) In at least some of the one or more double-stranded RNA molecules (P), the ribonucleotides 1, 2, and 3 of the sense RNA sequence (H) are paired with ribonucleotides 18, 19, and 20 of the antisense RNA sequence (J), respectively, or
[0156] (ii) In at least some of the one or more double-stranded RNA molecules (P), the ribonucleotides 17, 18, and 19 of the sense RNA sequence (H) are paired with the ribonucleotides 1, 2, and 3 of the antisense RNA sequence (J), respectively, or
[0157] Preferably both (i) and (ii). The exemplary RNA molecule of this embodiment... Figure 53The small figures A and H schematically illustrate product RNA molecules having at least three consecutive base pairs at both ends of the double-stranded region of the product RNA molecule. In further features of these embodiments, the product RNA molecule may have at least four, at least five, or at least six consecutive base pairs at one or both ends of the double-stranded molecule before any protrusion. In these embodiments, any one of those base pairs may be a G:U base pair, preferably one or more ribonucleotides of ribonucleotides 1, 2, and 3 of the antisense sequence (J) participating in the G:U base pair, more preferably one or both ribonucleotides of ribonucleotides 1 and 2 of the antisense sequence (J) participating in the G:U base pair, and even more preferably ribonucleotide 1 of the antisense sequence (J) participating in the G:U base pair. Most preferably, one or more ribonucleotides of ribonucleotides 1, 2 and 3 in the antisense sequence (J) are U ribonucleotides, or one or both ribonucleotides of ribonucleotides 1 and 2 are U ribonucleotides, or ribonucleotide 1 is a U ribonucleotide participating in the G:U base pair.
[0158] Each feature in the embodiments of the first aspect can be applied to a longer double-stranded region to generally provide a combination of multimers or different designs of the product RNA molecule (P). In one embodiment of the first aspect, the precursor RNA molecule is cleaved in a eukaryotic cell by one or more ribonucleases (RNases) to produce a plurality of different double-stranded product RNA molecules (P), each of the plurality of different double-stranded product RNA molecules (P) consisting of a sense RNA sequence (H) of 21 consecutive ribonucleotides from the first RNA sequence (E) and an antisense RNA sequence (J) of 22 consecutive ribonucleotides from the second RNA sequence (G), wherein at least some of the plurality of different double-stranded product RNA molecules (P) have overlapping antisense RNA sequences (J). In another embodiment, at least some of the plurality of different double-stranded product RNA molecules (P) have non-overlapping antisense RNA sequences (J), wherein the population of double-stranded product RNA molecules (P) generated from the precursor RNA molecule includes some overlapping and some non-overlapping antisense RNA sequences (J). Preferably, there are more non-overlapping antisense RNA sequences (J) that are readily present in a longer (> 42 base pairs) double-stranded region (B), wherein each siRNA molecule consisting of a sense RNA sequence of 21 nts hybridized with an antisense RNA sequence of 22 nts is phased along the length of (B).
[0159] In one embodiment of the first aspect, the precursor RNA molecule is cleaved in a eukaryotic cell by one or more ribonucleases (RNases) to produce a plurality of different double-stranded product RNA molecules (P), each of the plurality of different double-stranded product RNA molecules (P) consisting of a sense RNA sequence (H) of 21 consecutive ribonucleotides from a first RNA sequence (E) and an antisense RNA sequence (J) of 22 consecutive ribonucleotides from a second RNA sequence (G), wherein at least some of the different double-stranded product RNA molecules (P) have non-overlapping antisense RNA sequences (J), preferably adjacent to non-overlapping antisense RNA sequences (J). This is readily achieved in a longer double-stranded region (B), wherein siRNA molecules consisting of 21-nt sense RNA sequences, each hybridized to an antisense RNA sequence of 22 nt, are repeated along the length of (B), wherein phase-fixed cleavage by Dicer can occur.
[0160] In one embodiment of the first aspect, the precursor RNA molecule can be cleaved in a eukaryotic cell by one or more ribonucleases (RNases) to produce a plurality of different double-stranded RNA product molecules (P), the plurality of different double-stranded RNA product molecules (P) comprising double-stranded RNA product molecules as defined in two or more of the embodiments described above.
[0161] Each embodiment of the first aspect may have the following feature: at least some of the one or more double-stranded product RNA molecules (P) contain one, two or three non-base-paired ribonucleotides selected from the group consisting of: ribonucleotides 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16 and 17 of the antisense RNA sequence (J).
[0162] Each embodiment of the first aspect may have the following feature: at least some of the one or more double-stranded product RNA molecules (P) contain one or two non-base-paired ribonucleotides selected from the group consisting of: ribonucleotides 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16 and 17 of the antisense RNA sequence (J).
[0163] In a second aspect, the present invention provides an asymmetric precursor RNA molecule processed to produce a siRNA molecule, said siRNA molecule consisting of a sense RNA sequence of 21 nts hybridized with an antisense RNA sequence of 23 nts. Therefore, in this aspect, the present invention provides a precursor RNA molecule (A) comprising at least one double-stranded RNA region (B), wherein:
[0164] (i) The double-stranded RNA region (B) comprises:
[0165] (a) A first RNA strand (D) of at least 23 consecutive ribonucleotides, the first RNA strand (D) comprising a first RNA sequence (E) of at least 21 consecutive ribonucleotides, and
[0166] (b) A second RNA strand (F) of at least 25 consecutive ribonucleotides, wherein the second RNA strand (F) contains a second RNA sequence (G) of at least 23 consecutive ribonucleotides.
[0167] The first RNA chain (D) and the second RNA chain (F) are covalently linked by a linker RNA sequence (L).
[0168] The first RNA sequence (E) hybridizes with the second RNA sequence (G) through base pairing between at least 20 of the at least 21 consecutive ribonucleotides of the first RNA sequence (E) and at least 20 of the at least 23 consecutive ribonucleotides of the second RNA sequence (G), thereby forming at least a portion (C) of the double-stranded RNA region (B).
[0169] In the portion (C) of the double-stranded RNA region (B), two or three of the at least 23 ribonucleotides in (G) are non-base-paired, and zero or one of the at least 21 ribonucleotides in (E) are non-base-paired, thereby forming one, two, three, or four protrusions in the portion (C) of the double-stranded RNA region (B).
[0170] Each of the one, two, three, or four protrusions is immediately followed by a ribonucleotide, which is base-paired in the portion (C) of the double-stranded RNA region (B); and
[0171] (ii) The precursor RNA molecule (A) can be cleaved in eukaryotic cells by one or more ribonucleases (RNases) to produce one or more double-stranded product RNA molecules (P), said one or more double-stranded product RNA molecules (P) consisting of a sense RNA sequence (H) of 21 consecutive ribonucleotides from the first RNA sequence (E) and an antisense RNA sequence (J) of 23 consecutive ribonucleotides from the second RNA strand (F), including at least 21 consecutive ribonucleotides from (G).
[0172] The one or more double-stranded RNA molecules (P) described herein contain one, two, three, or four protrusions.
[0173] In one or more of the double-stranded RNA molecules (P), 18 or 19 of the ribonucleotides 1 to 19 of the sense RNA sequence (H) are each paired with ribonucleotide bases 1 to 21 of the antisense RNA sequence (J).
[0174] In the one or more double-stranded RNA molecules (P), ribonucleotides 20 and 21 of the sense RNA sequence (H) form unpaired 3' overhangs consisting of two ribonucleotides, and ribonucleotides 22 and 23 of the antisense RNA sequence (J) form unpaired 3' overhangs consisting of two ribonucleotides.
[0175] In one or more of the double-stranded RNA molecules (P), ribonucleotides 1 and 2 of the sense RNA sequence (H) are paired with ribonucleotides 20 and 21 of the antisense RNA sequence (J), respectively.
[0176] In one or more of the double-stranded RNA molecules (P), ribonucleotides 18 and 19 of the sense RNA sequence (H) are paired with ribonucleotides 1 and 2 of the antisense RNA sequence (J), respectively. An exemplary RNA molecule in this respect is... Figure 53 The small diagrams I to Q are shown schematically.
[0177] In one embodiment of the second aspect, one or two ribonucleotides of ribonucleotides 1 and 2 in the at least 23 consecutive ribonucleotides of the first RNA chain (D) do not pair with one or two ribonucleotide bases of ribonucleotides 24 and 25 in the at least 25 consecutive ribonucleotides of the second RNA chain (F). The exemplary RNA molecule of this embodiment... Figure 53 The small images O to Q are shown schematically.
[0178] In one embodiment of the second aspect, the first RNA sequence (E) hybridizes with the second RNA sequence (G) via base pairing between at least 20 consecutive ribonucleotides of the at least 21 consecutive ribonucleotides of the first RNA sequence (E) and at least 20 consecutive ribonucleotides of the at least 23 consecutive ribonucleotides of the second RNA sequence (G).
[0179] In the portion (C) of the double-stranded RNA region (B), three ribonucleotides (two of which are consecutive) of the at least 23 ribonucleotides in (G) are non-base-paired, and one ribonucleotide of the at least 21 ribonucleotides in (E) is non-base-paired. These non-base-paired ribonucleotides form two protrusions in the portion (C) of the double-stranded RNA region (B).
[0180] Each protrusion is immediately followed by a ribonucleotide, which is base-paired in the portion (C) of the double-stranded RNA region (B).
[0181] One of the protrusions is formed by a mismatched ribonucleotide pair between the first RNA sequence (E) and the second RNA sequence (G), and the second protrusion is a dinucleotide protrusion.
[0182] The one or more double-stranded RNA molecules (P) contain the protrusions, and
[0183] In one or more of the double-stranded RNA molecules (P), all but one of the ribonucleotides 1 to 19 of the sense RNA sequence (H) is paired with ribonucleotide bases 1 to 21 of the antisense RNA sequence (J). The exemplary RNA molecule of this embodiment... Figure 53 It is illustrated schematically in small figure I.
[0184] In one embodiment of the second aspect, the first RNA sequence (E) hybridizes with the second RNA sequence (G) via base pairing between at least 20 consecutive ribonucleotides of the at least 21 consecutive ribonucleotides of the first RNA sequence (E) and at least 20 consecutive ribonucleotides of the at least 23 consecutive ribonucleotides of the second RNA sequence (G).
[0185] In the portion (C) of the double-stranded RNA region (B), three of the at least 23 ribonucleotides in (G) are non-base-paired, and one of the at least 21 ribonucleotides in (E) is non-base-paired. These non-base-paired ribonucleotides form four single-ribonucleotide protrusions in the portion (C) of the double-stranded RNA region (B).
[0186] Each protrusion is immediately followed by a ribonucleotide, which is base-paired in the portion (C) of the double-stranded RNA region (B).
[0187] The one or more double-stranded RNA molecules (P) contain the protrusions, and
[0188] In one or more of the double-stranded RNA molecules (P), all but one of the ribonucleotides 1 to 19 of the sense RNA sequence (H) is paired with ribonucleotide bases 1 to 21 of the antisense RNA sequence (J). The exemplary RNA molecule of this embodiment... Figure 53 The small diagram J is shown schematically.
[0189] In one embodiment of the second aspect, the first RNA sequence (E) hybridizes with the second RNA sequence (G) through base pairing between at least 21 consecutive ribonucleotides of the at least 21 consecutive ribonucleotides of the first RNA sequence (E) and at least 21 consecutive ribonucleotides of the at least 23 consecutive ribonucleotides of the second RNA sequence (G).
[0190] In the portion (C) of the double-stranded RNA region (B), two consecutive ribonucleotides of the at least 23 ribonucleotides in (G) are non-base-paired, and all ribonucleotides of the at least 21 ribonucleotides in (E) are base-paired. The two non-base-paired ribonucleotides form a dinucleotide protrusion or two mononucleotide protrusions in the portion (C) of the double-stranded RNA region (B).
[0191] The protrusion is immediately followed by a ribonucleotide of the second RNA sequence (G), which is base-paired with the ribonucleotide of the first RNA sequence (E).
[0192] The one or more double-stranded RNA molecules (P) contain the protrusions, and
[0193] In one or more of the double-stranded RNA molecules (P), ribonucleotides 1 to 19 of the sense RNA sequence (H) are each paired with ribonucleotide bases 1 to 21 of the antisense RNA sequence (J). The exemplary RNA molecule of this embodiment... Figure 53 The small diagrams K, N, and P are shown schematically.
[0194] In one embodiment of the second aspect, the first RNA sequence (E) hybridizes with the second RNA sequence (G) through base pairing between at least 21 consecutive ribonucleotides of the at least 21 consecutive ribonucleotides of the first RNA sequence (E) and at least 21 consecutive ribonucleotides of the at least 23 consecutive ribonucleotides of the second RNA sequence (G).
[0195] In the portion (C) of the double-stranded RNA region (B), two of the at least 23 ribonucleotides in (G) are non-base-paired, and all of the at least 21 ribonucleotides in (E) are base-paired. The two non-base-paired ribonucleotides form two single-ribonucleotide protrusions in the portion (C) of the double-stranded RNA region (B).
[0196] Each protrusion is immediately followed by a ribonucleotide of the second RNA sequence (G), which is base-paired with the ribonucleotide of the first RNA sequence (E).
[0197] The one or more double-stranded RNA molecules (P) contain the two protrusions, and
[0198] In one or more of the double-stranded RNA molecules (P), ribonucleotides 1 to 19 of the sense RNA sequence (H) are each paired with ribonucleotide bases 1 to 21 of the antisense RNA sequence (J). The exemplary RNA molecule of this embodiment... Figure 53 small Figure L The diagrams are illustrated in M and Q.
[0199] In one embodiment of the second aspect, the first RNA sequence (E) hybridizes with the second RNA sequence (G) via base pairing between at least 20 consecutive ribonucleotides of the at least 21 consecutive ribonucleotides of the first RNA sequence (E) and at least 20 consecutive ribonucleotides of the at least 23 consecutive ribonucleotides of the second RNA sequence (G).
[0200] In the portion (C) of the double-stranded RNA region (B), three consecutive ribonucleotides of the at least 23 ribonucleotides in (G) are non-base-paired, and one ribonucleotide of the at least 21 ribonucleotides in (E) is non-base-paired, the non-base-paired ribonucleotide forming a protrusion in the portion (C) of the double-stranded RNA region (B).
[0201] The protrusion is immediately followed by a ribonucleotide, which is base-paired in the portion (C) of the double-stranded RNA region (B).
[0202] The one or more double-stranded RNA molecules (P) contain the protrusions, and
[0203] In the one or more double-stranded RNA molecules (P), all but one of the ribonucleotides in the sense RNA sequence (H) from ribonucleotide 1 to 19 are paired with ribonucleotide bases in the antisense RNA sequence (J) from ribonucleotide 1 to 21.
[0204] In one embodiment of the second aspect, the first RNA sequence (E) hybridizes with the second RNA sequence (G) via base pairing between at least 20 consecutive ribonucleotides of the at least 21 consecutive ribonucleotides of the first RNA sequence (E) and at least 20 consecutive ribonucleotides of the at least 23 consecutive ribonucleotides of the second RNA sequence (G).
[0205] In the portion (C) of the double-stranded RNA region (B), three of the at least 23 ribonucleotides in (G) are non-base-paired, and one of the at least 21 ribonucleotides in (E) is non-base-paired, the non-base-paired ribonucleotides forming three protrusions in the portion (C) of the double-stranded RNA region (B).
[0206] Each protrusion is immediately followed by a ribonucleotide, which is base-paired in the portion (C) of the double-stranded RNA region (B).
[0207] One of the protrusions is formed by a mismatched ribonucleotide pair between the first RNA sequence (E) and the second RNA sequence (G), and the other two protrusions are mononucleotide protrusions.
[0208] The one or more double-stranded RNA molecules (P) contain the protrusions, and
[0209] In the one or more double-stranded RNA molecules (P), all but one of the ribonucleotides in the sense RNA sequence (H) from ribonucleotide 1 to 19 are paired with ribonucleotide bases in the antisense RNA sequence (J) from ribonucleotide 1 to 21.
[0210] In one embodiment of the second aspect, the first RNA sequence (E) hybridizes with the second RNA sequence (G) via base pairing between at least 20 consecutive ribonucleotides of the at least 21 consecutive ribonucleotides of the first RNA sequence (E) and at least 20 consecutive ribonucleotides of the at least 23 consecutive ribonucleotides of the second RNA sequence (G).
[0211] In the portion (C) of the double-stranded RNA region (B), three of the at least 23 ribonucleotides in (G) are non-base-paired, and one of the at least 21 ribonucleotides in (E) is non-base-paired. The non-base-paired ribonucleotides form two protrusions in the portion (C) of the double-stranded RNA region (B).
[0212] Each protrusion is immediately followed by a ribonucleotide, which is base-paired in the portion (C) of the double-stranded RNA region (B).
[0213] One of the protrusions is a mononucleotide protrusion, and other non-base-paired ribonucleotides form another protrusion.
[0214] The one or more double-stranded RNA molecules (P) contain the protrusions, and
[0215] In one or more of the double-stranded RNA molecules (P), all but one of the ribonucleotides 1 to 19 of the sense RNA sequence (H) is paired with ribonucleotide bases 1 to 21 of the antisense RNA sequence (J). The exemplary RNA molecule of this embodiment... Figure 53 The small diagram O is shown schematically.
[0216] In one embodiment of the second aspect, the double-stranded RNA region (B) comprises:
[0217] (a) A first RNA strand (D), the first RNA strand (D) comprising a first RNA sequence (E) of at least 23 consecutive ribonucleotides, and
[0218] (b) A second RNA strand (F), wherein the second RNA strand (F) contains a second RNA sequence (G) of at least 25 consecutive ribonucleotides.
[0219] The first RNA chain (D) and the second RNA chain (F) are covalently linked by a linker RNA sequence (L).
[0220] The first RNA sequence (E) hybridizes with the second RNA sequence (G) through base pairing between at least 22 of the at least 23 consecutive ribonucleotides of the first RNA sequence (E) and at least 22 of the at least 25 consecutive ribonucleotides of the second RNA sequence (G), thereby forming at least a portion (C) of the double-stranded RNA region (B).
[0221] In the portion (C) of the double-stranded RNA region (B), two or three of the at least 25 ribonucleotides in (G) are non-base-paired, and zero or one of the at least 23 ribonucleotides in (E) are non-base-paired, thereby forming one, two, three, or four protrusions in the portion (C) of the double-stranded RNA region (B).
[0222] Each of the protrusions is immediately followed by a ribonucleotide, which is base-paired in the portion (C) of the double-stranded RNA region (B). The exemplary RNA molecule of this embodiment... Figure 53 The small diagrams I to Q are shown schematically.
[0223] Therefore, in one embodiment, the present invention provides a precursor RNA molecule (A) comprising at least one double-stranded RNA region (B), wherein:
[0224] (i) The double-stranded RNA region (B) comprises:
[0225] (a) A first RNA strand (D), the first RNA strand (D) comprising a first RNA sequence (E) of at least 23 consecutive ribonucleotides, and
[0226] (b) A second RNA strand (F), wherein the second RNA strand (F) contains a second RNA sequence (G) of at least 25 consecutive ribonucleotides.
[0227] The first RNA chain (D) and the second RNA chain (F) are covalently linked by a linker RNA sequence (L).
[0228] The first RNA sequence (E) hybridizes with the second RNA sequence (G) through base pairing between at least 22 of the at least 23 consecutive ribonucleotides of the first RNA sequence (E) and at least 22 of the at least 25 consecutive ribonucleotides of the second RNA sequence (G), thereby forming at least a portion (C) of the double-stranded RNA region (B).
[0229] In the portion (C) of the double-stranded RNA region (B), two or three of the at least 25 ribonucleotides in (G) are non-base-paired, and zero or one of the at least 23 ribonucleotides in (E) are non-base-paired, thereby forming one, two, three, or four protrusions in the portion (C) of the double-stranded RNA region (B).
[0230] Each of the protrusions is immediately followed by a ribonucleotide, which is base-paired in the portion (C) of the double-stranded RNA region (B); and
[0231] (ii) The precursor RNA molecule (A) can be cleaved in eukaryotic cells by one or more ribonucleases (RNases) to produce one or more double-stranded product RNA molecules (P), said one or more double-stranded product RNA molecules (P) consisting of a sense RNA sequence (H) of 21 consecutive ribonucleotides from the first RNA sequence (E) and an antisense RNA sequence (J) of 23 consecutive ribonucleotides from the second RNA sequence (G).
[0232] The one or more double-stranded RNA molecules (P) described herein contain one, two, three, or four protrusions.
[0233] In one or more of the double-stranded RNA molecules (P), 18 or 19 of the ribonucleotides 1 to 19 of the sense RNA sequence (H) are each paired with ribonucleotide bases 1 to 21 of the antisense RNA sequence (J).
[0234] In the one or more double-stranded RNA molecules (P), ribonucleotides 20 and 21 of the sense RNA sequence (H) form unpaired 3' overhangs consisting of two ribonucleotides, and ribonucleotides 22 and 23 of the antisense RNA sequence (J) form unpaired 3' overhangs consisting of two ribonucleotides.
[0235] In one or more of the double-stranded RNA molecules (P), ribonucleotides 1 and 2 of the sense RNA sequence (H) are paired with ribonucleotides 20 and 21 of the antisense RNA sequence (J), respectively.
[0236] In one or more double-stranded RNA molecules (P), ribonucleotides 18 and 19 of the sense RNA sequence (H) are paired with ribonucleotides 1 and 2 of the antisense RNA sequence (J), respectively.
[0237] In one embodiment of the second aspect, the first RNA sequence (E) hybridizes with the second RNA sequence (G) via base pairing between at least 22 consecutive ribonucleotides of the at least 23 consecutive ribonucleotides of the first RNA sequence (E) and at least 22 consecutive ribonucleotides of the at least 25 consecutive ribonucleotides of the second RNA sequence (G).
[0238] In the portion (C) of the double-stranded RNA region (B), three ribonucleotides (two of which are consecutive) of the at least 25 ribonucleotides in (G) are non-base-paired, and one ribonucleotide of the at least 23 ribonucleotides in (E) is non-base-paired. These non-base-paired ribonucleotides form two protrusions in the portion (C) of the double-stranded RNA region (B).
[0239] Each protrusion is immediately followed by a ribonucleotide, which is base-paired in the portion (C) of the double-stranded RNA region (B).
[0240] One of the protrusions is formed by a mismatched ribonucleotide pair between the first RNA sequence (E) and the second RNA sequence (G), and the second protrusion is a dinucleotide protrusion.
[0241] The one or more double-stranded RNA molecules (P) contain the protrusions, and
[0242] In the one or more double-stranded RNA molecules (P), all but one of the ribonucleotides in the sense RNA sequence (H) from ribonucleotide 1 to 19 are paired with ribonucleotide bases in the antisense RNA sequence (J) from ribonucleotide 1 to 21.
[0243] In one embodiment of the second aspect, the first RNA sequence (E) hybridizes with the second RNA sequence (G) via base pairing between at least 22 consecutive ribonucleotides of the at least 23 consecutive ribonucleotides of the first RNA sequence (E) and at least 22 consecutive ribonucleotides of the at least 25 consecutive ribonucleotides of the second RNA sequence (G).
[0244] In the portion (C) of the double-stranded RNA region (B), three of the at least 25 ribonucleotides in (G) are non-base-paired, and one of the at least 23 ribonucleotides in (E) is non-base-paired. These non-base-paired ribonucleotides form four single-ribonucleotide protrusions in the portion (C) of the double-stranded RNA region (B).
[0245] Each protrusion is immediately followed by a ribonucleotide, which is base-paired in the portion (C) of the double-stranded RNA region (B).
[0246] The one or more double-stranded RNA molecules (P) contain the protrusions, and
[0247] In one or more of the double-stranded RNA molecules (P), all but one of the ribonucleotides 1 to 19 of the sense RNA sequence (H) is paired with ribonucleotide bases 1 to 21 of the antisense RNA sequence (J). The exemplary RNA molecule of this embodiment... Figure 53 The small diagram J is shown schematically.
[0248] In one embodiment of the second aspect, the first RNA sequence (E) hybridizes with the second RNA sequence (G) through base pairing between at least 23 consecutive ribonucleotides of the at least 23 consecutive ribonucleotides of the first RNA sequence (E) and at least 23 consecutive ribonucleotides of the at least 25 consecutive ribonucleotides of the second RNA sequence (G).
[0249] In the portion (C) of the double-stranded RNA region (B), two consecutive ribonucleotides of the at least 25 ribonucleotides in (G) are non-base-paired, and all ribonucleotides of the at least 23 ribonucleotides in (E) are base-paired. The two non-base-paired ribonucleotides form a dinucleotide protrusion in the portion (C) of the double-stranded RNA region (B).
[0250] The protrusion is immediately followed by a ribonucleotide of the second RNA sequence (G), which is base-paired with the ribonucleotide of the first RNA sequence (E).
[0251] The one or more double-stranded RNA molecules (P) contain the protrusions, and
[0252] In one or more of the double-stranded RNA molecules (P), ribonucleotides 1 to 19 of the sense RNA sequence (H) are each paired with ribonucleotide bases 1 to 21 of the antisense RNA sequence (J). The exemplary RNA molecule of this embodiment... Figure 53 The small diagrams K and P are shown schematically.
[0253] In one embodiment of the second aspect, the first RNA sequence (E) hybridizes with the second RNA sequence (G) through base pairing between at least 23 consecutive ribonucleotides of the at least 23 consecutive ribonucleotides of the first RNA sequence (E) and at least 23 consecutive ribonucleotides of the at least 25 consecutive ribonucleotides of the second RNA sequence (G).
[0254] In the portion (C) of the double-stranded RNA region (B), two of the at least 25 ribonucleotides in (G) are non-base-paired, and all of the at least 23 ribonucleotides in (E) are base-paired. The two non-base-paired ribonucleotides form two single-ribonucleotide protrusions in the portion (C) of the double-stranded RNA region (B).
[0255] Each protrusion is immediately followed by a ribonucleotide of the second RNA sequence (G), which is base-paired with the ribonucleotide of the first RNA sequence (E).
[0256] The one or more double-stranded RNA molecules (P) contain the two protrusions, and
[0257] In one or more of the double-stranded RNA molecules (P), ribonucleotides 1 to 19 of the sense RNA sequence (H) are each paired with ribonucleotide bases 1 to 21 of the antisense RNA sequence (J). The exemplary RNA molecule of this embodiment... Figure 53 small Figure L The diagrams are illustrated in M and Q.
[0258] In one embodiment of the second aspect, the first RNA sequence (E) hybridizes with the second RNA sequence (G) via base pairing between at least 22 consecutive ribonucleotides of the at least 23 consecutive ribonucleotides of the first RNA sequence (E) and at least 22 consecutive ribonucleotides of the at least 25 consecutive ribonucleotides of the second RNA sequence (G).
[0259] In the portion (C) of the double-stranded RNA region (B), three consecutive ribonucleotides of the at least 25 ribonucleotides in (G) are non-base-paired, and one ribonucleotide of the at least 23 ribonucleotides in (E) is non-base-paired, the non-base-paired ribonucleotide forming a protrusion in the portion (C) of the double-stranded RNA region (B).
[0260] The protrusion is immediately followed by a ribonucleotide, which is base-paired in the portion (C) of the double-stranded RNA region (B).
[0261] The one or more double-stranded RNA molecules (P) contain the protrusions, and
[0262] In the one or more double-stranded RNA molecules (P), all but one of the ribonucleotides in the sense RNA sequence (H) from ribonucleotide 1 to 19 are paired with ribonucleotide bases in the antisense RNA sequence (J) from ribonucleotide 1 to 21.
[0263] In one embodiment of the second aspect, the first RNA sequence (E) hybridizes with the second RNA sequence (G) via base pairing between at least 22 consecutive ribonucleotides of the at least 23 consecutive ribonucleotides of the first RNA sequence (E) and at least 22 consecutive ribonucleotides of the at least 25 consecutive ribonucleotides of the second RNA sequence (G).
[0264] In the portion (C) of the double-stranded RNA region (B), three of the at least 25 ribonucleotides in (G) are non-base-paired, and one of the at least 23 ribonucleotides in (E) is non-base-paired, the non-base-paired ribonucleotides forming three protrusions in the portion (C) of the double-stranded RNA region (B).
[0265] Each protrusion is immediately followed by a ribonucleotide, which is base-paired in the portion (C) of the double-stranded RNA region (B).
[0266] One of the protrusions is formed by a mismatched ribonucleotide pair between the first RNA sequence (E) and the second RNA sequence (G), and the other two protrusions are mononucleotide protrusions.
[0267] The one or more double-stranded RNA molecules (P) contain the protrusions, and
[0268] In the one or more double-stranded RNA molecules (P), all but one of the ribonucleotides in the sense RNA sequence (H) from ribonucleotide 1 to 19 are paired with ribonucleotide bases in the antisense RNA sequence (J) from ribonucleotide 1 to 21.
[0269] In one embodiment of the second aspect, the first RNA sequence (E) hybridizes with the second RNA sequence (G) via base pairing between at least 22 consecutive ribonucleotides of the at least 23 consecutive ribonucleotides of the first RNA sequence (E) and at least 22 consecutive ribonucleotides of the at least 25 consecutive ribonucleotides of the second RNA sequence (G).
[0270] In the portion (C) of the double-stranded RNA region (B), three of the at least 25 ribonucleotides in (G) are non-base-paired, and one of the at least 23 ribonucleotides in (E) is non-base-paired, the non-base-paired ribonucleotides forming two protrusions in the portion (C) of the double-stranded RNA region (B).
[0271] Each protrusion is immediately followed by a ribonucleotide, which is base-paired in the portion (C) of the double-stranded RNA region (B).
[0272] One of the protrusions is a mononucleotide protrusion, and other non-base-paired ribonucleotides form another protrusion.
[0273] The one or more double-stranded RNA molecules (P) contain the protrusions, and
[0274] In the one or more double-stranded RNA molecules (P), all but one of the ribonucleotides in the sense RNA sequence (H) from ribonucleotide 1 to 19 are paired with ribonucleotide bases in the antisense RNA sequence (J) from ribonucleotide 1 to 21.
[0275] Each embodiment in the second aspect may have the following features:
[0276] (i) In at least some of the one or more double-stranded RNA product molecules (P), the ribonucleotides 1, 2, and 3 of the sense RNA sequence (H) are paired with ribonucleotides 19, 20, and 21 of the antisense RNA sequence (J), respectively, or
[0277] (ii) In at least some of the one or more double-stranded RNA molecules (P), the ribonucleotides 17, 18, and 19 of the sense RNA sequence (H) are paired with the ribonucleotides 1, 2, and 3 of the antisense RNA sequence (J), respectively, or
[0278] Preferably both (i) and (ii). The exemplary RNA molecule of this embodiment... Figure 53 The small figures I through Q schematically illustrate product RNA molecules having at least three consecutive base pairs at both ends of the double-stranded region of the product RNA molecule. In further features of these embodiments, the product RNA molecule may have at least four, at least five, or at least six consecutive base pairs at one or both ends of the double-stranded molecule before any protrusion. In these embodiments, any one of those base pairs may be a G:U base pair, preferably one or more ribonucleotides of ribonucleotides 1, 2, and 3 of the antisense sequence (J) participating in the G:U base pair, more preferably one or both ribonucleotides of ribonucleotides 1 and 2 of the antisense sequence (J) participating in the G:U base pair, and even more preferably ribonucleotide 1 of the antisense sequence (J) participating in the G:U base pair. Most preferably, one or more ribonucleotides of ribonucleotides 1, 2 and 3 in the antisense sequence (J) are U ribonucleotides, or one or both ribonucleotides of ribonucleotides 1 and 2 are U ribonucleotides, or ribonucleotide 1 is a U ribonucleotide participating in the G:U base pair.
[0279] The design principle of the asymmetric precursor RNA molecule described in the second aspect can be applied in an extended manner to longer double-stranded regions. For example, the non-base-paired ribonucleotides in the second RNA sequence (G) (antisense sequence) can be arranged in a periodic manner to provide a population of product RNA molecules (P) having multiple 23 nt non-overlapping antisense RNA sequences (J). Such precursor RNA molecules are particularly useful for reducing the expression of target RNA molecules in plant cells, fungal cells, or nematode cells. They can also be used in other invertebrate cells such as arthropod cells or insect cells, or in non-mammalian vertebrate cells. They can be produced in plant cells to reduce insect target RNA molecules or fungal pathogen or nematode target RNA molecules, or applied locally to plants or insects to reduce target RNA molecules. For example, in one embodiment of the second aspect, the first RNA sequence (E) contains at least 44 consecutive ribonucleotides, and the second RNA sequence (G) contains at least 48 consecutive ribonucleotides.
[0280] The first RNA sequence (E) hybridizes with the second RNA sequence (G) through base pairing between at least 42, preferably at least 43, or at least 44 consecutive ribonucleotides of the first RNA sequence (E) and at least 42, preferably at least 43, or at least 44 consecutive ribonucleotides of the second RNA sequence (G) from at least 48 consecutive ribonucleotides.
[0281] In the portion (C) of the double-stranded RNA region (B), 4, 5, or 6 of the at least 48 consecutive ribonucleotides in (G) are non-base-paired, and 0, 1, or 2 of the at least 44 consecutive ribonucleotides in (E) are non-base-paired, thereby forming a protrusion in the portion (C) of the double-stranded RNA region (B).
[0282] Each of the protrusions is immediately followed by a ribonucleotide, which is base-paired in the portion (C) of the double-stranded RNA region (B).
[0283] The precursor RNA molecule can be cleaved in eukaryotic cells by one or more ribonucleases (RNases) to produce multiple different double-stranded RNA molecules (P). Each of the multiple different double-stranded RNA molecules (P) consists of a sense RNA sequence (H) of 21 consecutive ribonucleotides and an antisense RNA sequence (J) of 23 consecutive ribonucleotides.
[0284] Each of the plurality of different double-stranded RNA molecules (P) contains at least one of the protrusions, and
[0285] At least some of the different double-stranded RNA molecules (P) contain non-overlapping antisense RNA sequences (J), preferably adjacent to non-overlapping antisense RNA sequences (J).
[0286] In another embodiment of the second aspect, the first RNA chain (D) comprises a first RNA sequence (E) of at least 44 consecutive ribonucleotides, and the second RNA chain (F) comprises a second RNA sequence (G) of at least 48 consecutive ribonucleotides.
[0287] The first RNA sequence (E) hybridizes with the second RNA sequence (G) through base pairing between all 44 consecutive ribonucleotides of the first RNA sequence (E) and 44 consecutive ribonucleotides of the second RNA sequence (G) out of 48 consecutive ribonucleotides, thereby forming a portion (C) of the double-stranded RNA region (B).
[0288] In the portion (C) of the double-stranded RNA region (B), four of the 48 consecutive ribonucleotides in (G) are non-base-paired, thereby forming two, three, or four protrusions in the portion (C) of the double-stranded RNA region (B).
[0289] Each of the protrusions is immediately followed by a ribonucleotide, which is base-paired in the portion (C) of the double-stranded RNA region (B).
[0290] The precursor RNA molecule can be cleaved in eukaryotic cells by one or more ribonucleases (RNases) to produce multiple different double-stranded RNA molecules (P). Each of the multiple different double-stranded RNA molecules (P) consists of a sense RNA sequence (H) of 21 consecutive ribonucleotides and an antisense RNA sequence (J) of 23 consecutive ribonucleotides.
[0291] Each of the plurality of different double-stranded RNA molecules (P) contains at least one of the protrusions, and
[0292] At least some of the different double-stranded RNA molecules (P) have non-overlapping antisense RNA sequences (J), preferably adjacent to non-overlapping antisense RNA sequences (J). In this embodiment and the foregoing embodiments, the protrusions are preferably separated by 6-16 consecutive base pairs, more preferably by 7-15 or 8-14 consecutive base pairs, even more preferably by 9-13 consecutive base pairs, and most preferably by 10, 11, or 12 consecutive base pairs. In a specific example, the protrusions are separated by 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, or 16 consecutive base pairs. In one embodiment, all these base pairs are typical base pairs. Alternatively, one, two, three, four, or five base pairs among the base pairs between the protrusions are G:U base pairs. The precursor RNA molecule may contain two or more such double-stranded RNA regions, for example, including ledRNA structures.
[0293] In one embodiment of a longer dsRNA region having at least 44 base pairs, the precursor RNA molecule lacks the linker RNA sequence (L), and the first RNA strand (D) and the second RNA strand (F) hybridize to form the double-stranded RNA region (B). Such precursor RNA molecules can be readily produced in cell-free systems, for example, in vitro. In one embodiment, the first RNA strand (D) comprises a first RNA sequence (E) of at least 44 consecutive ribonucleotides, and the second RNA strand (F) comprises a second RNA sequence (G) of at least 48 consecutive ribonucleotides.
[0294] The first RNA sequence (E) hybridizes with the second RNA sequence (G) through base pairing between all 44 consecutive ribonucleotides of the first RNA sequence (E) and 44 consecutive ribonucleotides of the second RNA sequence (G) out of 48 consecutive ribonucleotides, thereby forming a portion (C) of the double-stranded RNA region (B).
[0295] In the portion (C) of the double-stranded RNA region (B), four of the 48 consecutive ribonucleotides in (G) are non-base-paired, thereby forming two, three, or four protrusions in the portion (C) of the double-stranded RNA region (B).
[0296] Each of the protrusions is immediately followed by a ribonucleotide, which is base-paired in the portion (C) of the double-stranded RNA region (B).
[0297] The precursor RNA molecule can be cleaved in eukaryotic cells by one or more ribonucleases (RNases) to produce multiple different double-stranded RNA molecules (P). Each of the multiple different double-stranded RNA molecules (P) consists of a sense RNA sequence (H) of 21 consecutive ribonucleotides and an antisense RNA sequence (J) of 23 consecutive ribonucleotides.
[0298] Each of the plurality of different double-stranded RNA molecules (P) contains at least one of the protrusions, and
[0299] At least some of the different double-stranded RNA molecules (P) have non-overlapping antisense RNA sequences (J), preferably adjacent to non-overlapping antisense RNA sequences (J). In this embodiment, the protrusions are preferably separated by 6-16 consecutive base pairs, more preferably by 7-15 or 8-14 consecutive base pairs, even more preferably by 9-13 consecutive base pairs, and most preferably by 10, 11, or 12 consecutive base pairs. In specific examples, the protrusions are separated by 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, or 16 consecutive base pairs. In a preferred example, all these base pairs are typical base pairs. Alternatively, one, two, three, four, or five base pairs among the base pairs between the protrusions are G:U base pairs.
[0300] For example, in one embodiment, the first RNA sequence (E) comprises at least 65 consecutive ribonucleotides, and the second RNA sequence (G) comprises at least 71 consecutive ribonucleotides, wherein the first RNA sequence (E) hybridizes with the second RNA sequence (G) through base pairing between at least 62, preferably at least 63, at least 64, or at least 65 consecutive ribonucleotides of the first RNA sequence (E) and at least 62, preferably at least 63, at least 64, or at least 65 consecutive ribonucleotides of the second RNA sequence (G) out of the at least 71 consecutive ribonucleotides.
[0301] In another embodiment of the second aspect, the first RNA chain (D) comprises a first RNA sequence (E) of at least 65 consecutive ribonucleotides, and the second RNA chain (F) comprises a second RNA sequence (G) of at least 71 consecutive ribonucleotides.
[0302] The first RNA sequence (E) hybridizes with the second RNA sequence (G) through base pairing between all 65 consecutive ribonucleotides of the first RNA sequence (E) and 65 consecutive ribonucleotides of the 71 consecutive ribonucleotides of the second RNA sequence (G), thereby forming a portion (C) of the double-stranded RNA region (B).
[0303] In the portion (C) of the double-stranded RNA region (B), six of the 71 consecutive ribonucleotides in (G) are non-base-paired, thereby forming three, four, five, or six protrusions in the portion (C) of the double-stranded RNA region (B).
[0304] Each of the protrusions is immediately followed by a ribonucleotide, which is base-paired in the portion (C) of the double-stranded RNA region (B).
[0305] The precursor RNA molecule can be cleaved in eukaryotic cells by one or more ribonucleases (RNases) to produce multiple different double-stranded RNA molecules (P). Each of the multiple different double-stranded RNA molecules (P) consists of a sense RNA sequence (H) of 21 consecutive ribonucleotides and an antisense RNA sequence (J) of 23 consecutive ribonucleotides.
[0306] Each of the plurality of different double-stranded RNA molecules (P) contains at least one of the protrusions, and
[0307] At least some of the different double-stranded RNA molecules (P) have non-overlapping antisense RNA sequences (J), preferably adjacent to each other. In this embodiment and the foregoing embodiments, the protrusions are preferably periodically spaced, for example, by 6-16 consecutive base pairs, more preferably by 7-15 or 8-14 consecutive base pairs, even more preferably by 9-13 consecutive base pairs, and most preferably by 10, 11, or 12 consecutive base pairs. In a specific example, the protrusions are spaced by 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, or 16 consecutive base pairs. In one example, all these base pairs are typical base pairs. Alternatively, one, two, three, four, or five base pairs among the base pairs between the protrusions are G:U base pairs. The precursor RNA molecule may contain two or more such double-stranded RNA regions, for example, including ledRNA structures.
[0308] In one embodiment of a longer dsRNA region having at least 65 base pairs, the precursor RNA molecule lacks the linker RNA sequence (L), and the first RNA strand (D) and the second RNA strand (F) hybridize to form the double-stranded RNA region (B). Such precursor RNA molecules can be readily produced in cell-free systems, for example, in vitro. In one embodiment, the first RNA strand (D) comprises a first RNA sequence (E) of at least 65 consecutive ribonucleotides, and the second RNA strand (F) comprises a second RNA sequence (G) of at least 71 consecutive ribonucleotides.
[0309] The first RNA sequence (E) hybridizes with the second RNA sequence (G) through base pairing between all 65 consecutive ribonucleotides of the first RNA sequence (E) and 65 consecutive ribonucleotides of the 71 consecutive ribonucleotides of the second RNA sequence (G), thereby forming a portion (C) of the double-stranded RNA region (B).
[0310] In the portion (C) of the double-stranded RNA region (B), six of the 71 consecutive ribonucleotides in (G) are non-base-paired, thereby forming three, four, five, or six protrusions in the portion (C) of the double-stranded RNA region (B).
[0311] Each of the protrusions is immediately followed by a ribonucleotide, which is base-paired in the portion (C) of the double-stranded RNA region (B).
[0312] The precursor RNA molecule can be cleaved in eukaryotic cells by one or more ribonucleases (RNases) to produce multiple different double-stranded RNA molecules (P). Each of the multiple different double-stranded RNA molecules (P) consists of a sense RNA sequence (H) of 21 consecutive ribonucleotides and an antisense RNA sequence (J) of 23 consecutive ribonucleotides.
[0313] Each of the plurality of different double-stranded RNA molecules (P) contains at least one of the protrusions, and
[0314] At least some of the different double-stranded RNA molecules (P) have non-overlapping antisense RNA sequences (J), preferably adjacent to non-overlapping antisense RNA sequences (J). In this embodiment, the protrusions are preferably separated by 6-16 consecutive base pairs, more preferably by 7-15 or 8-14 consecutive base pairs, even more preferably by 9-13 consecutive base pairs, and most preferably by 10, 11, or 12 consecutive base pairs. In specific examples, the protrusions are separated by 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, or 16 consecutive base pairs. In a preferred example, all these base pairs are typical base pairs. Alternatively, one, two, three, four, or five base pairs among the base pairs between the protrusions are G:U base pairs.
[0315] In the three embodiments described above, the first RNA sequence (E) and the second RNA sequence (G) may be extended to more than 65 and 71 ribonucleotides, respectively. In another embodiment, the first RNA sequence (E) comprises at least 86 consecutive ribonucleotides, and the second RNA sequence (G) comprises at least 94 consecutive ribonucleotides, wherein the first RNA sequence (E) hybridizes with the second RNA sequence (G) through base pairing between at least 82, preferably at least 83, at least 84, at least 85, or at least 86 of the at least 86 consecutive ribonucleotides of the first RNA sequence (E) and at least 82, preferably at least 83, at least 84, at least 85, or at least 86 of the at least 94 consecutive ribonucleotides of the second RNA sequence (G).
[0316] In another embodiment of the second aspect, the first RNA chain (D) comprises a first RNA sequence (E) of at least 86 consecutive ribonucleotides, and the second RNA chain (F) comprises a second RNA sequence (G) of at least 94 consecutive ribonucleotides.
[0317] The first RNA sequence (E) hybridizes with the second RNA sequence (G) through base pairing between all 86 consecutive ribonucleotides of the first RNA sequence (E) and 86 consecutive ribonucleotides of the 94 consecutive ribonucleotides of the second RNA sequence (G), thereby forming a portion (C) of the double-stranded RNA region (B).
[0318] In the portion (C) of the double-stranded RNA region (B), 8 of the 94 consecutive ribonucleotides in (G) are non-base-paired, thereby forming 4-8 protrusions in the portion (C) of the double-stranded RNA region (B).
[0319] Each of the protrusions is immediately followed by a ribonucleotide, which is base-paired in the portion (C) of the double-stranded RNA region (B).
[0320] The precursor RNA molecule can be cleaved in eukaryotic cells by one or more ribonucleases (RNases) to produce multiple different double-stranded RNA molecules (P). Each of the multiple different double-stranded RNA molecules (P) consists of a sense RNA sequence (H) of 21 consecutive ribonucleotides and an antisense RNA sequence (J) of 23 consecutive ribonucleotides.
[0321] Each of the plurality of different double-stranded RNA molecules (P) contains at least one of the protrusions, and
[0322] At least some of the different double-stranded RNA molecules (P) have non-overlapping antisense RNA sequences (J), preferably adjacent to each other. In this embodiment and the foregoing embodiments, the protrusions are preferably periodically spaced, for example, by 6-16 consecutive base pairs, more preferably by 7-15 or 8-14 consecutive base pairs, even more preferably by 9-13 consecutive base pairs, and most preferably by 10, 11, or 12 consecutive base pairs. In a specific example, the protrusions are spaced by 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, or 16 consecutive base pairs. In a preferred embodiment, all these base pairs are typical base pairs. Alternatively, one, two, three, four, or five base pairs among the base pairs between the protrusions are G:U base pairs. The precursor RNA molecule may contain two or more such double-stranded RNA regions, for example, including ledRNA structures.
[0323] In one embodiment of a longer dsRNA region having at least 86 base pairs, the precursor RNA molecule lacks the linker RNA sequence (L), and the first RNA strand (D) and the second RNA strand (F) hybridize to form the double-stranded RNA region (B). Such precursor RNA molecules can be readily produced in cell-free systems, for example, in vitro. In one embodiment, the first RNA strand (D) comprises a first RNA sequence (E) of at least 86 consecutive ribonucleotides, and the second RNA strand (F) comprises a second RNA sequence (G) of at least 94 consecutive ribonucleotides.
[0324] The first RNA sequence (E) hybridizes with the second RNA sequence (G) through base pairing between all 86 consecutive ribonucleotides of the first RNA sequence (E) and 86 consecutive ribonucleotides of the 94 consecutive ribonucleotides of the second RNA sequence (G), thereby forming a portion (C) of the double-stranded RNA region (B).
[0325] In the portion (C) of the double-stranded RNA region (B), 8 of the 94 consecutive ribonucleotides in (G) are non-base-paired, thereby forming 4-8 protrusions in the portion (C) of the double-stranded RNA region (B).
[0326] Each of the protrusions is immediately followed by a ribonucleotide, which is base-paired in the portion (C) of the double-stranded RNA region (B).
[0327] The precursor RNA molecule can be cleaved in eukaryotic cells by one or more ribonucleases (RNases) to produce multiple different double-stranded RNA molecules (P). Each of the multiple different double-stranded RNA molecules (P) consists of a sense RNA sequence (H) of 21 consecutive ribonucleotides and an antisense RNA sequence (J) of 23 consecutive ribonucleotides.
[0328] Each of the plurality of different double-stranded RNA molecules (P) contains at least one of the protrusions, and
[0329] At least some of the different double-stranded RNA molecules (P) have non-overlapping antisense RNA sequences (J), preferably adjacent to non-overlapping antisense RNA sequences (J). In this embodiment, the protrusions are preferably separated by 6-16 consecutive base pairs, more preferably by 7-15 or 8-14 consecutive base pairs, even more preferably by 9-13 consecutive base pairs, and most preferably by 10, 11, or 12 consecutive base pairs. In specific examples, the protrusions are separated by 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, or 16 consecutive base pairs. In a preferred example, all these base pairs are typical base pairs. Alternatively, one, two, three, four, or five base pairs among the base pairs between the protrusions are G:U base pairs. In a preferred embodiment, all of these base pairs are typical base pairs. Alternatively, one, two, three, four, or five base pairs among the base pairs between the protrusions may be G:U base pairs.
[0330] In the three embodiments described above, the first RNA sequence (E) and the second RNA sequence (G) may be extended to lengths of 86 and 94 ribonucleotides, respectively. In another embodiment of the second aspect, the first RNA sequence (E) comprises at least 107 consecutive ribonucleotides, and the second RNA sequence (G) comprises at least 117 consecutive ribonucleotides, wherein the first RNA sequence (E) hybridizes with the second RNA sequence (G) through base pairing between at least 102, preferably at least 103, at least 104, at least 105, at least 106, or at least 107 of the at least 107 consecutive ribonucleotides of the first RNA sequence (E) and at least 102, preferably at least 103, at least 104, at least 105, at least 106, or at least 107 of the at least 117 consecutive ribonucleotides of the second RNA sequence (G). In this embodiment, at least 10 and at most 15 ribonucleotides of the second RNA sequence are non-base-paired and form bumps, preferably at least some of the bumps are mononucleotide bumps.
[0331] In another embodiment of the second aspect, the first RNA chain (D) comprises a first RNA sequence (E) of at least 107 consecutive ribonucleotides, and the second RNA chain (F) comprises a second RNA sequence (G) of at least 117 consecutive ribonucleotides.
[0332] The first RNA sequence (E) hybridizes with the second RNA sequence (G) through base pairing between all 107 consecutive ribonucleotides of the first RNA sequence (E) and 107 consecutive ribonucleotides of the 117 consecutive ribonucleotides of the second RNA sequence (G), thereby forming a portion (C) of the double-stranded RNA region (B).
[0333] In the portion (C) of the double-stranded RNA region (B), 10 of the 117 consecutive ribonucleotides in (G) are non-base-paired, thereby forming 5-10 protrusions in the portion (C) of the double-stranded RNA region (B).
[0334] Each of the protrusions is immediately followed by a ribonucleotide, which is base-paired in the portion (C) of the double-stranded RNA region (B).
[0335] The precursor RNA molecule can be cleaved in eukaryotic cells by one or more ribonucleases (RNases) to produce multiple different double-stranded RNA molecules (P). Each of the multiple different double-stranded RNA molecules (P) consists of a sense RNA sequence (H) of 21 consecutive ribonucleotides and an antisense RNA sequence (J) of 23 consecutive ribonucleotides.
[0336] Each of the plurality of different double-stranded RNA molecules (P) contains at least one of the protrusions, and
[0337] At least some of the different double-stranded RNA molecules (P) have non-overlapping antisense RNA sequences (J), preferably adjacent to each other. In this embodiment and the foregoing embodiments, the protrusions are preferably periodically spaced, for example, by 6-16 consecutive base pairs, more preferably by 7-15 or 8-14 consecutive base pairs, even more preferably by 9-13 consecutive base pairs, and most preferably by 10, 11, or 12 consecutive base pairs. In a specific example, the protrusions are spaced by 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, or 16 consecutive base pairs. In one example, all these base pairs are typical base pairs. Alternatively, one, two, three, four, or five base pairs among the base pairs between the protrusions are G:U base pairs. The precursor RNA molecule may contain two or more such double-stranded RNA regions, for example, including ledRNA structures.
[0338] In one embodiment of a longer dsRNA region having at least 107 base pairs, the precursor RNA molecule lacks the linker RNA sequence (L), and the first RNA strand (D) and the second RNA strand (F) hybridize to form the double-stranded RNA region (B). Such precursor RNA molecules can be readily produced in cell-free systems, for example, in vitro. In one embodiment, the first RNA strand (D) comprises a first RNA sequence (E) of at least 107 consecutive ribonucleotides, and the second RNA strand (F) comprises a second RNA sequence (G) of at least 117 consecutive ribonucleotides.
[0339] The first RNA sequence (E) hybridizes with the second RNA sequence (G) through base pairing between all 107 consecutive ribonucleotides of the first RNA sequence (E) and 107 consecutive ribonucleotides of the 117 consecutive ribonucleotides of the second RNA sequence (G), thereby forming a portion (C) of the double-stranded RNA region (B).
[0340] In the portion (C) of the double-stranded RNA region (B), 10 of the 117 consecutive ribonucleotides in (G) are non-base-paired, thus forming a protrusion in the portion (C) of the double-stranded RNA region (B).
[0341] Each of the protrusions is immediately followed by a ribonucleotide, which is base-paired in the portion (C) of the double-stranded RNA region (B).
[0342] The precursor RNA molecule can be cleaved in eukaryotic cells by one or more ribonucleases (RNases) to produce multiple different double-stranded RNA molecules (P). Each of the multiple different double-stranded RNA molecules (P) consists of a sense RNA sequence (H) of 21 consecutive ribonucleotides and an antisense RNA sequence (J) of 23 consecutive ribonucleotides.
[0343] Each of the plurality of different double-stranded RNA molecules (P) contains at least one of the protrusions, and
[0344] At least some of the different double-stranded RNA molecules (P) have non-overlapping antisense RNA sequences (J), preferably adjacent to non-overlapping antisense RNA sequences (J). In this embodiment, the protrusions are preferably separated by 6-16 consecutive base pairs, more preferably by 7-15 or 8-14 consecutive base pairs, even more preferably by 9-13 consecutive base pairs, and most preferably by 10, 11, or 12 consecutive base pairs. In specific examples, the protrusions are separated by 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, or 16 consecutive base pairs. In a preferred example, all these base pairs are typical base pairs. Alternatively, one, two, three, four, or five base pairs among the base pairs between the protrusions are G:U base pairs.
[0345] In each of the above embodiments of the second aspect, the second RNA sequence (G) is longer than the first RNA sequence (E) because the non-base-paired ribonucleotides protrude from (G). Preferably, the length of the first RNA sequence (E) is 90%-94% or 90%-93% or 91%-94% or 91%-93% of the length of the second RNA sequence (G). These features can also be applied across the full length of the double-stranded region (B), wherein the portion (C) of the double-stranded region is the full length of (B).
[0346] As those skilled in the art will understand, other embodiments include a first RNA sequence (E) following the same principles as those described above and a second RNA sequence (G) having a longer, continuous ribonucleotide sequence.
[0347] In one embodiment of the first or second aspect, or in a molecule lacking a loop, both the first RNA sequence (E) and the second RNA sequence (G) comprise at least 100 consecutive ribonucleotides, or at least 110 or 120, or at least 150, or at least 200, or at least 250, or at least 300 consecutive ribonucleotides, preferably up to a maximum of 1000 ribonucleotides, more preferably up to a maximum of 800 consecutive ribonucleotides, or even more preferably up to a maximum of 600 consecutive ribonucleotides. For example, both the first RNA sequence (E) and the second RNA sequence (G) comprise consecutive ribonucleotides in the range of 100-1000, 100-800, or 100-600 ribonucleotides, or in the range of 150-1000, 150-800, or 150-600 ribonucleotides. In a preferred embodiment, the length of the sense RNA sequence in the dsRNA region is 90%-97% or 90%-96% of the length of the antisense sequence, for example, 90%-94%, 90%-93%, 91%-94%, or 91%-93% compared to the antisense sequence. These features apply to hairpin RNAs and dsRNAs formed by the annealing of two RNA strands, i.e., without connecting loop sequences. Each of these features can also be applied to a second dsRNA region in the precursor RNA molecule (e.g., in ledRNA molecules). In these embodiments, the eukaryotic cell cleaving the precursor RNA molecule (A) is preferably a plant cell, fungal cell, nematode cell, or arthropod cell such as an insect cell, or the target RNA molecule is preferably in a plant cell, fungal cell, nematode cell, or arthropod cell such as an insect cell. Such precursor RNA molecules are particularly useful for reducing the expression of target RNA molecules in plant cells, fungal cells, or nematode cells. They can also be used in other invertebrate cells such as arthropod cells, such as insect cells, or in non-mammalian vertebrate cells. It can be produced in plant cells to reduce target RNA molecules in insects, fungal pathogens, or nematodes, or applied locally to plants or insects to reduce target RNA molecules.
[0348] Each embodiment or molecule lacking a loop in the second aspect of the embodiments may have the following characteristics: the precursor RNA molecule can be cleaved in eukaryotic cells by one or more ribonucleases (RNases) to produce a plurality of different double-stranded product RNA molecules (P), each of the plurality of different double-stranded product RNA molecules (P) consisting of a sense RNA sequence (H) of 21 consecutive ribonucleotides from the first RNA sequence (E) and an antisense RNA sequence (J) of 23 consecutive ribonucleotides from the second RNA sequence (G), wherein at least some of the plurality of different double-stranded product RNA molecules (P) have overlapping antisense RNA sequences (J). In another embodiment, at least some of the plurality of different double-stranded product RNA molecules (P) have non-overlapping antisense RNA sequences (J), wherein the population of double-stranded product RNA molecules (P) generated from the precursor RNA molecule includes some overlapping and some non-overlapping antisense RNA sequences (J). Preferably, there are more non-overlapping antisense RNA sequences (J) that are readily present in a longer (> 42 base pairs) double-stranded region (B), wherein each siRNA molecule consisting of a sense RNA sequence of 21 nts hybridized with an antisense RNA sequence of 23 nts is phased along the length of (B).
[0349] Each embodiment or molecule lacking a loop in the second aspect of the embodiments may have the following characteristics: the precursor RNA molecule is capable of being cleaved in eukaryotic cells by one or more ribonucleases (RNases) to produce a plurality of different double-stranded product RNA molecules (P), each of the plurality of different double-stranded product RNA molecules (P) consisting of a sense RNA sequence (H) of 21 consecutive ribonucleotides from a first RNA sequence (E) and an antisense RNA sequence (J) of 23 consecutive ribonucleotides from a second RNA sequence (G), wherein at least some of the plurality of different double-stranded product RNA molecules (P) have non-overlapping antisense RNA sequences (J), preferably adjacent to non-overlapping antisense RNA sequences (J).
[0350] In one embodiment of the second aspect, or in a molecule lacking a loop, the molecule can be cleaved in a eukaryotic cell by one or more ribonucleases (RNases) to produce a plurality of different double-stranded RNA molecules (P), the plurality of different double-stranded RNA molecules (P) comprising double-stranded RNA molecules as defined in two or more embodiments of the second aspect.
[0351] In a third aspect, the present invention provides an asymmetric precursor RNA molecule processed to produce a siRNA molecule, said siRNA molecule consisting of a sense RNA sequence of 21 nts hybridized with an antisense RNA sequence of 24 nts. Therefore, in this aspect, the present invention provides a precursor RNA molecule (A) comprising at least one double-stranded RNA region (B), wherein:
[0352] (i) The double-stranded RNA region (B) comprises:
[0353] (a) A first RNA strand (D) of at least 23 consecutive ribonucleotides, the first RNA strand (D) comprising a first RNA sequence (E) of at least 21 consecutive ribonucleotides, and
[0354] (b) A second RNA strand (F) of at least 26 consecutive ribonucleotides, wherein the second RNA strand (F) contains a second RNA sequence (G) of at least 24 consecutive ribonucleotides.
[0355] The first RNA chain (D) and the second RNA chain (F) are covalently linked by a linker RNA sequence (L).
[0356] The first RNA sequence (E) hybridizes with the second RNA sequence (G) through base pairing between at least 20 of the at least 21 consecutive ribonucleotides of the first RNA sequence (E) and at least 20 of the at least 24 consecutive ribonucleotides of the second RNA sequence (G), thereby forming at least a portion (C) of the double-stranded RNA region (B).
[0357] In the portion (C) of the double-stranded RNA region (B), three or four of the at least 24 ribonucleotides in (G) are non-base-paired, and zero or one of the at least 21 ribonucleotides in (E) are non-base-paired, thereby forming one, two, three, four, or five protrusions in the portion (C) of the double-stranded RNA region (B).
[0358] Each of the one, two, three, four, or five protrusions is immediately followed by a ribonucleotide, which is base-paired in the portion (C) of the double-stranded RNA region (B); and
[0359] (ii) The precursor RNA molecule (A) can be cleaved in eukaryotic cells by one or more ribonucleases (RNases) to produce one or more double-stranded product RNA molecules (P), said one or more double-stranded product RNA molecules (P) consisting of a sense RNA sequence (H) of 21 consecutive ribonucleotides from the first RNA sequence (E) and an antisense RNA sequence (J) of 24 consecutive ribonucleotides from the second RNA strand (F), including at least 22 consecutive ribonucleotides from (G).
[0360] The one or more double-stranded RNA molecules (P) contain one, two, three, four, or five protrusions.
[0361] In one or more of the double-stranded RNA molecules (P), 18 or 19 of the ribonucleotides 1 to 19 of the sense RNA sequence (H) are each paired with ribonucleotide bases 1 to 22 of the antisense RNA sequence (J).
[0362] In the one or more double-stranded RNA molecules (P), ribonucleotides 20 and 21 of the sense RNA sequence (H) form unpaired 3' overhangs consisting of two ribonucleotides, and ribonucleotides 23 and 24 of the antisense RNA sequence (J) form unpaired 3' overhangs consisting of two ribonucleotides.
[0363] In one or more of the double-stranded RNA molecules (P), ribonucleotides 1 and 2 of the sense RNA sequence (H) are paired with ribonucleotides 21 and 22 of the antisense RNA sequence (J), respectively.
[0364] In one or more of the double-stranded RNA molecules (P), ribonucleotides 18 and 19 of the sense RNA sequence (H) are paired with ribonucleotides 1 and 2 of the antisense RNA sequence (J), respectively. The exemplary RNA molecule of this embodiment... Figure 53 The small diagrams from R to Z are shown schematically.
[0365] In one embodiment of the third aspect, one or two ribonucleotides of ribonucleotides 1 and 2 in the at least 23 consecutive ribonucleotides of the first RNA chain (D) are not paired with one or two ribonucleotide bases of ribonucleotides 25 and 26 in the at least 26 consecutive ribonucleotides of the second RNA chain (F).
[0366] In one embodiment of the third aspect, the first RNA sequence (E) hybridizes with the second RNA sequence (G) through base pairing between at least 20 consecutive ribonucleotides of the at least 21 consecutive ribonucleotides of the first RNA sequence (E) and at least 20 consecutive ribonucleotides of the at least 24 consecutive ribonucleotides of the second RNA sequence (G).
[0367] In the portion (C) of the double-stranded RNA region (B), four of the at least 24 ribonucleotides in (G) (three of which are consecutive) are non-base-paired, and one of the at least 21 ribonucleotides in (E) is non-base-paired. These non-base-paired ribonucleotides form two protrusions in the portion (C) of the double-stranded RNA region (B).
[0368] Each protrusion is immediately followed by a ribonucleotide, which is base-paired in the portion (C) of the double-stranded RNA region (B).
[0369] One of the protrusions is formed by a mismatched ribonucleotide pair between the first RNA sequence (E) and the second RNA sequence (G), and the second protrusion is a triribonucleotide protrusion.
[0370] The one or more double-stranded RNA molecules (P) contain the protrusions, and
[0371] In one or more of the double-stranded RNA molecules (P), all but one of the ribonucleotides in ribonucleotides 1 to 19 of the sense RNA sequence (H) are each paired with ribonucleotide bases in ribonucleotides 1 to 22 of the antisense RNA sequence (J). The exemplary RNA molecule of this embodiment... Figure 53 The small diagram R is shown schematically.
[0372] In one embodiment of the third aspect, the first RNA sequence (E) hybridizes with the second RNA sequence (G) through base pairing between at least 20 consecutive ribonucleotides of the at least 21 consecutive ribonucleotides of the first RNA sequence (E) and at least 20 consecutive ribonucleotides of the at least 24 consecutive ribonucleotides of the second RNA sequence (G).
[0373] In the portion (C) of the double-stranded RNA region (B), four of the at least 24 ribonucleotides in (G) are non-base-paired, and one of the at least 21 ribonucleotides in (E) is non-base-paired. These non-base-paired ribonucleotides form five single-ribonucleotide protrusions in the portion (C) of the double-stranded RNA region (B).
[0374] Each protrusion is immediately followed by a ribonucleotide, which is base-paired in the portion (C) of the double-stranded RNA region (B).
[0375] The one or more double-stranded RNA molecules (P) contain the protrusions, and
[0376] In one or more of the double-stranded RNA molecules (P), all but one of the ribonucleotides in ribonucleotides 1 to 19 of the sense RNA sequence (H) are each paired with ribonucleotide bases in ribonucleotides 1 to 22 of the antisense RNA sequence (J). The exemplary RNA molecule of this embodiment... Figure 53 The small diagram S is shown schematically.
[0377] In one embodiment of the third aspect, the first RNA sequence (E) hybridizes with the second RNA sequence (G) through base pairing between at least 21 consecutive ribonucleotides of the at least 21 consecutive ribonucleotides of the first RNA sequence (E) and at least 21 consecutive ribonucleotides of the at least 24 consecutive ribonucleotides of the second RNA sequence (G).
[0378] In the portion (C) of the double-stranded RNA region (B), three of the at least 24 ribonucleotides in (G) are non-base-paired, and all of the at least 21 ribonucleotides in (E) are base-paired. The three non-base-paired ribonucleotides form three single-ribonucleotide protrusions in the portion (C) of the double-stranded RNA region (B).
[0379] Each protrusion is immediately followed by a ribonucleotide of the second RNA sequence (G), which is base-paired with the ribonucleotide of the first RNA sequence (E).
[0380] The one or more double-stranded RNA molecules (P) contain the protrusions, and
[0381] In one or more of the double-stranded RNA molecules (P), ribonucleotides 1 to 19 of the sense RNA sequence (H) are each paired with ribonucleotide bases 1 to 22 of the antisense RNA sequence (J). The exemplary RNA molecule of this embodiment... Figure 53 The small diagrams T and Z are shown schematically.
[0382] In one embodiment of the third aspect, the first RNA sequence (E) hybridizes with the second RNA sequence (G) through base pairing between at least 21 consecutive ribonucleotides of the at least 21 consecutive ribonucleotides of the first RNA sequence (E) and at least 21 consecutive ribonucleotides of the at least 24 consecutive ribonucleotides of the second RNA sequence (G).
[0383] In the portion (C) of the double-stranded RNA region (B), three of the at least 24 ribonucleotides in (G) are non-base-paired, and all of the at least 21 ribonucleotides in (E) are base-paired. The non-base-paired ribonucleotides form two protrusions in the portion (C) of the double-stranded RNA region (B).
[0384] Each protrusion is immediately followed by a ribonucleotide of the second RNA sequence (G), which is base-paired with the ribonucleotide of the first RNA sequence (E).
[0385] One of the protrusions is a mononucleotide protrusion, and the other is a dinucleotide protrusion.
[0386] The one or more double-stranded RNA molecules (P) contain the protrusions, and
[0387] In one or more of the double-stranded RNA molecules (P), ribonucleotides 1 to 19 of the sense RNA sequence (H) are each paired with ribonucleotide bases 1 to 22 of the antisense RNA sequence (J). The exemplary RNA molecule of this embodiment... Figure 53 The small diagrams U and Y are shown schematically.
[0388] In one embodiment of the third aspect, the first RNA sequence (E) hybridizes with the second RNA sequence (G) through base pairing between at least 21 consecutive ribonucleotides of the at least 21 consecutive ribonucleotides of the first RNA sequence (E) and at least 21 consecutive ribonucleotides of the at least 24 consecutive ribonucleotides of the second RNA sequence (G).
[0389] In the portion (C) of the double-stranded RNA region (B), three consecutive ribonucleotides of the at least 24 ribonucleotides in (G) are unpaired, and all ribonucleotides of the at least 21 ribonucleotides in (E) are paired. The three unpaired ribonucleotides form a trinucleotide protrusion in the portion (C) of the double-stranded RNA region (B).
[0390] The protrusion is immediately followed by a ribonucleotide of the second RNA sequence (G), which is base-paired with the ribonucleotide of the first RNA sequence (E).
[0391] The one or more double-stranded RNA molecules (P) contain the protrusions, and
[0392] In one or more of the double-stranded RNA molecules (P), ribonucleotides 1 to 19 of the sense RNA sequence (H) are each paired with ribonucleotide bases 1 to 22 of the antisense RNA sequence (J). The exemplary RNA molecule of this embodiment... Figure 53 The small diagrams V and X are shown schematically.
[0393] In one embodiment of the third aspect, the first RNA sequence (E) hybridizes with the second RNA sequence (G) through base pairing between at least 20 consecutive ribonucleotides of the at least 21 consecutive ribonucleotides of the first RNA sequence (E) and at least 20 consecutive ribonucleotides of the at least 24 consecutive ribonucleotides of the second RNA sequence (G).
[0394] In the portion (C) of the double-stranded RNA region (B), four consecutive ribonucleotides of the at least 24 ribonucleotides in (G) are non-base-paired, and one ribonucleotide of the at least 21 ribonucleotides in (E) is non-base-paired, the non-base-paired ribonucleotide forming a protrusion in the portion (C) of the double-stranded RNA region (B).
[0395] The protrusion is immediately followed by a ribonucleotide, which is base-paired in the portion (C) of the double-stranded RNA region (B).
[0396] The one or more double-stranded RNA molecules (P) contain the protrusions, and
[0397] In the one or more double-stranded RNA molecules (P), all but one of the ribonucleotides in ribonucleotides 1 to 19 of the sense RNA sequence (H) are paired with ribonucleotide bases in ribonucleotides 1 to 22 of the antisense RNA sequence (J).
[0398] In one embodiment of the third aspect, the first RNA sequence (E) hybridizes with the second RNA sequence (G) through base pairing between at least 20 consecutive ribonucleotides of the at least 21 consecutive ribonucleotides of the first RNA sequence (E) and at least 20 consecutive ribonucleotides of the at least 24 consecutive ribonucleotides of the second RNA sequence (G).
[0399] In the portion (C) of the double-stranded RNA region (B), four of the at least 24 ribonucleotides in (G) are non-base-paired, and one of the at least 21 ribonucleotides in (E) is non-base-paired, the non-base-paired ribonucleotides forming four protrusions in the portion (C) of the double-stranded RNA region (B).
[0400] Each protrusion is immediately followed by a ribonucleotide, which is base-paired in the portion (C) of the double-stranded RNA region (B).
[0401] One of the protrusions is formed by a mismatched ribonucleotide pair between the first RNA sequence (E) and the second RNA sequence (G), and the other three protrusions are single nucleotide protrusions.
[0402] The one or more double-stranded RNA molecules (P) contain the protrusions, and
[0403] In the one or more double-stranded RNA molecules (P), all but one of the ribonucleotides in ribonucleotides 1 to 19 of the sense RNA sequence (H) are paired with ribonucleotide bases in ribonucleotides 1 to 22 of the antisense RNA sequence (J).
[0404] In one embodiment of the third aspect, the first RNA sequence (E) hybridizes with the second RNA sequence (G) through base pairing between at least 20 consecutive ribonucleotides of the at least 21 consecutive ribonucleotides of the first RNA sequence (E) and at least 20 consecutive ribonucleotides of the at least 24 consecutive ribonucleotides of the second RNA sequence (G).
[0405] In the portion (C) of the double-stranded RNA region (B), four of the at least 24 ribonucleotides in (G), including two consecutive ribonucleotides, are non-base-paired, and one of the at least 21 ribonucleotides in (E) is non-base-paired. These non-base-paired ribonucleotides form three protrusions in the portion (C) of the double-stranded RNA region (B).
[0406] Each protrusion is immediately followed by a ribonucleotide, which is base-paired in the portion (C) of the double-stranded RNA region (B).
[0407] Two of the protrusions are mononucleotide protrusions, and other non-base-paired ribonucleotides form the other protrusion.
[0408] The one or more double-stranded RNA molecules (P) contain the protrusions, and
[0409] In the one or more double-stranded RNA molecules (P), all but one of the ribonucleotides in ribonucleotides 1 to 19 of the sense RNA sequence (H) are paired with ribonucleotide bases in ribonucleotides 1 to 22 of the antisense RNA sequence (J).
[0410] In one embodiment of the third aspect, the first RNA sequence (E) hybridizes with the second RNA sequence (G) through base pairing between at least 20 consecutive ribonucleotides of the at least 21 consecutive ribonucleotides of the first RNA sequence (E) and at least 20 consecutive ribonucleotides of the at least 24 consecutive ribonucleotides of the second RNA sequence (G).
[0411] In the portion (C) of the double-stranded RNA region (B), four of the at least 24 ribonucleotides in (G), including two consecutive ribonucleotides, are non-base-paired, and one of the at least 21 ribonucleotides in (E) is non-base-paired. These non-base-paired ribonucleotides form two protrusions in the portion (C) of the double-stranded RNA region (B).
[0412] Each protrusion is immediately followed by a ribonucleotide, which is base-paired in the portion (C) of the double-stranded RNA region (B).
[0413] One of the protrusions is a dinucleotide protrusion, and other non-base-paired ribonucleotides form another protrusion.
[0414] The one or more double-stranded RNA molecules (P) contain the protrusions, and
[0415] In the one or more double-stranded RNA molecules (P), all but one of the ribonucleotides in ribonucleotides 1 to 19 of the sense RNA sequence (H) are paired with ribonucleotide bases in ribonucleotides 1 to 22 of the antisense RNA sequence (J).
[0416] In one embodiment of the third aspect, the double-stranded RNA region (B) comprises:
[0417] (a) A first RNA strand (D), the first RNA strand (D) comprising a first RNA sequence (E) of at least 23 consecutive ribonucleotides, and
[0418] (b) A second RNA strand (F), wherein the second RNA strand (F) contains a second RNA sequence (G) of at least 26 consecutive ribonucleotides.
[0419] The first RNA chain (D) and the second RNA chain (F) are covalently linked by a linker RNA sequence (L).
[0420] The first RNA sequence (E) hybridizes with the second RNA sequence (G) through base pairing between at least 22 of the at least 23 consecutive ribonucleotides of the first RNA sequence (E) and at least 22 of the at least 26 consecutive ribonucleotides of the second RNA sequence (G), thereby forming at least a portion (C) of the double-stranded RNA region (B).
[0421] In the portion (C) of the double-stranded RNA region (B), three or four of the at least 26 ribonucleotides in (G) are non-base-paired, and zero or one of the at least 23 ribonucleotides in (E) are non-base-paired, thereby forming one, two, three, four, or five protrusions in the portion (C) of the double-stranded RNA region (B).
[0422] Each of the protrusions is immediately followed by a ribonucleotide, which is base-paired in the portion (C) of the double-stranded RNA region (B). The exemplary RNA molecule of this embodiment... Figure 53 The small diagrams R to V are shown schematically.
[0423] Therefore, in one embodiment, the present invention provides a precursor RNA molecule (A) comprising at least one double-stranded RNA region (B), wherein:
[0424] (i) The double-stranded RNA region (B) comprises:
[0425] (a) A first RNA strand (D), the first RNA strand (D) comprising a first RNA sequence (E) of at least 23 consecutive ribonucleotides, and
[0426] (b) A second RNA strand (F), wherein the second RNA strand (F) contains a second RNA sequence (G) of at least 26 consecutive ribonucleotides.
[0427] The first RNA chain (D) and the second RNA chain (F) are covalently linked by a linker RNA sequence (L).
[0428] The first RNA sequence (E) hybridizes with the second RNA sequence (G) through base pairing between at least 22 of the at least 23 consecutive ribonucleotides of the first RNA sequence (E) and at least 22 of the at least 26 consecutive ribonucleotides of the second RNA sequence (G), thereby forming at least a portion (C) of the double-stranded RNA region (B).
[0429] In the portion (C) of the double-stranded RNA region (B), three or four of the at least 26 ribonucleotides in (G) are non-base-paired, and zero or one of the at least 23 ribonucleotides in (E) are non-base-paired, thereby forming one, two, three, four, or five protrusions in the portion (C) of the double-stranded RNA region (B).
[0430] Each of the protrusions is immediately followed by a ribonucleotide, which is base-paired in the portion (C) of the double-stranded RNA region (B); and
[0431] (ii) The precursor RNA molecule (A) can be cleaved in eukaryotic cells by one or more ribonucleases (RNases) to produce one or more double-stranded product RNA molecules (P), said one or more double-stranded product RNA molecules (P) consisting of a sense RNA sequence (H) of 21 consecutive ribonucleotides from the first RNA sequence (E) and an antisense RNA sequence (J) of 24 consecutive ribonucleotides from the second RNA sequence (G).
[0432] The one or more double-stranded RNA molecules (P) contain one, two, three, four, or five protrusions.
[0433] In one or more of the double-stranded RNA molecules (P), 18 or 19 of the ribonucleotides 1 to 19 of the sense RNA sequence (H) are each paired with ribonucleotide bases 1 to 22 of the antisense RNA sequence (J).
[0434] In the one or more double-stranded RNA molecules (P), ribonucleotides 20 and 21 of the sense RNA sequence (H) form unpaired 3' overhangs consisting of two ribonucleotides, and ribonucleotides 23 and 24 of the antisense RNA sequence (J) form unpaired 3' overhangs consisting of two ribonucleotides.
[0435] In one or more of the double-stranded RNA molecules (P), ribonucleotides 1 and 2 of the sense RNA sequence (H) are paired with ribonucleotides 21 and 22 of the antisense RNA sequence (J), respectively.
[0436] In one or more of the double-stranded RNA molecules (P), ribonucleotides 18 and 19 of the sense RNA sequence (H) are paired with ribonucleotides 1 and 2 of the antisense RNA sequence (J), respectively. The exemplary RNA molecule of this embodiment... Figure 53 The small diagrams R to V are shown schematically.
[0437] In one embodiment of the third aspect, the first RNA sequence (E) hybridizes with the second RNA sequence (G) through base pairing between at least 22 of the at least 23 consecutive ribonucleotides of the first RNA sequence (E) and at least 22 of the at least 26 consecutive ribonucleotides of the second RNA sequence (G).
[0438] In the portion (C) of the double-stranded RNA region (B), four of the at least 26 ribonucleotides in (G) (three of which are consecutive) are non-base-paired, and one of the at least 23 ribonucleotides in (E) is non-base-paired. These non-base-paired ribonucleotides form two protrusions in the portion (C) of the double-stranded RNA region (B).
[0439] Each protrusion is immediately followed by a ribonucleotide, which is base-paired in the portion (C) of the double-stranded RNA region (B).
[0440] One of the protrusions is formed by a mismatched ribonucleotide pair between the first RNA sequence (E) and the second RNA sequence (G), and the second protrusion is a triribonucleotide protrusion.
[0441] The one or more double-stranded RNA molecules (P) contain the protrusions, and
[0442] In one or more of the double-stranded RNA molecules (P), all but one of the ribonucleotides in ribonucleotides 1 to 19 of the sense RNA sequence (H) are each paired with ribonucleotide bases in ribonucleotides 1 to 22 of the antisense RNA sequence (J). The exemplary RNA molecule of this embodiment... Figure 53 The small diagram R is shown schematically.
[0443] In one embodiment of the third aspect, the first RNA sequence (E) hybridizes with the second RNA sequence (G) through base pairing between at least 22 of the at least 23 consecutive ribonucleotides of the first RNA sequence (E) and at least 22 of the at least 26 consecutive ribonucleotides of the second RNA sequence (G).
[0444] In the portion (C) of the double-stranded RNA region (B), four of the at least 26 ribonucleotides in (G) are non-base-paired, and one of the at least 23 ribonucleotides in (E) is non-base-paired. These non-base-paired ribonucleotides form five single-ribonucleotide protrusions in the portion (C) of the double-stranded RNA region (B).
[0445] Each protrusion is immediately followed by a ribonucleotide, which is base-paired in the portion (C) of the double-stranded RNA region (B).
[0446] The one or more double-stranded RNA molecules (P) contain the protrusions, and
[0447] In one or more of the double-stranded RNA molecules (P), all but one of the ribonucleotides in ribonucleotides 1 to 19 of the sense RNA sequence (H) are each paired with ribonucleotide bases in ribonucleotides 1 to 22 of the antisense RNA sequence (J). The exemplary RNA molecule of this embodiment... Figure 53 The small diagram S is shown schematically.
[0448] In one embodiment of the third aspect, the first RNA sequence (E) hybridizes with the second RNA sequence (G) through base pairing between at least 23 consecutive ribonucleotides of the at least 23 consecutive ribonucleotides of the first RNA sequence (E) and at least 23 consecutive ribonucleotides of the at least 26 consecutive ribonucleotides of the second RNA sequence (G).
[0449] In the portion (C) of the double-stranded RNA region (B), three of the at least 26 ribonucleotides in (G) are non-base-paired, and all of the at least 23 ribonucleotides in (E) are base-paired. The three non-base-paired ribonucleotides form three single-ribonucleotide protrusions in the portion (C) of the double-stranded RNA region (B).
[0450] Each protrusion is immediately followed by a ribonucleotide of the second RNA sequence (G), which is base-paired with the ribonucleotide of the first RNA sequence (E).
[0451] The one or more double-stranded RNA molecules (P) contain the protrusions, and
[0452] In one or more of the double-stranded RNA molecules (P), ribonucleotides 1 to 19 of the sense RNA sequence (H) are each paired with ribonucleotide bases 1 to 22 of the antisense RNA sequence (J). The exemplary RNA molecule of this embodiment... Figure 53 The small diagrams T and Z are shown schematically.
[0453] In one embodiment of the third aspect, the first RNA sequence (E) hybridizes with the second RNA sequence (G) through base pairing between at least 23 consecutive ribonucleotides of the at least 23 consecutive ribonucleotides of the first RNA sequence (E) and at least 23 consecutive ribonucleotides of the at least 26 consecutive ribonucleotides of the second RNA sequence (G).
[0454] In the portion (C) of the double-stranded RNA region (B), three of the at least 26 ribonucleotides in (G) are non-base-paired, and all of the at least 23 ribonucleotides in (E) are base-paired. The non-base-paired ribonucleotides form two protrusions in the portion (C) of the double-stranded RNA region (B).
[0455] Each protrusion is immediately followed by a ribonucleotide of the second RNA sequence (G), which is base-paired with the ribonucleotide of the first RNA sequence (E).
[0456] One of the protrusions is a mononucleotide protrusion, and the other is a dinucleotide protrusion.
[0457] The one or more double-stranded RNA molecules (P) contain the protrusions, and
[0458] In one or more of the double-stranded RNA molecules (P), ribonucleotides 1 to 19 of the sense RNA sequence (H) are each paired with ribonucleotide bases 1 to 22 of the antisense RNA sequence (J). The exemplary RNA molecule of this embodiment... Figure 53 The small diagrams U and Y are shown schematically.
[0459] In one embodiment of the third aspect, the first RNA sequence (E) hybridizes with the second RNA sequence (G) through base pairing between at least 23 consecutive ribonucleotides of the at least 23 consecutive ribonucleotides of the first RNA sequence (E) and at least 23 consecutive ribonucleotides of the at least 26 consecutive ribonucleotides of the second RNA sequence (G).
[0460] In the portion (C) of the double-stranded RNA region (B), three consecutive ribonucleotides of the at least 26 ribonucleotides in (G) are unpaired, and all ribonucleotides of the at least 23 ribonucleotides in (E) are paired. The three unpaired ribonucleotides form a trinucleotide protrusion in the portion (C) of the double-stranded RNA region (B).
[0461] The protrusion is immediately followed by a ribonucleotide of the second RNA sequence (G), which is base-paired with the ribonucleotide of the first RNA sequence (E).
[0462] The one or more double-stranded RNA molecules (P) contain the protrusions, and
[0463] In one or more of the double-stranded RNA molecules (P), ribonucleotides 1 to 19 of the sense RNA sequence (H) are each paired with ribonucleotide bases 1 to 22 of the antisense RNA sequence (J). The exemplary RNA molecule of this embodiment... Figure 53 The small diagrams V and X are shown schematically.
[0464] In one embodiment of the third aspect, the first RNA sequence (E) hybridizes with the second RNA sequence (G) through base pairing between at least 22 of the at least 23 consecutive ribonucleotides of the first RNA sequence (E) and at least 22 of the at least 26 consecutive ribonucleotides of the second RNA sequence (G).
[0465] In the portion (C) of the double-stranded RNA region (B), four consecutive ribonucleotides of the at least 26 ribonucleotides in (G) are non-base-paired, and one ribonucleotide of the at least 23 ribonucleotides in (E) is non-base-paired, the non-base-paired ribonucleotide forming a protrusion in the portion (C) of the double-stranded RNA region (B).
[0466] The protrusion is immediately followed by a ribonucleotide, which is base-paired in the portion (C) of the double-stranded RNA region (B).
[0467] The one or more double-stranded RNA molecules (P) contain the protrusions, and
[0468] In the one or more double-stranded RNA molecules (P), all but one of the ribonucleotides in ribonucleotides 1 to 19 of the sense RNA sequence (H) are paired with ribonucleotide bases in ribonucleotides 1 to 22 of the antisense RNA sequence (J).
[0469] In one embodiment of the third aspect, the first RNA sequence (E) hybridizes with the second RNA sequence (G) through base pairing between at least 22 of the at least 23 consecutive ribonucleotides of the first RNA sequence (E) and at least 22 of the at least 26 consecutive ribonucleotides of the second RNA sequence (G).
[0470] In the portion (C) of the double-stranded RNA region (B), four of the at least 26 ribonucleotides in (G) are non-base-paired, and one of the at least 23 ribonucleotides in (E) is non-base-paired, the non-base-paired ribonucleotides forming four protrusions in the portion (C) of the double-stranded RNA region (B).
[0471] Each protrusion is immediately followed by a ribonucleotide, which is base-paired in the portion (C) of the double-stranded RNA region (B).
[0472] One of the protrusions is formed by a mismatched ribonucleotide pair between the first RNA sequence (E) and the second RNA sequence (G), and the other three protrusions are single nucleotide protrusions.
[0473] The one or more double-stranded RNA molecules (P) contain the protrusions, and
[0474] In the one or more double-stranded RNA molecules (P), all but one of the ribonucleotides in ribonucleotides 1 to 19 of the sense RNA sequence (H) are paired with ribonucleotide bases in ribonucleotides 1 to 22 of the antisense RNA sequence (J).
[0475] In one embodiment of the third aspect, the first RNA sequence (E) hybridizes with the second RNA sequence (G) through base pairing between at least 22 of the at least 23 consecutive ribonucleotides of the first RNA sequence (E) and at least 22 of the at least 26 consecutive ribonucleotides of the second RNA sequence (G).
[0476] In the portion (C) of the double-stranded RNA region (B), four of the at least 26 ribonucleotides in (G), including two consecutive ribonucleotides, are non-base-paired, and one of the at least 23 ribonucleotides in (E) is non-base-paired. These non-base-paired ribonucleotides form three protrusions in the portion (C) of the double-stranded RNA region (B).
[0477] Each protrusion is immediately followed by a ribonucleotide, which is base-paired in the portion (C) of the double-stranded RNA region (B).
[0478] Two of the protrusions are mononucleotide protrusions, and other non-base-paired ribonucleotides form the other protrusion.
[0479] The one or more double-stranded RNA molecules (P) contain the protrusions, and
[0480] In the one or more double-stranded RNA molecules (P), all but one of the ribonucleotides in ribonucleotides 1 to 19 of the sense RNA sequence (H) are paired with ribonucleotide bases in ribonucleotides 1 to 22 of the antisense RNA sequence (J).
[0481] In one embodiment of the third aspect, the first RNA sequence (E) hybridizes with the second RNA sequence (G) through base pairing between at least 22 of the at least 23 consecutive ribonucleotides of the first RNA sequence (E) and at least 22 of the at least 26 consecutive ribonucleotides of the second RNA sequence (G).
[0482] In the portion (C) of the double-stranded RNA region (B), four of the at least 26 ribonucleotides in (G) (two of which are consecutive) are non-base-paired, and one of the at least 23 ribonucleotides in (E) is non-base-paired. These non-base-paired ribonucleotides form two protrusions in the portion (C) of the double-stranded RNA region (B).
[0483] Each protrusion is immediately followed by a ribonucleotide, which is base-paired in the portion (C) of the double-stranded RNA region (B).
[0484] One of the protrusions is a dinucleotide protrusion, and other non-base-paired ribonucleotides form another protrusion.
[0485] The one or more double-stranded RNA molecules (P) contain the protrusions, and
[0486] In the one or more double-stranded RNA molecules (P), all but one of the ribonucleotides in ribonucleotides 1 to 19 of the sense RNA sequence (H) are paired with ribonucleotide bases in ribonucleotides 1 to 22 of the antisense RNA sequence (J).
[0487] Each embodiment in the third aspect may have the following features:
[0488] (i) In at least some of the one or more double-stranded RNA product molecules (P), the ribonucleotides 1, 2, and 3 of the sense RNA sequence (H) are paired with ribonucleotides 20, 21, and 22 of the antisense RNA sequence (J), respectively, or
[0489] (ii) In at least some of the one or more double-stranded RNA molecules (P), the ribonucleotides 17, 18, and 19 of the sense RNA sequence (H) are paired with the ribonucleotides 1, 2, and 3 of the antisense RNA sequence (J), respectively, or
[0490] Preferably both (i) and (ii). The exemplary RNA molecule of this embodiment... Figure 53The small figures R to Z schematically illustrate product RNA molecules having at least three consecutive base pairs at both ends of the product RNA molecule. In further features of these embodiments, the product RNA molecule may have at least four, five, or six consecutive base pairs at one or both ends of the double-stranded molecule before any protrusion. In these embodiments, any one of those base pairs may be a G:U base pair, preferably one or more ribonucleotides of ribonucleotides 1, 2, and 3 of the antisense sequence (J) participating in the G:U base pair, more preferably one or both ribonucleotides of ribonucleotides 1 and 2 of the antisense sequence (J) participating in the G:U base pair, and even more preferably ribonucleotide 1 of the antisense sequence (J) participating in the G:U base pair. Most preferably, one or more ribonucleotides of ribonucleotides 1, 2, and 3 of the antisense sequence (J) are U ribonucleotides, or one or both ribonucleotides of ribonucleotides 1 and 2 are U ribonucleotides, or ribonucleotide 1 is a U ribonucleotide participating in the G:U base pair.
[0491] The design principles of the asymmetric precursor RNA molecule described in the third aspect can be applied in an extended manner to longer double-stranded regions. For example, the non-base-paired ribonucleotides in the second RNA sequence (G) (antisense sequence) can be arranged in a periodic manner to provide a population of product RNA molecules (P) having multiple 24 nt non-overlapping antisense RNA sequences (J). Such precursor RNA molecules are particularly useful for reducing the expression of target RNA molecules in plant cells, fungal cells, or nematode cells. They can also be used in other invertebrate cells such as arthropod cells or insect cells, or in non-mammalian vertebrate cells. They can be produced in plant cells to reduce insect target RNA molecules or fungal pathogen or nematode target RNA molecules, or applied locally to plants or insects to reduce target RNA molecules. For example, in one embodiment of the third aspect, the first RNA sequence (E) contains at least 44 consecutive ribonucleotides, and the second RNA sequence (G) contains at least 50 consecutive ribonucleotides.
[0492] The first RNA sequence (E) hybridizes with the second RNA sequence (G) through base pairing between at least 42, preferably at least 43, or at least 44 consecutive ribonucleotides of the first RNA sequence (E) and at least 42, preferably at least 43, or at least 44 consecutive ribonucleotides of the second RNA sequence (G) out of the at least 50 consecutive ribonucleotides.
[0493] In the portion (C) of the double-stranded RNA region (B), 6, 7, or 8 of the at least 50 consecutive ribonucleotides in (G) are non-base-paired, and 0, 1, or 2 of the at least 44 consecutive ribonucleotides in (E) are non-base-paired, thereby forming a protrusion in the portion (C) of the double-stranded RNA region (B).
[0494] Each of the protrusions is immediately followed by a ribonucleotide, which is base-paired in the portion (C) of the double-stranded RNA region (B).
[0495] The precursor RNA molecule can be cleaved in eukaryotic cells by one or more ribonucleases (RNases) to produce multiple different double-stranded RNA molecules (P). Each of the multiple different double-stranded RNA molecules (P) consists of a sense RNA sequence (H) of 21 consecutive ribonucleotides and an antisense RNA sequence (J) of 24 consecutive ribonucleotides.
[0496] Each of the plurality of different double-stranded RNA molecules (P) contains at least one of the protrusions, and
[0497] At least some of the different double-stranded RNA molecules (P) contain non-overlapping antisense RNA sequences (J), preferably adjacent to non-overlapping antisense RNA sequences (J).
[0498] In another embodiment of the third aspect, the first RNA chain (D) comprises a first RNA sequence (E) of at least 44 consecutive ribonucleotides, and the second RNA chain (F) comprises a second RNA sequence (G) of at least 50 consecutive ribonucleotides.
[0499] The first RNA sequence (E) hybridizes with the second RNA sequence (G) through base pairing between all 44 consecutive ribonucleotides of the first RNA sequence (E) and 44 consecutive ribonucleotides of the 50 consecutive ribonucleotides of the second RNA sequence (G), thereby forming a portion (C) of the double-stranded RNA region (B).
[0500] In the portion (C) of the double-stranded RNA region (B), six of the 50 consecutive ribonucleotides in (G) are non-base-paired, thereby forming 2-6 protrusions in the portion (C) of the double-stranded RNA region (B).
[0501] Each of the protrusions is immediately followed by a ribonucleotide, which is base-paired in the portion (C) of the double-stranded RNA region (B).
[0502] The precursor RNA molecule can be cleaved in eukaryotic cells by one or more ribonucleases (RNases) to produce multiple different double-stranded RNA molecules (P). Each of the multiple different double-stranded RNA molecules (P) consists of a sense RNA sequence (H) of 21 consecutive ribonucleotides and an antisense RNA sequence (J) of 24 consecutive ribonucleotides.
[0503] Each of the plurality of different double-stranded RNA molecules (P) contains at least one of the protrusions, and
[0504] At least some of the different double-stranded RNA molecules (P) have non-overlapping antisense RNA sequences (J), preferably adjacent to the non-overlapping antisense RNA sequences (J). In this embodiment and the foregoing embodiments, the protrusions are preferably separated by 6-23 consecutive base pairs, more preferably by 7-22 or 8-21 consecutive base pairs, even more preferably by 9-20 consecutive base pairs, and most preferably by 7, 8, 9, 10, 11 or 12 consecutive base pairs, or 7-12, 7-11 or 7-10 consecutive base pairs. In a specific example, the protrusions are separated by 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 or 21 consecutive base pairs. In one embodiment, all of these base pairs are typical base pairs. Alternatively, one, two, three, four, five, or six base pairs between the protrusions may be G:U base pairs. The precursor RNA molecule may contain two or more such double-stranded RNA regions, for example, leading RNA structures.
[0505] In one embodiment of a longer dsRNA region having at least 44 base pairs, the precursor RNA molecule lacks the linker RNA sequence (L), and the first RNA strand (D) and the second RNA strand (F) hybridize to form the double-stranded RNA region (B). Such precursor RNA molecules can be readily produced in cell-free systems, for example, in vitro. In one embodiment, the first RNA strand (D) comprises a first RNA sequence (E) of at least 44 consecutive ribonucleotides, and the second RNA strand (F) comprises a second RNA sequence (G) of at least 50 consecutive ribonucleotides.
[0506] The first RNA sequence (E) hybridizes with the second RNA sequence (G) through base pairing between all 44 consecutive ribonucleotides of the first RNA sequence (E) and 44 consecutive ribonucleotides of the 50 consecutive ribonucleotides of the second RNA sequence (G), thereby forming a portion (C) of the double-stranded RNA region (B).
[0507] In the portion (C) of the double-stranded RNA region (B), six of the 50 consecutive ribonucleotides in (G) are non-base-paired, thereby forming 2-6 protrusions in the portion (C) of the double-stranded RNA region (B).
[0508] Each of the protrusions is immediately followed by a ribonucleotide, which is base-paired in the portion (C) of the double-stranded RNA region (B).
[0509] The precursor RNA molecule can be cleaved in eukaryotic cells by one or more ribonucleases (RNases) to produce multiple different double-stranded RNA molecules (P). Each of the multiple different double-stranded RNA molecules (P) consists of a sense RNA sequence (H) of 21 consecutive ribonucleotides and an antisense RNA sequence (J) of 24 consecutive ribonucleotides.
[0510] Each of the plurality of different double-stranded RNA molecules (P) contains at least one of the protrusions, and
[0511] At least some of the different double-stranded RNA molecules (P) have non-overlapping antisense RNA sequences (J), preferably adjacent to the non-overlapping antisense RNA sequences (J). In this embodiment, the protrusions are preferably separated by 6-23 consecutive base pairs, more preferably by 7-22 or 8-21 consecutive base pairs, even more preferably by 9-20 consecutive base pairs, and most preferably by 7, 8, 9, 10, 11, or 12 consecutive base pairs, or 7-12, 7-11, or 7-10 consecutive base pairs. In a specific example, the protrusions are separated by 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, or 21 consecutive base pairs. In a preferred example, all these base pairs are typical base pairs. Alternatively, one, two, three, four, five, or six base pairs between the protrusions may be G:U base pairs.
[0512] In one embodiment of the third aspect, the first RNA sequence (E) comprises at least 65 consecutive ribonucleotides, and the second RNA sequence (G) comprises at least 74 consecutive ribonucleotides.
[0513] The first RNA sequence (E) hybridizes with the second RNA sequence (G) through base pairing between at least 62, preferably at least 63, at least 64, or at least 65 consecutive ribonucleotides of the first RNA sequence (E) and at least 62, preferably at least 63, at least 64, or at least 65 consecutive ribonucleotides of the second RNA sequence (G) from the at least 74 consecutive ribonucleotides.
[0514] In the portion (C) of the double-stranded RNA region (B), 9-12 of the at least 74 consecutive ribonucleotides in (G) are non-base-paired, and 0-3 of the at least 44 consecutive ribonucleotides in (E) are non-base-paired, thereby forming a protrusion in the portion (C) of the double-stranded RNA region (B).
[0515] Each of the protrusions is immediately followed by a ribonucleotide, which is base-paired in the portion (C) of the double-stranded RNA region (B).
[0516] The precursor RNA molecule can be cleaved in eukaryotic cells by one or more ribonucleases (RNases) to produce multiple different double-stranded RNA molecules (P). Each of the multiple different double-stranded RNA molecules (P) consists of a sense RNA sequence (H) of 21 consecutive ribonucleotides and an antisense RNA sequence (J) of 24 consecutive ribonucleotides.
[0517] Each of the plurality of different double-stranded RNA molecules (P) contains at least one of the protrusions, and
[0518] At least some of the different double-stranded RNA molecules (P) contain non-overlapping antisense RNA sequences (J), preferably adjacent to non-overlapping antisense RNA sequences (J).
[0519] In another embodiment of the third aspect, the first RNA chain (D) comprises a first RNA sequence (E) of at least 65 consecutive ribonucleotides, and the second RNA chain (F) comprises a second RNA sequence (G) of at least 74 consecutive ribonucleotides.
[0520] The first RNA sequence (E) hybridizes with the second RNA sequence (G) through base pairing between all 65 consecutive ribonucleotides of the first RNA sequence (E) and 65 consecutive ribonucleotides of the 74 consecutive ribonucleotides of the second RNA sequence (G), thereby forming a portion (C) of the double-stranded RNA region (B).
[0521] In the portion (C) of the double-stranded RNA region (B), 9 of the 74 consecutive ribonucleotides in (G) are non-base-paired, thereby forming 3-9 protrusions in the portion (C) of the double-stranded RNA region (B).
[0522] Each of the protrusions is immediately followed by a ribonucleotide, which is base-paired in the portion (C) of the double-stranded RNA region (B).
[0523] The precursor RNA molecule can be cleaved in eukaryotic cells by one or more ribonucleases (RNases) to produce multiple different double-stranded RNA molecules (P). Each of the multiple different double-stranded RNA molecules (P) consists of a sense RNA sequence (H) of 21 consecutive ribonucleotides and an antisense RNA sequence (J) of 24 consecutive ribonucleotides.
[0524] Each of the plurality of different double-stranded RNA molecules (P) contains at least one of the protrusions, and
[0525] At least some of the different double-stranded RNA molecules (P) have non-overlapping antisense RNA sequences (J), preferably adjacent to the non-overlapping antisense RNA sequences (J). In this embodiment and the foregoing embodiments, the protrusions are preferably separated by 6-23 consecutive base pairs, more preferably by 7-22 or 8-21 consecutive base pairs, even more preferably by 9-20 consecutive base pairs, and most preferably by 7, 8, 9, 10, 11 or 12 consecutive base pairs, or 7-12, 7-11 or 7-10 consecutive base pairs. In a specific example, the protrusions are separated by 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 or 21 consecutive base pairs. In one embodiment, all of these base pairs are typical base pairs. Alternatively, one, two, three, four, five, or six base pairs between the protrusions may be G:U base pairs. The precursor RNA molecule may contain two or more such double-stranded RNA regions, for example, leading RNA structures.
[0526] In one embodiment of a longer dsRNA region having at least 65 base pairs, the precursor RNA molecule lacks the linker RNA sequence (L), and the first RNA strand (D) and the second RNA strand (F) hybridize to form the double-stranded RNA region (B). Such precursor RNA molecules can be readily produced in cell-free systems, for example, in vitro. In one embodiment, the first RNA strand (D) comprises a first RNA sequence (E) of at least 65 consecutive ribonucleotides, and the second RNA strand (F) comprises a second RNA sequence (G) of at least 74 consecutive ribonucleotides.
[0527] The first RNA sequence (E) hybridizes with the second RNA sequence (G) through base pairing between all 65 consecutive ribonucleotides of the first RNA sequence (E) and 65 consecutive ribonucleotides of the 74 consecutive ribonucleotides of the second RNA sequence (G), thereby forming a portion (C) of the double-stranded RNA region (B).
[0528] In the portion (C) of the double-stranded RNA region (B), 9 of the 74 consecutive ribonucleotides in (G) are non-base-paired, thereby forming 3-9 protrusions in the portion (C) of the double-stranded RNA region (B).
[0529] Each of the protrusions is immediately followed by a ribonucleotide, which is base-paired in the portion (C) of the double-stranded RNA region (B).
[0530] The precursor RNA molecule can be cleaved in eukaryotic cells by one or more ribonucleases (RNases) to produce multiple different double-stranded RNA molecules (P). Each of the multiple different double-stranded RNA molecules (P) consists of a sense RNA sequence (H) of 21 consecutive ribonucleotides and an antisense RNA sequence (J) of 24 consecutive ribonucleotides.
[0531] Each of the plurality of different double-stranded RNA molecules (P) contains at least one of the protrusions, and
[0532] At least some of the different double-stranded RNA molecules (P) have non-overlapping antisense RNA sequences (J), preferably adjacent to the non-overlapping antisense RNA sequences (J). In this embodiment, the protrusions are preferably separated by 6-23 consecutive base pairs, more preferably by 7-22 or 8-21 consecutive base pairs, even more preferably by 9-20 consecutive base pairs, and most preferably by 7, 8, 9, 10, 11, or 12 consecutive base pairs, or 7-12, 7-11, or 7-10 consecutive base pairs. In a specific example, the protrusions are separated by 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, or 21 consecutive base pairs. In a preferred example, all these base pairs are typical base pairs. Alternatively, one, two, three, four, five, or six base pairs between the protrusions may be G:U base pairs.
[0533] In the three embodiments described above, the first RNA sequence (E) and the second RNA sequence (G) may be extended to more than 65 and 74 ribonucleotides, respectively. In another embodiment, the first RNA sequence (E) comprises at least 86 consecutive ribonucleotides, and the second RNA sequence (G) comprises at least 98 consecutive ribonucleotides, wherein the first RNA sequence (E) hybridizes with the second RNA sequence (G) through base pairing between at least 82, preferably at least 83, at least 84, at least 85, or at least 86 of the at least 86 consecutive ribonucleotides of the first RNA sequence (E) and at least 82, preferably at least 83, at least 84, at least 85, or at least 86 of the at least 98 consecutive ribonucleotides of the second RNA sequence (G).
[0534] In another embodiment of the third aspect, the first RNA chain (D) comprises a first RNA sequence (E) of at least 86 consecutive ribonucleotides, and the second RNA chain (F) comprises a second RNA sequence (G) of at least 98 consecutive ribonucleotides.
[0535] The first RNA sequence (E) hybridizes with the second RNA sequence (G) through base pairing between all 86 consecutive ribonucleotides of the first RNA sequence (E) and 86 consecutive ribonucleotides of the 98 consecutive ribonucleotides of the second RNA sequence (G), thereby forming a portion (C) of the double-stranded RNA region (B).
[0536] In the portion (C) of the double-stranded RNA region (B), 12 of the 98 consecutive ribonucleotides in (G) are non-base-paired, thereby forming 4-12 protrusions in the portion (C) of the double-stranded RNA region (B).
[0537] Each of the protrusions is immediately followed by a ribonucleotide, which is base-paired in the portion (C) of the double-stranded RNA region (B).
[0538] The precursor RNA molecule can be cleaved in eukaryotic cells by one or more ribonucleases (RNases) to produce multiple different double-stranded RNA molecules (P). Each of the multiple different double-stranded RNA molecules (P) consists of a sense RNA sequence (H) of 21 consecutive ribonucleotides and an antisense RNA sequence (J) of 24 consecutive ribonucleotides.
[0539] Each of the plurality of different double-stranded RNA molecules (P) contains at least one of the protrusions, and
[0540] At least some of the different double-stranded RNA molecules (P) have non-overlapping antisense RNA sequences (J), preferably adjacent to the non-overlapping antisense RNA sequences (J). In this embodiment and the foregoing embodiments, the protrusions are preferably periodically spaced, for example, by 6-23 consecutive base pairs, more preferably by 7-2 or 8-21 consecutive base pairs, even more preferably by 9-20 consecutive base pairs, and most preferably by 7, 8, 9, 10, 11 or 12 consecutive base pairs, or 7-12, 7-11 or 7-10 consecutive base pairs. In a specific example, the protrusions are spaced by 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 or 21 consecutive base pairs. In a preferred embodiment, all these base pairs are typical base pairs. Alternatively, one, two, three, four, five, or six base pairs between the protrusions may be G:U base pairs. The precursor RNA molecule may contain two or more such double-stranded RNA regions, for example, leading RNA structures.
[0541] In one embodiment of a longer dsRNA region having at least 86 base pairs, the precursor RNA molecule lacks the linker RNA sequence (L), and the first RNA strand (D) and the second RNA strand (F) hybridize to form the double-stranded RNA region (B). Such precursor RNA molecules can be readily produced in cell-free systems, for example, in vitro. In one embodiment, the first RNA strand (D) comprises a first RNA sequence (E) of at least 86 consecutive ribonucleotides, and the second RNA strand (F) comprises a second RNA sequence (G) of at least 98 consecutive ribonucleotides.
[0542] The first RNA sequence (E) hybridizes with the second RNA sequence (G) through base pairing between all 86 consecutive ribonucleotides of the first RNA sequence (E) and 86 consecutive ribonucleotides of the 98 consecutive ribonucleotides of the second RNA sequence (G), thereby forming a portion (C) of the double-stranded RNA region (B).
[0543] In the portion (C) of the double-stranded RNA region (B), 12 of the 98 consecutive ribonucleotides in (G) are non-base-paired, thereby forming 4-12 protrusions in the portion (C) of the double-stranded RNA region (B).
[0544] Each of the protrusions is immediately followed by a ribonucleotide, which is base-paired in the portion (C) of the double-stranded RNA region (B).
[0545] The precursor RNA molecule can be cleaved in eukaryotic cells by one or more ribonucleases (RNases) to produce multiple different double-stranded RNA molecules (P). Each of the multiple different double-stranded RNA molecules (P) consists of a sense RNA sequence (H) of 21 consecutive ribonucleotides and an antisense RNA sequence (J) of 24 consecutive ribonucleotides.
[0546] Each of the plurality of different double-stranded RNA molecules (P) contains at least one of the protrusions, and
[0547] At least some of the different double-stranded RNA molecules (P) have non-overlapping antisense RNA sequences (J), preferably adjacent to the non-overlapping antisense RNA sequences (J). In this embodiment, the protrusions are preferably separated by 66-23 consecutive base pairs, more preferably by 7-22 or 8-21 consecutive base pairs, even more preferably by 9-20 consecutive base pairs, and most preferably by 7, 8, 9, 10, 11, or 12 consecutive base pairs, or 7-12, 7-11, or 7-10 consecutive base pairs. In a specific example, the protrusions are separated by 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, or 21 consecutive base pairs. In a preferred embodiment, all of these base pairs are typical base pairs. Alternatively, one, two, three, four, five, or six base pairs among the base pairs between the protrusions are G:U base pairs. In a preferred embodiment, all of these base pairs are typical base pairs. Alternatively, one, two, three, four, or five base pairs among the base pairs between the protrusions are G:U base pairs.
[0548] In each of these embodiments of the third aspect, or in a molecule lacking a loop, both the first RNA sequence (E) and the second RNA sequence (G) may contain at least 100 consecutive ribonucleotides, or at least 110 or at least 120 consecutive ribonucleotides, or at least 150, or at least 200, or at least 250, or at least 300 consecutive ribonucleotides, preferably up to a maximum of 1000 consecutive ribonucleotides, more preferably up to a maximum of 800 consecutive ribonucleotides, or even more preferably up to a maximum of 600 consecutive ribonucleotides. For example, both the first RNA sequence (E) and the second RNA sequence (G) may contain consecutive ribonucleotides in the range of 100-1000, 100-800, 100-600, or in the range of 150-1000, 150-800, 150-600. In a preferred embodiment, the length of the sense RNA sequence in the dsRNA region is 87%-97% or 87%-96% of the length of the antisense sequence, for example, 87%-91% or 87%-90% compared to the antisense sequence. These features apply to hairpin RNAs and dsRNAs formed by the annealing of two RNA strands, i.e., without connecting loop sequences. Each of these features can also be applied to a second dsRNA region in the precursor RNA molecule (e.g., in ledRNA molecules). In these embodiments, the eukaryotic cell cleaving the precursor RNA molecule (A) is preferably a plant cell, fungal cell, nematode cell, or arthropod cell such as an insect cell, arachnid cell, or decapod cell, or the target RNA molecule is preferably in a plant cell, fungal cell, nematode cell, or arthropod cell such as an insect cell, arachnid cell, or decapod cell.
[0549] Each embodiment or molecule lacking a loop in the third aspect of the embodiments may have the following characteristics: the precursor RNA molecule can be cleaved in eukaryotic cells by one or more ribonucleases (RNases) to produce a plurality of different double-stranded product RNA molecules (P), each of the plurality of different double-stranded product RNA molecules (P) consisting of a sense RNA sequence (H) of 21 consecutive ribonucleotides from the first RNA sequence (E) and an antisense RNA sequence (J) of 24 consecutive ribonucleotides from the second RNA sequence (G), wherein at least some of the plurality of different double-stranded product RNA molecules (P) have overlapping antisense RNA sequences (J). In another embodiment, at least some of the plurality of different double-stranded product RNA molecules (P) have non-overlapping antisense RNA sequences (J), wherein the population of double-stranded product RNA molecules (P) generated from the precursor RNA molecule includes some overlapping and some non-overlapping antisense RNA sequences (J). Preferably, there are more product RNA molecules (P) containing non-overlapping antisense RNA sequences (J) that are readily present in a longer (> 42 base pairs) double-stranded region (B), wherein each siRNA molecule consisting of a sense RNA sequence of 21 nts hybridized with an antisense RNA sequence of 24 nts is phased along the length of (B).
[0550] Each embodiment of the third aspect may have the following features: the precursor RNA molecule can be cleaved in a eukaryotic cell by one or more ribonucleases (RNases) to produce a plurality of different double-stranded product RNA molecules (P), each of the plurality of different double-stranded product RNA molecules (P) consisting of a sense RNA sequence (H) of 21 consecutive ribonucleotides from a first RNA sequence (E) and an antisense RNA sequence (J) of 24 consecutive ribonucleotides from a second RNA sequence (G), wherein at least some of the plurality of different double-stranded product RNA molecules (P) have non-overlapping antisense RNA sequences (J), preferably adjacent to non-overlapping antisense RNA sequences (J).
[0551] In one embodiment of the third aspect, the molecule is capable of being cleaved in a eukaryotic cell by one or more ribonucleases (RNases) to produce a plurality of different double-stranded RNA molecules (P), the plurality of different double-stranded RNA molecules (P) comprising double-stranded RNA molecules as defined in two or more embodiments of the third aspect.
[0552] The present invention also provides symmetrical and asymmetric precursor RNA molecules that contain G:U base pairs in a double-stranded RNA region of one or more RNA molecules targeting insect or fungal cells. Therefore, in a fourth aspect, the present invention provides a precursor RNA molecule comprising at least one double-stranded RNA region, wherein:
[0553] (i) The double-stranded RNA region comprises:
[0554] (a) A first RNA strand of at least 46 consecutive ribonucleotides, the first RNA strand comprising a first RNA sequence of at least 44 consecutive ribonucleotides, and
[0555] (b) A second RNA strand of at least 46 consecutive ribonucleotides, the second RNA strand comprising a second RNA sequence of at least 44 consecutive ribonucleotides.
[0556] The first RNA sequence hybridizes with the second RNA sequence through base pairing between at least 44 consecutive ribonucleotides of the first RNA sequence and at least 44 consecutive ribonucleotides of the second RNA sequence, thereby forming at least a portion of the double-stranded RNA region.
[0557] In the first RNA sequence and the second RNA sequence, a total of 10% to 35% of the ribonucleotides are paired with G:U base pairs.
[0558] The second RNA sequence is at least 80% identical to the sequence of at least 44 consecutive ribonucleotides, the sequence of which is completely complementary to the first region of the target RNA molecule in insect cells; and
[0559] (ii) The precursor RNA molecule can be cleaved in insect cells by one or more Dicer sequences to produce double-stranded product RNA molecules, each of which independently consists of a sense RNA sequence of 21 consecutive ribonucleotides from the first RNA sequence and an antisense RNA sequence of 21 consecutive ribonucleotides from the second RNA sequence.
[0560] In each of the double-stranded RNA product molecules, ribonucleotides 1 to 19 of the sense RNA sequence are base-paired with ribonucleotides 1 to 19 of the antisense RNA sequence.
[0561] In each of the double-stranded RNA product molecules, the 19 base pairs between the sense RNA sequence and the antisense RNA sequence independently contain 2, 3, 4, 5, or 6 G:U base pairs.
[0562] In each of the double-stranded product RNA molecules, ribonucleotides 20 and 21 of the sense RNA sequence form an unpaired 3' overhang consisting of two ribonucleotides, and in each of the double-stranded product RNA molecules, ribonucleotides 20 and 21 of the antisense RNA sequence form an unpaired 3' overhang consisting of two ribonucleotides.
[0563] Wherein (c) at least some of the antisense RNA sequences in the double-stranded product RNA molecule are capable of reducing the expression and / or activity of the target RNA molecule in the insect cells, or
[0564] (d) The antisense RNA sequences in the double-stranded product RNA molecule are each independently identical in sequence to the corresponding regions of the complementary sequences of the target RNA molecule by at least 80%, or
[0565] (e), (c), and (d) are both.
[0566] In a preferred embodiment, the insect cell is a lepidopteran insect cell, such as a lepidopteran insect cell of the genera *Helicoverpa* or *Spodoptera*, such as a lepidopteran insect cell of the cotton bollworm (*Helicoverpa armigera*) or the fall armyworm (*Spodoptera frugiperda*), and / or the second RNA sequence is at least 90% identical, preferably 100% identical, to the sequence of at least 44 consecutive ribonucleotides, the sequence of which is completely complementary to the first region of the target RNA molecule in the insect cell.
[0567] In a fifth aspect, the present invention provides a precursor RNA molecule comprising at least one double-stranded RNA region, wherein:
[0568] (i) The double-stranded RNA region comprises:
[0569] (a) A first RNA strand of at least 46 consecutive ribonucleotides, the first RNA strand comprising a first RNA sequence of at least 44 consecutive ribonucleotides, and
[0570] (b) A second RNA strand of at least 46 consecutive ribonucleotides, the second RNA strand comprising a second RNA sequence of at least 44 consecutive ribonucleotides.
[0571] The first RNA sequence hybridizes with the second RNA sequence through base pairing between at least 44 consecutive ribonucleotides of the first RNA sequence and at least 44 consecutive ribonucleotides of the second RNA sequence, thereby forming at least a portion of the double-stranded RNA region.
[0572] In the first RNA sequence and the second RNA sequence, a total of 10% to 35% of the ribonucleotides are paired with G:U base pairs.
[0573] The second RNA sequence is at least 80% identical to the sequence of at least 44 consecutive ribonucleotides, the sequence of which is completely complementary to the first region of the target RNA molecule in the fungal cell; and
[0574] (ii) The precursor RNA molecule can be cleaved in the fungal cell by one or more Dicers to produce double-stranded product RNA molecules, each of which independently consists of a sense RNA sequence of 21 consecutive ribonucleotides from the first RNA sequence and an antisense RNA sequence of 21 consecutive ribonucleotides from the second RNA sequence.
[0575] In each of the double-stranded RNA product molecules, ribonucleotides 1 to 19 of the sense RNA sequence are base-paired with ribonucleotides 1 to 19 of the antisense RNA sequence.
[0576] In each of the double-stranded RNA product molecules, the 19 base pairs between the sense RNA sequence and the antisense RNA sequence independently contain 2, 3, 4, 5, or 6 G:U base pairs.
[0577] In each of the double-stranded product RNA molecules, ribonucleotides 20 and 21 of the sense RNA sequence form an unpaired 3' overhang consisting of two ribonucleotides, and in each of the double-stranded product RNA molecules, ribonucleotides 20 and 21 of the antisense RNA sequence form an unpaired 3' overhang consisting of two ribonucleotides.
[0578] Wherein (c) at least some of the antisense RNA sequences in the double-stranded product RNA molecule are capable of reducing the expression and / or activity of the target RNA molecule in the fungal cells, or
[0579] (d) The antisense RNA sequences in the double-stranded product RNA molecule are each independently identical in sequence to the corresponding regions of the complementary sequences of the target RNA molecule by at least 80%, or
[0580] (e), (c), and (d) are both.
[0581] In a preferred embodiment, the fungal cell is a plant pathogenic fungal cell, such as a Fusarium or Verticillium plant pathogenic fungal cell, and / or the second RNA sequence is at least 90% identical, preferably 100% identical, to a sequence of at least 44 consecutive ribonucleotides, the sequence of which is completely complementary to the first region of the target RNA molecule in the fungal cell.
[0582] In each embodiment of the fourth and fifth aspects, the characteristics of the first RNA sequence (E) and the second RNA sequence (G) of the precursor RNA molecules of the first, second, and third aspects can also be applied to the precursor RNA molecules of the fourth and fifth aspects, particularly the length characteristics.
[0583] In one embodiment of the asymmetric precursor RNA molecule containing G:U base pairs, the precursor RNA molecule comprises at least one double-stranded RNA region, wherein:
[0584] (i) The double-stranded RNA region comprises:
[0585] (a) A first RNA strand of at least 46 consecutive ribonucleotides, the first RNA strand comprising a first RNA sequence of at least 44 consecutive ribonucleotides, and
[0586] (b) A second RNA strand of at least 48 consecutive ribonucleotides, the second RNA strand comprising a second RNA sequence of at least 46 consecutive ribonucleotides.
[0587] The first RNA sequence hybridizes with the second RNA sequence through base pairing between at least 42 ribonucleotides from the at least 44 consecutive ribonucleotides of the first RNA sequence and at least 42 ribonucleotides from the at least 46 consecutive ribonucleotides of the second RNA sequence, thereby forming at least a portion of the double-stranded RNA region.
[0588] In the portion of the double-stranded RNA region, two, three, or four ribonucleotides of the at least 46 consecutive ribonucleotides of the second RNA sequence are non-base-paired, and zero, one, or two ribonucleotides of the at least 44 consecutive ribonucleotides of the first RNA sequence are non-base-paired, thereby forming a protrusion in the portion of the double-stranded RNA region.
[0589] Each of the protrusions is immediately followed by a ribonucleotide, which is base-paired in the specified portion of the double-stranded RNA region.
[0590] In the first RNA sequence and the second RNA sequence, a total of 10% to 35% of the ribonucleotides are paired with G:U base pairs.
[0591] The second RNA sequence is at least 80% identical to the sequence of at least 46 consecutive ribonucleotides, the sequence of which is completely complementary to the first region of the target RNA molecule in insect or fungal cells; and
[0592] (ii) The precursor RNA molecule can be cleaved by one or more Dicers in the insect cell or the fungal cell to produce double-stranded product RNA molecules, each of which independently consists of a sense RNA sequence of 21 consecutive ribonucleotides from the first RNA sequence and an antisense RNA sequence of 22 consecutive ribonucleotides from the second RNA sequence.
[0593] Each of the antisense RNA sequences in the double-stranded product RNA molecule contains at least one of the protrusions.
[0594] In each of the double-stranded RNA product molecules, the base pair between the sense RNA sequence and the antisense RNA sequence independently comprises 2, 3, 4, 5, or 6 G:U base pairs.
[0595] In each of the double-stranded product RNA molecules, ribonucleotides 20 and 21 of the sense RNA sequence form an unpaired 3' overhang consisting of two ribonucleotides.
[0596] In each of the double-stranded product RNA molecules, ribonucleotides 21 and 22 of the antisense RNA sequence form an unpaired 3' overhang consisting of two ribonucleotides.
[0597] Wherein (c) at least some of the antisense RNA sequences in the double-stranded product RNA molecule are capable of reducing the expression and / or activity of the target RNA molecule in the insect cell or the fungal cell, or
[0598] (d) The antisense RNA sequences in the double-stranded product RNA molecule are each independently identical in sequence to the corresponding regions of the complementary sequences of the target RNA molecule by at least 80%, or
[0599] (e), (c), and (d) are both.
[0600] In another embodiment of the asymmetric precursor RNA molecule containing G:U base pairs, the precursor RNA molecule comprises at least one double-stranded RNA region, wherein:
[0601] (i) The double-stranded RNA region comprises:
[0602] (a) A first RNA strand of at least 46 consecutive ribonucleotides, the first RNA strand comprising a first RNA sequence of at least 44 consecutive ribonucleotides, and
[0603] (b) A second RNA strand of at least 50 consecutive ribonucleotides, the second RNA strand comprising a second RNA sequence of at least 48 consecutive ribonucleotides.
[0604] The first RNA sequence hybridizes with the second RNA sequence through base pairing between at least 42 ribonucleotides from the at least 44 consecutive ribonucleotides of the first RNA sequence and at least 42 ribonucleotides from the at least 48 consecutive ribonucleotides of the second RNA sequence, thereby forming at least a portion of the double-stranded RNA region.
[0605] In the portion of the double-stranded RNA region, 4, 5, or 6 of the at least 48 consecutive ribonucleotides of the second RNA sequence are non-base-paired, and 0, 1, or 2 of the at least 44 consecutive ribonucleotides of the first RNA sequence are non-base-paired, thereby forming a protrusion in the portion of the double-stranded RNA region.
[0606] Each of the protrusions is immediately followed by a ribonucleotide, which is base-paired in the specified portion of the double-stranded RNA region.
[0607] In the first RNA sequence and the second RNA sequence, a total of 10% to 35% of the ribonucleotides are paired with G:U base pairs.
[0608] The second RNA sequence is at least 80% identical to the sequence of at least 48 consecutive ribonucleotides, the sequence of which is completely complementary to the first region of the target RNA molecule in insect or fungal cells; and
[0609] (ii) The precursor RNA molecule can be cleaved by one or more Dicers in the insect cell or the fungal cell to produce double-stranded product RNA molecules, each of which independently consists of a sense RNA sequence of 21 consecutive ribonucleotides from the first RNA sequence and an antisense RNA sequence of 23 consecutive ribonucleotides from the second RNA sequence.
[0610] Each of the antisense RNA sequences in the double-stranded product RNA molecule contains at least one of the protrusions.
[0611] In each of the double-stranded RNA product molecules, the base pair between the sense RNA sequence and the antisense RNA sequence independently comprises 2, 3, 4, 5, or 6 G:U base pairs.
[0612] In each of the double-stranded product RNA molecules, ribonucleotides 20 and 21 of the sense RNA sequence form an unpaired 3' overhang consisting of two ribonucleotides.
[0613] In each of the double-stranded product RNA molecules, ribonucleotides 22 and 23 of the antisense RNA sequence form an unpaired 3' overhang consisting of two ribonucleotides, and
[0614] Wherein (c) at least some of the antisense RNA sequences in the double-stranded product RNA molecule are capable of reducing the expression and / or activity of the target RNA molecule in the insect cell or the fungal cell, or
[0615] (d) The antisense RNA sequences in the double-stranded product RNA molecule are each independently identical in sequence to the corresponding regions of the complementary sequences of the target RNA molecule by at least 80%, or
[0616] (e), (c), and (d) are both.
[0617] In another embodiment of the asymmetric precursor RNA molecule containing G:U base pairs, the precursor RNA molecule comprises at least one double-stranded RNA region, wherein:
[0618] (i) The double-stranded RNA region comprises:
[0619] (a) A first RNA strand of at least 46 consecutive ribonucleotides, the first RNA strand comprising a first RNA sequence of at least 44 consecutive ribonucleotides, and
[0620] (b) A second RNA strand of at least 52 consecutive ribonucleotides, the second RNA strand comprising a second RNA sequence of at least 50 consecutive ribonucleotides.
[0621] The first RNA sequence hybridizes with the second RNA sequence through base pairing between at least 42 ribonucleotides from the at least 44 consecutive ribonucleotides of the first RNA sequence and at least 42 ribonucleotides from the at least 50 consecutive ribonucleotides of the second RNA sequence, thereby forming at least a portion of the double-stranded RNA region.
[0622] In the portion of the double-stranded RNA region, 6, 7, or 8 of the at least 50 consecutive ribonucleotides of the second RNA sequence are non-base-paired, and 0, 1, or 2 of the at least 44 consecutive ribonucleotides of the first RNA sequence are non-base-paired, thereby forming a protrusion in the portion of the double-stranded RNA region.
[0623] Each of the protrusions is immediately followed by a ribonucleotide, which is base-paired in the specified portion of the double-stranded RNA region.
[0624] In the first RNA sequence and the second RNA sequence, a total of 10% to 35% of the ribonucleotides are paired with G:U base pairs.
[0625] The second RNA sequence is at least 80% identical to the sequence of at least 50 consecutive ribonucleotides, and the sequence of said at least 50 consecutive ribonucleotides is completely complementary to the first region of the target RNA molecule in insect or fungal cells; and
[0626] (ii) The precursor RNA molecule can be cleaved by one or more Dicers in the insect cell or the fungal cell to produce double-stranded product RNA molecules, each of which independently consists of a sense RNA sequence of 21 consecutive ribonucleotides from the first RNA sequence and an antisense RNA sequence of 24 consecutive ribonucleotides from the second RNA sequence.
[0627] Each of the antisense RNA sequences in the double-stranded product RNA molecule contains at least one of the protrusions.
[0628] In each of the double-stranded RNA product molecules, the base pair between the sense RNA sequence and the antisense RNA sequence independently comprises 2, 3, 4, 5, or 6 G:U base pairs.
[0629] In each of the double-stranded product RNA molecules, ribonucleotides 20 and 21 of the sense RNA sequence form an unpaired 3' overhang consisting of two ribonucleotides.
[0630] In each of the double-stranded product RNA molecules, ribonucleotides 23 and 24 of the antisense RNA sequence form an unpaired 3' overhang consisting of two ribonucleotides.
[0631] Wherein (c) at least some of the antisense RNA sequences in the double-stranded product RNA molecule are capable of reducing the expression and / or activity of the target RNA molecule in the insect cell or the fungal cell, or
[0632] (d) The antisense RNA sequences in the double-stranded product RNA molecule are each independently identical in sequence to the corresponding regions of the complementary sequences of the target RNA molecule by at least 80%, or
[0633] (e), (c), and (d) are both.
[0634] It should be understood that, in the embodiments of the fourth or fifth aspect or in the context of the asymmetric precursor RNA molecule, at least some, but not necessarily all, of the double-stranded product RNA molecules generated from the precursor RNA molecule have the features described in part (ii). For example, sense RNA or antisense RNA of lengths different from 21 ribonucleotides or 22, 23, or 24 (as the case may be) can be generated, as well as sense RNA or antisense RNA of a specified length (such as 21 ribonucleotides).
[0635] In an embodiment of the first, second, third, fourth, or fifth aspect, or in an embodiment of the asymmetric precursor RNA molecule, the precursor RNA molecule comprises a linker RNA sequence, wherein the linker RNA sequence links the 3' end of the first RNA strand to the 5' end of the second RNA strand, or links the 5' end of the first RNA strand to the 3' end of the second RNA strand. In an alternative embodiment, the precursor RNA molecule lacks a linker RNA sequence, i.e., the first RNA strand and the second RNA strand are not covalently linked by a linker RNA sequence. In an embodiment of the first, second, third, fourth, or fifth aspect, or in an embodiment of the asymmetric precursor RNA molecule, the precursor RNA molecule comprises a second double-stranded RNA region and a second linker RNA sequence forming an ledRNA structure.
[0636] In an embodiment of the first, second, third, fourth, or fifth aspect, or in an embodiment of the asymmetric precursor RNA molecule, one or more of the following may be applied:
[0637] (i) The linker RNA sequence comprises at least 50 consecutive ribonucleotides that are at least 90% identical to the second region of the target RNA molecule in the eukaryotic cell, such as a plant cell, nematode cell, insect cell, or fungal cell, and / or the linker RNA sequence comprises at least 50 consecutive ribonucleotides that are at least 90% identical to the complementary sequence of the second region of the target RNA molecule in the eukaryotic cell, such as a plant cell, nematode cell, insect cell, or fungal cell.
[0638] (ii) The precursor RNA molecule further comprises at least 50 consecutive ribonucleotides of a sequence at least 90% identical to the second region of the target RNA molecule in the eukaryotic cell, such as a plant cell, nematode cell, insect cell, or fungal cell, said sequence being covalently linked to the 5' or 3' end of the first RNA strand or to the 5' or 3' end of the second RNA strand, and / or at least 50 consecutive ribonucleotides of a sequence at least 90% identical to the complementary sequence of the second region of the target RNA molecule in the eukaryotic cell, such as a plant cell, nematode cell, insect cell, or fungal cell, said sequence being covalently linked to the 5' or 3' end of the first RNA strand or to the 5' or 3' end of the second RNA strand.
[0639] (iii) The linker RNA sequence comprises a single-stranded RNA sequence of at least 44 consecutive ribonucleotides identical to a region of the first RNA sequence or the second RNA sequence.
[0640] (iv) The precursor RNA molecule contains the linker RNA sequence and is encoded by a polynucleotide lacking an intron in the region encoding the linker RNA sequence.
[0641] (v) The first RNA sequence and the second RNA sequence have the same length across the entire length of the double-stranded RNA region.
[0642] (vi) In embodiments of the asymmetric precursor RNA molecule, the first RNA sequence and the second RNA sequence have different lengths across the full length of the double-stranded RNA region, with the first RNA sequence being longer than the second RNA sequence, or preferably, the first RNA sequence being shorter than the second RNA sequence.
[0643] (vii) The first RNA sequence differs from the first region of the target RNA molecule only in that at least some A ribonucleotides are replaced by G ribonucleotides, or at least some C ribonucleotides are replaced by U ribonucleotides, or a combination of at least some A ribonucleotides being replaced by G ribonucleotides and at least some C ribonucleotides being replaced by U ribonucleotides, or some but not all A ribonucleotides being replaced by G ribonucleotides, or some but not all C ribonucleotides being replaced by U ribonucleotides, or a combination of some but not all A ribonucleotides being replaced by G ribonucleotides and some but not all C ribonucleotides being replaced by U ribonucleotides, and optionally wherein the second RNA sequence is sequence-complementary to the first region of the target RNA molecule.
[0644] (viii) The second RNA sequence differs from the complementary sequence of the first region of the target RNA molecule only in that at least some A ribonucleotides are replaced by G ribonucleotides, or at least some C ribonucleotides are replaced by U ribonucleotides, or a combination of at least some A ribonucleotides being replaced by G ribonucleotides and at least some C ribonucleotides being replaced by U ribonucleotides, or some but not all A ribonucleotides being replaced by G ribonucleotides, or some but not all C ribonucleotides being replaced by U ribonucleotides, or a combination of some but not all A ribonucleotides being replaced by G ribonucleotides and some but not all C ribonucleotides being replaced by U ribonucleotides, and optionally wherein the first RNA sequence is sequence-identical to the first region of the target RNA molecule.
[0645] (ix) Relative to the target RNA molecule, at least some of the double-stranded product RNA molecules have non-overlapping antisense RNA sequences, preferably adjacent to non-overlapping antisense RNA sequences.
[0646] (x) The sense RNA sequence of each double-stranded product RNA molecule differs from its corresponding sequence in the first region of the target RNA molecule only in that at least some A ribonucleotides are replaced by G ribonucleotides, or at least some C ribonucleotides are replaced by U ribonucleotides, or a combination of at least some A ribonucleotides being replaced by G ribonucleotides and at least some C ribonucleotides being replaced by U ribonucleotides, or some but not all A ribonucleotides being replaced by G ribonucleotides, or some but not all C ribonucleotides being replaced by U ribonucleotides, or a combination of some but not all A ribonucleotides being replaced by G ribonucleotides and some but not all C ribonucleotides being replaced by U ribonucleotides.
[0647] (xi) The difference between the antisense RNA sequence of each double-stranded product RNA molecule and the corresponding sequence in the complementary sequence of the first region of the target RNA molecule is only that at least some A ribonucleotides are replaced by G ribonucleotides, or at least some C ribonucleotides are replaced by U ribonucleotides, or a combination of at least some A ribonucleotides being replaced by G ribonucleotides and at least some C ribonucleotides being replaced by U ribonucleotides, or some but not all A ribonucleotides being replaced by G ribonucleotides, or some but not all C ribonucleotides being replaced by U ribonucleotides, or a combination of some but not all A ribonucleotides being replaced by G ribonucleotides and some but not all C ribonucleotides being replaced by U ribonucleotides.
[0648] (xii) The percentage of G ribonucleotides in the first RNA sequence is between 26% and 40% of the total number of ribonucleotides in the first RNA sequence, and / or the percentage of G ribonucleotides in the second RNA sequence is between 26% and 40% of the total number of ribonucleotides in the second RNA sequence.
[0649] (xiii) The percentage of U ribonucleotides in the first RNA sequence is between 26% and 40% of the total number of ribonucleotides in the first RNA sequence, and / or the percentage of U ribonucleotides in the second RNA sequence is between 26% and 40% of the total number of ribonucleotides in the second RNA sequence.
[0650] The double-stranded RNA region described in (xiv) has at most 18 consecutive typical base pairs.
[0651] (xv) The precursor RNA molecule can be prepared by transcriptional enzymatic reaction in vitro or in cells or both.
[0652] In the embodiments, combinations of features (i) to (xv) described above are applied. Preferred combinations include any of (i) and (ii), (i) and (iv), (i) and (v) to (xv), (ii) and (iii), (ii) and (iv), (ii) and (v) to (xv), (iii) and (iv), (iii) and (v) to (xv), (iv) and (v) to (xv), (v) and (vii), (v) and (viii), (v) and (x), (v) and (xi), (v) and (xii), (v) and (xiii), (v) and (xiv), (vi) and (vii), (vi) and (viii), (vi) and (x), (vi) and (xi), (vi) and (xii). (vi) and (xiii), (vi) and (xiv), (vii) and (viii), (vii) and (x), (vii) and (xi), (vii) and (xii), (vii) and (xiii), (vii) and (xiv), (viii) and (x), (viii) and (xii), (viii) and (xiii), (viii) and (xiv), (x) and (xi), (x) and (xii), (x) and (xiii), (x) and (xiv), (xi) and (xii), (xi) and (xiii), (xi) and (xiv), (xii) and (xiv).
[0653] In an embodiment of the first, second, third, fourth, or fifth aspect, or in an embodiment of the asymmetric precursor RNA molecule, the precursor RNA molecule comprises a linker RNA sequence comprising at least 50 consecutive ribonucleotides that are at least 90% identical, preferably at least 95% or 100% identical, to the second region of the target RNA molecule. The second region of the target RNA molecule is preferably the 3' of the first region of the target RNA molecule. Similarly, the linker RNA sequence comprises at least 50 consecutive ribonucleotides that are at least 90% identical, preferably at least 95% or 100% identical, to the complementary sequence of the second region of the target RNA molecule.
[0654] In an embodiment of the first, second, third, fourth, or fifth aspect, or in an embodiment of the asymmetric precursor RNA molecule, the precursor RNA molecule further comprises at least 50 consecutive ribonucleotides of a sequence that is at least 90% identical, preferably at least 95% or 100% identical, to the second region of the target RNA molecule in the eukaryotic cell, such as a plant cell, nematode cell, insect cell, or fungal cell, said sequence being covalently linked to the 5' or 3' end of the first RNA strand or to the 5' or 3' end of the second RNA strand, and / or at least 50 consecutive ribonucleotides of a complementary sequence to the second region of the target RNA molecule that is at least 90% identical, preferably at least 95% or 100% identical, to the 5' or 3' end of the first RNA strand or to the 5' or 3' end of the second RNA strand.
[0655] In an embodiment of the first, second, third, fourth, or fifth aspect, or in an embodiment of the asymmetric precursor RNA molecule, the linker RNA sequence comprises a single-stranded RNA sequence of at least 44, at least 50, or at least 100 consecutive ribonucleotides, the single-stranded RNA sequence being identical to the region of the first or second RNA sequence in the double-stranded RNA region. A second copy of the RNA sequence in such a single-stranded precursor RNA molecule is considered to increase the repressive activity of the precursor RNA molecule, for example, by increasing the production of secondary siRNA.
[0656] In an embodiment of the first, second, third, fourth, or fifth aspect, or in an embodiment of the asymmetric precursor RNA molecule, the precursor RNA molecule comprises a linker RNA sequence and is encoded by a polynucleotide lacking an intron in the region encoding the linker RNA sequence. That is, the initial transcript from the polynucleotide lacks the intron sequence but instead has a linker RNA sequence without introns.
[0657] In an embodiment where a fourth or fifth aspect of a symmetrical precursor RNA molecule is applied, or in an embodiment where an asymmetric precursor RNA molecule is also applied to a first, second, third, fourth, or fifth aspect, the first RNA sequence and the second RNA sequence are of the same length across the full length of the double-stranded RNA region. That is, if non-base-paired ribonucleotides are present in the first RNA sequence and the second RNA sequence, the number of non-base-paired ribonucleotides in the first RNA sequence is equal to the number of non-base-paired ribonucleotides in the second RNA sequence. This can be achieved by insertion and / or deletion in one or both sequences.
[0658] In embodiments of the asymmetric precursor RNA molecule described in the first, second, third, fourth, or fifth aspects, or in embodiments of the asymmetric precursor RNA molecule, the first RNA sequence and the second RNA sequence differ in length across the full length of the double-stranded RNA region, with the first RNA sequence being longer than the second RNA sequence, or preferably, the first RNA sequence being shorter than the second RNA sequence. In one embodiment, the difference in length is at least partially, preferably entirely, attributed to non-base-paired ribonucleotides protruding from the double-stranded RNA region in the second RNA sequence. In one embodiment, the length of the sense sequence is between 87% and 97%, or 87% and 96%, or 91% and 97%, or 91% and 96%, or more preferably between 94% and 97% or 94% and 96%, of the length of the antisense sequence, or the length of the sense sequence is approximately 21 / 22, 21 / 23, or 21 / 24 of the length of the antisense sequence, calculated as a fraction.
[0659] In an embodiment of the first, second, third, fourth, or fifth aspect, or in an embodiment of the asymmetric precursor RNA molecule, the first RNA sequence and / or the second RNA sequence differ from the first region of the target RNA molecule or its complementary sequence only in that at least some A ribonucleotides (preferably 40-60% of A ribonucleotides) are replaced by G ribonucleotides, or at least some C ribonucleotides (preferably 40-60% of C ribonucleotides) are replaced by U ribonucleotides, or a combination of at least some A ribonucleotides (preferably 40-60% of A ribonucleotides) being replaced by G ribonucleotides and at least some C ribonucleotides (preferably 40-60% of C ribonucleotides) being replaced by U ribonucleotides. In one embodiment, some, but not all, of the A ribonucleotides are replaced by G ribonucleotides, or some, but not all, of the C ribonucleotides are replaced by U ribonucleotides, or a combination of some, but not all, of the A ribonucleotides and G ribonucleotides and some, but not all, of the C ribonucleotides and U ribonucleotides. In a preferred embodiment, the second RNA sequence is identical in sequence to the complementary sequence of the first region of the target RNA molecule, i.e., without substitution. These characteristics also apply to the double-stranded product RNA molecule generated from the precursor RNA molecule.
[0660] In an embodiment of the first, second, third, fourth, or fifth aspect, or in an embodiment of the asymmetric precursor RNA molecule, the ribonucleotide substitution produces G:U base pairs in the double-stranded RNA region, for example, a total of 10% to 35%, 10% to 30%, or 10% to 25% of the ribonucleotides in the double-stranded RNA region and / or the portion of the double-stranded RNA region totaling G:U base pairs. In one embodiment, a total of 15% to 35%, 15% to 30%, or 15% to 25% of the ribonucleotides in the double-stranded RNA region and / or the portion of the double-stranded RNA region totaling G:U base pairs. In one embodiment, a total of 17% to 35%, 17% to 30%, or 17% to 25% of the ribonucleotides in the double-stranded RNA region and / or the portion of the double-stranded RNA region totaling G:U base pairs. In one embodiment, a total of about 12%, about 15%, about 20%, about 25%, or about 30% of the ribonucleotides in the double-stranded RNA region and / or the portion of the double-stranded RNA region collectively form G:U base pairs.
[0661] In one embodiment of the first, second, third, fourth, or fifth aspect, or in an embodiment of the asymmetric precursor RNA molecule, the percentage of G ribonucleotides in the first RNA sequence is increased by substitution of A for G. For example, 26-40% of the total number of ribonucleotides in the first RNA sequence are G ribonucleotides, preferably 28-40%, 30-40%, 32-40%, 34-40%, or 26-38%, 26-36%, or 26-34% of the total number of ribonucleotides in the first RNA sequence are G ribonucleotides. In one embodiment, the percentage of G ribonucleotides in the second RNA sequence is increased by substitution of A for G, for example, 26-40% of the total number of ribonucleotides in the second RNA sequence are G ribonucleotides, preferably 28-40%, 30-40%, 32-40%, 34-40%, or 26-38%, 26-36%, or 26-34% of the total number of ribonucleotides in the first RNA sequence are G ribonucleotides. In this context, substitution is a sequence relative to a region of the target RNA molecule or its complementary sequence. In one embodiment, the first RNA sequence or the second RNA sequence, or both, lack the substitution of A to G relative to a region of the target RNA molecule or its complementary sequence.
[0662] In one embodiment of the first, second, third, fourth, or fifth aspect, or in an embodiment of the asymmetric precursor RNA molecule, the percentage of U ribonucleotides in the first RNA sequence is increased by substitution of C for U. For example, 26-40% of the total number of ribonucleotides in the first RNA sequence is U ribonucleotides, preferably 28-40%, 30-40%, 32-40%, 34-40%, or 26-38%, 26-36%, or 26-34% of the total number of ribonucleotides in the first RNA sequence is U ribonucleotides. In one embodiment, the percentage of U ribonucleotides in the second RNA sequence is increased by substitution of C for U, for example, 26-40% of the total number of ribonucleotides in the second RNA sequence is G ribonucleotides, preferably 28-40%, 30-40%, 32-40%, 34-40%, or 26-38%, 26-36%, or 26-34% of the total number of ribonucleotides in the first RNA sequence is G ribonucleotides. In this context, substitution is a sequence relative to a region of the target RNA molecule or its complementary sequence. In one embodiment, the first RNA sequence or the second RNA sequence, or both, respectively lack a C-to-U substitution relative to a region of the target RNA molecule or its complementary sequence.
[0663] In an embodiment of the first, second, third, fourth, or fifth aspect, or in an embodiment of the asymmetric precursor RNA molecule, the double-stranded RNA region has at most 18 consecutive typical base pairs, preferably at most 17, 16, 15, 14, 13, 12, 11, 10, 9, 8, or 7 consecutive typical base pairs. That is, these numbers represent the maximum number of consecutive typical base pairs in the longest subregion of the dsRNA region. The calculation of the number of consecutive typical base pairs ignores the presence of any non-base-paired ribonucleotides in the double-stranded region. Reducing the number of consecutive typical base pairs in any subregion can be achieved through regular intervals of substitutions of A to G and C to U in any one or two sequences.
[0664] In an embodiment of the fourth or fifth aspect, or an embodiment of the asymmetric precursor RNA molecule of the first, second, third, fourth, or fifth aspect, or an embodiment of the asymmetric precursor RNA molecule, at least some of the antisense RNA sequences in the antisense RNA sequence of the double-stranded product RNA molecule generated from the precursor RNA molecule pair with the region bases of the target RNA molecule along the full length of the antisense RNA sequence, preferably by typical base pairs along the full length.
[0665] In an embodiment of the fourth or fifth aspect, or in an embodiment of the asymmetric precursor RNA molecule described in the first, second, third, fourth, or fifth aspect, at least some of the antisense RNA sequences in the double-stranded product RNA molecule generated from the precursor RNA molecule are capable of reducing the expression and / or activity of the target RNA molecules in eukaryotic cells such as plant cells, nematode cells, insect cells, or fungal cells. In one embodiment, the antisense RNA sequences in the double-stranded product RNA molecule generated from the precursor RNA molecule are capable of reducing the expression and / or activity of multiple different target RNA molecules in the eukaryotic cells such as plant cells, nematode cells, insect cells, or fungal cells, wherein said different target RNA molecules are sequence-independent.
[0666] In one embodiment, reduced expression and / or activity of the target RNA molecule in insect cells, relative to the use of an antisense RNA sequence generated from a corresponding precursor RNA molecule having only typical base pairings, leads to increased larval mortality or mortality in insects. For example, 87.5-100% of insect larvae that ingested the precursor RNA molecule and / or the antisense RNA sequence were killed. In one embodiment, reduced expression and / or activity of the target RNA molecule in fungal cells, relative to the use of an antisense RNA sequence generated from a corresponding precursor RNA molecule having only typical base pairings, results in symptom relief and / or increased resistance to fungal infections.
[0667] In one embodiment of the ledRNA molecule or the asymmetric precursor RNA molecule of the first, second, third, fourth, or fifth aspect, the sense RNA sequences of the two double-stranded RNA regions are continuous relative to the target RNA molecule, or the antisense RNA sequences of the two double-stranded RNA regions are continuous relative to the complementary sequence of the target RNA molecule. In one embodiment, the two double-stranded RNA regions are cleavable by Dicer to produce a double-stranded product RNA molecule containing an antisense RNA sequence that hybridizes to a region of the target RNA molecule or to a different discontinuous region of the target RNA molecule. In one embodiment, wherein the two double-stranded RNA regions are cleavable by Dicer to produce a double-stranded product RNA molecule containing an antisense RNA sequence that hybridizes to a region of a different target RNA molecule or to a corresponding region in a family of target RNA molecules. In one embodiment, the second double-stranded region lacks non-base-paired ribonucleotide protrusions.
[0668] In one embodiment of the ledRNA molecule of the first, second, third, fourth, or fifth aspect, or in an embodiment of the asymmetric precursor RNA molecule, the second double-stranded region comprises a third RNA sequence of at least 23 consecutive ribonucleotides and a fourth RNA sequence of at least 26 consecutive ribonucleotides, wherein the third RNA sequence hybridizes with the fourth RNA sequence through base pairing between at least 20 ribonucleotides of the at least 23 consecutive ribonucleotides of the third RNA sequence and at least 20 ribonucleotides of the at least 26 consecutive ribonucleotides of the fourth RNA sequence, thereby forming at least a portion of the second double-stranded RNA region.
[0669] In the portion of the double-stranded RNA region, one, two, three, four, five, or six ribonucleotides of the at least 26 consecutive ribonucleotides of the fourth RNA sequence are non-base-paired, and zero, one, two, or three ribonucleotides of the at least 23 consecutive ribonucleotides of the first RNA sequence are non-base-paired, thereby forming a protrusion in the portion of the second double-stranded RNA region.
[0670] Each of the protrusions is immediately followed by a ribonucleotide, which is base-paired within the portion of the second double-stranded RNA region.
[0671] The fourth RNA sequence is at least 80% identical to the sequence of at least 26 consecutive ribonucleotides, the sequence of which is completely complementary to the region of the target RNA molecule in eukaryotic cells such as plant cells, nematode cells, insect cells or fungal cells.
[0672] In one embodiment, (i) the first RNA sequence and / or the third RNA sequence differs from the corresponding wild-type RNA sequence in the target RNA molecule in that one or more ribonucleotides are deleted from the corresponding wild-type RNA sequence to prepare the first RNA sequence or the third RNA sequence, and / or (ii) the second RNA sequence and / or the fourth RNA sequence differs from a perfectly complementary sequence of the corresponding wild-type RNA sequence in the target RNA molecule in that one or more ribonucleotides are inserted into the perfectly complementary sequence to prepare the second RNA sequence or the fourth RNA sequence, preferably (i). In one embodiment, the deletion of ribonucleotides from the corresponding wild-type RNA sequence occurs at one or more ribonucleotide positions corresponding to the non-base-paired ribonucleotides in the second RNA sequence or the fourth RNA sequence. In one embodiment, the precursor RNA molecule can be cleaved by one or more Dicer cleavages in eukaryotic cells such as plant cells, nematode cells, insect cells, or fungal cells to produce any of the double-stranded product RNA molecules defined in any of the first, second, third, fourth, or fifth aspects.
[0673] In an embodiment of the first, second, third, fourth, or fifth aspect, or in an embodiment of the asymmetric precursor RNA molecule, the precursor RNA molecule has a single double-stranded RNA region, and optionally, the portion of the double-stranded RNA region extends to cover the entire double-stranded RNA region.
[0674] In an embodiment of the first, second, third, fourth, or fifth aspect, or in an embodiment of the asymmetric precursor RNA molecule, all ribonucleotides of the antisense RNA sequence are capable of pairing with ribonucleotide bases in the region of the target RNA molecule.
[0675] In one embodiment of the first, second, third, fourth, or fifth aspect, or in an embodiment of the asymmetric precursor RNA molecule, the precursor RNA molecule is produced in plant cells or microbial cells, such as yeast cells, through transcription of exogenous polynucleotides.
[0676] Each embodiment of the embodiments of the first, second, and third aspects may have the following feature: the antisense RNA sequence (J) of at least one product RNA molecule (P) derived from the precursor RNA molecule is capable of hybridizing with the region (R) of the target RNA molecule in a eukaryotic cell by at least all ribonucleotides 2 to 8 of the antisense RNA sequence (J) pairing with ribonucleotide bases in region (R) of the target RNA molecule. The hybridization may be performed by at least all ribonucleotides 2 to 10 or 2 to 11 of the antisense RNA sequence (J).
[0677] In one embodiment, including the preceding paragraph, the eukaryotic cell is a vertebrate cell such as a mammalian cell or a non-mammalian vertebrate cell, wherein the reduction in the activity of the target RNA molecule can be achieved primarily by inhibiting the translation of the target RNA molecule. When base pairing with the target RNA molecule occurs through a region longer than 2 to 11 ribonucleotides, the reduction in activity can be achieved by inhibiting the translation and / or cleavage of the target RNA molecule.
[0678] Preferably, most of the antisense RNA sequences (J) in the product RNA molecule (P) generated from the precursor RNA molecule are capable of hybridizing with region (R) or more than one region (R) of the target RNA molecule. More preferably, all of the antisense RNA sequences (J) in the product RNA molecule (P) generated from the precursor RNA molecule are capable of hybridizing with region (R) or more than one region of the target RNA molecule.
[0679] In each embodiment of the embodiments of the first, second, third, fourth, or fifth aspects, or in the embodiment of the asymmetric precursor RNA molecule, at least 50%, at least 60%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, or at least 95% of the ribonucleotides of one or more or all of the antisense RNA sequences (J) are capable of pairing with the ribonucleotide bases of the region (R) of the target RNA molecule in a eukaryotic cell. Preferably, the plurality of non-overlapping antisense RNA sequences (J) are capable of pairing with the ribonucleotide bases of the region (R) of the target RNA molecule or with the bases of multiple regions (R) of the target molecule, or with the bases of each of the plurality of target RNA molecules, at any of these minimum percentages.
[0680] In one embodiment, all ribonucleotides of the antisense RNA sequence (J) are capable of pairing with ribonucleotide bases of regions (R) of a target RNA molecule in a eukaryotic cell. Preferably, this feature occurs for each of a plurality of non-overlapping antisense RNA sequences (J) that pair with ribonucleotide bases of the region (R) of the target RNA molecule, or with bases of multiple regions (R) of the target molecule, or with bases of multiple target RNA molecules. This can be readily achieved by using a longer antisense sequence of at least 50 nt or at least 100 nt in the precursor RNA molecule that is fully complementary to the target RNA molecule. Preferably, all ribonucleotides of the plurality of different antisense RNA sequences (J) are capable of pairing with ribonucleotide bases across the length of a region (R) of the target RNA molecule, said length being at least 150, or at least 200, or at least 250, or at least 300 ribonucleotides, preferably up to a maximum of 1000 ribonucleotides, more preferably up to a maximum of 800 ribonucleotides, or even more preferably up to a maximum of 600 ribonucleotides. For example, preferably, all ribonucleotides of the plurality of different antisense RNA sequences (J) are capable of pairing with ribonucleotide bases across the length of a region (R) of the target RNA molecule, said length being in the range of 100-1000, 100-800, or 100-600 ribonucleotides of the target RNA molecule, or in the range of 150-1000, 150-800, or 150-600 ribonucleotides.
[0681] Each embodiment of the first, second, third, fourth, or fifth aspect, or the embodiment of the asymmetric precursor RNA molecule, may have the following feature: the base pairing of the ribonucleotides of the region (R) of the target RNA molecule comprises one or more G:U base pairs, preferably two, three, four, or five G:U base pairs.
[0682] Each embodiment of the first, second, third, fourth, or fifth aspect, or the embodiment of the asymmetric precursor RNA molecule, may have the following characteristic: the base pairing of the ribonucleotides of the region (R) of the target RNA molecule contains only typical base pairs.
[0683] Where applicable, each embodiment of the embodiments of the first, second, third, fourth, or fifth aspects, or the embodiment of the asymmetric precursor RNA molecule, may have one or more of the following features: the length of the region (R) of the target RNA molecule is 22-30, 23-30, 23-33, 24-30, 30-50, 34-200, 50-100, 100-600, or 100-1000 ribonucleotides, and / or the length of the antisense sequence of the dsRNA region is 22-30, 23-30, 23-33, 24-30, 30-50, 34-200, 50-100, 100-600, or 100-1000 ribonucleotides. 1 ribonucleotide; and / or the sense sequence of the dsRNA region of the precursor RNA molecule within these ranges is shorter than the corresponding antisense sequence, preferably the sense sequence is completely shorter than the corresponding antisense sequence because there are non-base-paired ribonucleotides protruding from the dsRNA region or the product RNA molecule (P) in the antisense sequence, more preferably the length of the sense sequence is between 87% and 97%, or 87% and 96%, or 91% and 97%, or 91% and 96%, or more preferably between 94% and 97% or 94% and 96%, or the length of the sense sequence is about 21 / 22, 21 / 23, or 21 / 24 of the length of the antisense sequence, in fractional terms. Preferably, the antisense sequence in the precursor RNA molecule is completely complementary to the target RNA molecule at least along the length of the antisense sequence.
[0684] Each embodiment of the embodiments in the first, second, third, fourth, or fifth aspects, or an embodiment of the asymmetric precursor RNA molecule, may have the following feature: the precursor RNA molecule comprises two or more distinct double-stranded RNA regions (B), wherein each double-stranded RNA region (B) is independently defined herein. An example of this embodiment is... Figure 1 The structure of ledRNA is schematically shown in the figure.
[0685] In one embodiment, the sequences of the two or more distinct double-stranded RNA regions (B) with respect to the target RNA molecule are sequential.
[0686] In an alternative embodiment, the two distinct double-stranded RNA regions (B) are covalently linked by one or two linker RNA sequences. In this context, when two linker RNA sequences are present, one linker RNA sequence links the 3' end of one strand of the first double-stranded region to the 5' end of one strand of the second double-stranded region, and the other linker RNA sequence links the 3' end of the other strand of the second double-stranded region to the 5' end of the other strand of the first double-stranded region, thereby effectively forming a longer double-stranded region in the precursor RNA molecule.
[0687] In one embodiment, one or both of the adapters comprise or consist of non-base-paired ribonucleotides, preferably forming one or more protrusions or loops in the precursor RNA molecule.
[0688] Where applicable, each embodiment of the first, second, third, fourth, or fifth aspect, or the embodiment of the asymmetric precursor RNA molecule, may have the following characteristics: the two or more distinct double-stranded RNA regions (B) are capable of being cleaved by one or more RNases to produce product RNA molecules (P), the product RNA molecules (P) containing an antisense RNA sequence (J) that hybridizes to a region (R) of the target RNA molecule or to a different discontinuous region (R) of the target RNA molecule.
[0689] Where applicable, each embodiment of the first, second, third, fourth, or fifth aspect, or the embodiment of the asymmetric precursor RNA molecule, may have the following characteristics: the two or more different double-stranded RNA regions (B) are capable of being cleaved by one or more RNases to produce product RNA molecules (P), said product RNA molecules (P) containing antisense RNA sequences (J) that hybridize with regions (R) of different target RNA molecules or with corresponding regions (R) in a family of target RNA molecules.
[0690] Each embodiment of the first, second, third, fourth, or fifth aspect, or the embodiment of the asymmetric precursor RNA molecule, may have the following characteristic: the target RNA molecule encodes one or more proteins. Alternatively, the target RNA molecule may not encode a protein; for example, the target RNA may be a miRNA.
[0691] Each embodiment of the first, second, and third aspects, or the embodiment of the asymmetric precursor RNA molecule, may have the following characteristics: the eukaryotic cell is a plant cell, animal cell, or fungal cell, preferably a plant cell, arthropod cell such as an insect cell, arachnid cell, or decapod cell, nematode cell, or fungal cell. Preferred insect cells are from Lepidoptera, Coleoptera, Diptera, and Hemiptera. Other preferred arthropods include arachnids such as spiders and ticks, or decapods such as shrimp. In one embodiment, the target RNA molecule is an RNA molecule of a viral pathogen of the eukaryotic cell or organism such as a plant, insect, or decapod. In the embodiments of the first, second, and third aspects, wherein the double-stranded region (B) contains 20 to 30 base pairs, wherein all base pairs are typical base pairs, or wherein the base pairs include one or more G:U base pairs, and the eukaryotic cell may be a vertebrate cell such as a mammalian cell, a human cell, or a non-human mammalian cell, or a non-mammal vertebrate cell. In embodiments of the first, second, and third aspects, the double-stranded region (B) comprises 31 to 50 base pairs, and the eukaryotic cell is a vertebrate cell, preferably 10% to 40%, more preferably 16% to 30%, or 16% to 25% of the base pairs are G:U base pairs. More preferably, in the context of these cells, the precursor RNA molecule comprises ledRNA structures in addition to having G:U base pairs. In one embodiment, the vertebrate cell is a mammalian cell, a human cell, a non-human mammalian cell, or a non-mammal vertebrate cell. In one embodiment, the non-mammal vertebrate cell is a bird cell or a fish cell. The vertebrate cell, mammalian cell, human cell, or non-human cell can be a cultured or in vitro cell. The cell can be used for screening assays to identify suitable target RNA molecules.
[0692] In one embodiment, applicable to each embodiment of the first, second, third, fourth, or fifth aspect, or the embodiment of the asymmetric precursor RNA molecule, the target RNA molecule or multiple different target RNA molecules are located in a eukaryotic cell, which is a plant cell, animal cell, or fungal cell, preferably a plant cell, arthropod cell, nematode cell, or fungal cell. The animal cell may be an arthropod cell such as an insect cell, arachnid cell, or decapod cell. Any one of these cells may be a cell in a cell culture.
[0693] In one embodiment, for each embodiment of the first, second, third, fourth, or fifth aspect, or for the embodiment of the asymmetric precursor RNA molecule, the precursor RNA molecule is present in and / or produced in the eukaryotic cell, optionally cleaved in the eukaryotic cell by one or more RNases to produce the one or more double-stranded product RNA molecules (P). Furthermore, the target RNA molecule may be in the same cell. Alternatively, the target RNA molecule may not be in the same cell, or may not have entered the cell, for example, the target RNA molecule may originate from a viral pathogen that may or may not enter the cell. For example, the precursor RNA molecule may be produced in microbial cells such as bacterial cells or yeast cells (e.g., Saccharomyces cerevisiae), and applied to a cell or organism containing the target RNA molecule, with or without RNA extraction from the microbial cell. In one embodiment, the microbial cell is taken up by the target organism, and the precursor RNA molecule and / or the siRNA product derived from the precursor RNA molecule is released from the microbial cell.
[0694] In one embodiment, for each embodiment of the first, second, third, fourth, or fifth aspect, or for the embodiment of the asymmetric precursor RNA molecule, one or more double-stranded regions (B) comprise protrusions uniformly spaced along most or all of each double-stranded region (B). For example, Δ22-modified protrusions are spaced approximately one ribonucleotide protrusion per 22nd ribonucleotide in the second RNA sequence (G), suitable for longer sequences (G). Similarly, Δ23-modified or Δ24-modified protrusions are spaced approximately two or three antisense ribonucleotide protrusions per 23 or 24 ribonucleotides in the second RNA sequence (G), respectively. In this context, "approximately" means + / - 10%, preferably + / - 5%.
[0695] In one embodiment, for each embodiment of the first, second, third, fourth, or fifth aspect or for the embodiment of the asymmetric precursor RNA molecule, each double-stranded region (B) includes a protrusion closer to the linker RNA sequence (L) than any other protrusion in the double-stranded region (B), wherein the closer protrusion and the linker RNA sequence (L) are separated by at least four or more consecutive intermediate base pairs, preferably at least 5, at least 6, at least 7, at least 8, at least 9, or at least 10 consecutive intermediate base pairs, more preferably by 5-15, 5-14, 5-13, 5-12, or 5-11 consecutive intermediate base pairs.
[0696] In one embodiment, applicable to each embodiment of the first, second, third, fourth, or fifth aspect, or the embodiment of the asymmetric precursor RNA molecule, the precursor RNA molecule comprising a terminal base pair at the junction of the double-stranded region (B) and the linker RNA sequence (L), wherein the terminal base pair comprises a U ribonucleotide as the last 3' ribonucleotide in the first RNA sequence (E) or the first 5' ribonucleotide in the second RNA sequence (G), preferably the first 5' ribonucleotide in the second RNA sequence (G) is a U ribonucleotide.
[0697] In one embodiment, the terminal base pair at the junction of the double-stranded region (B) and the linker RNA sequence (L) is an A:U base pair or a G:U base pair, preferably a G:U base pair, and more preferably U is located in the second RNA sequence (G).
[0698] In one embodiment, applicable to each embodiment of the first, second, third, fourth, or fifth aspect, or the embodiment of the asymmetric precursor RNA molecule, the precursor RNA molecule has a single linker RNA sequence (L), thereby forming a hairpin RNA (hpRNA) structure. In one embodiment, the linker RNA sequence links the 3' end of the first RNA strand (D) and the 5' end of the second RNA strand (F). Alternatively, the linker RNA sequence links the 3' end of the second RNA strand (F) and the 5' end of the first RNA strand (D). Visually representing this alternative structure, the loop (L) will appear... Figure 53 The diagram is shown on the left side, and the transcription order is second RNA chain (F) - loop (L) - first RNA chain (D).
[0699] Alternatively, the present invention provides a precursor RNA molecule (A) identical to the precursor RNA molecule (A) or the asymmetric precursor RNA molecule of the first, second, third, fourth, or fifth aspects, except that it lacks the linker RNA sequence (L). That is, the precursor RNA molecule consists of two RNA strands annealed together. In one embodiment, the precursor RNA molecule (A) lacking (L) contains at least 44 base pairs, preferably at least 50 base pairs, more preferably at least 100 base pairs, of the second RNA strand (F), with a length of at least 100 ribonucleotides. All features of the embodiments of the first, second, and third aspects, individually or in combination, are applicable to these precursor RNA molecules (A) lacking aspect (L).
[0700] In one embodiment, each embodiment of the embodiments of the first, second, third, fourth, or fifth aspects, or the embodiment of the asymmetric precursor RNA molecule, having two double-stranded regions (B) and two linker RNA sequences (L), thereby forming an ledRNA structure (also known as a dumbbell structure). All features of the embodiments of the ledRNA structure described herein may be applied individually or in combination.
[0701] In one embodiment, each embodiment of the hairpin RNA or the ledRNA applicable to the first, second, third, fourth, or fifth aspects, or the embodiment of the asymmetric precursor RNA molecule, the precursor RNA molecule comprising a terminal base pair at the junction of the double-stranded region (B) and the linker RNA sequence (L), wherein the terminal base pair is the first base pair of a portion (C) of the double-stranded RNA region.
[0702] In one embodiment, each embodiment of the hairpin RNA or the ledRNA applicable to the first, second, third, fourth, or fifth aspects, or the embodiment of the asymmetric precursor RNA molecule, the precursor RNA molecule comprising at least one linker RNA sequence (L), the at least one linker RNA sequence (L) having a length of 4 to 2000 ribonucleotides, preferably 4 to 1000 ribonucleotides, more preferably 4 to 200 ribonucleotides or 4 to 50 ribonucleotides, and most preferably 4 to 20 nucleotides, preferably all of the linker RNA sequences in the precursor RNA molecule having the aforementioned length.
[0703] In one embodiment, each of the hairpin RNAs or ledRNAs applicable to the embodiments of the first, second, third, fourth, or fifth aspects, or as in embodiments of asymmetric precursor RNA molecules encoded by polynucleotides, at least one linker RNA sequence (L) contains an intron, preferably all of the linker RNA sequences in the precursor RNA molecule contain introns. In an alternative embodiment, precursor RNA molecules encoded by polynucleotides lack introns.
[0704] In embodiments of the first, second, third, fourth, or fifth aspects, or embodiments of the asymmetric precursor RNA molecule, the loop sequence of the hairpin precursor RNA molecule or any one or both loops of the precursor led RNA molecule contains a second copy of a sequence (seed sequence) from the dsRNA region, containing part or all of the sense or antisense sequence from the dsRNA region. For example, the precursor RNA molecule contains a second sense or antisense sequence as a seed sequence, the second sense or antisense sequence comprising at least 100 ribonucleotides from the dsRNA region (seed region), incorporated into the loop sequence or other locations within the precursor RNA molecule. The loop sequence may be chimeric, comprising the seed sequence and other sequences associated with the target RNA molecule or its complementary sequence. In one embodiment, the seed sequence is inserted into a region of the RNA molecule other than the loop, for example, into the 5' or 3' end of the precursor RNA molecule. In one embodiment, the first and second components of the precursor ledRNA molecule have double-stranded regions that target different target RNA molecules, and the first and second loop sequences correspond to regions from different target transcripts.
[0705] In one embodiment, for each embodiment of the first, second, third, fourth, or fifth aspect, or for an embodiment of the asymmetric precursor RNA molecule (including ledRNA structures), the double-stranded region (B) in the precursor RNA molecule contains only protrusions as defined herein.
[0706] In one embodiment, applicable to each embodiment of the first, second, third, fourth, or fifth aspect, or to embodiments of the asymmetric precursor RNA molecule (including precursor hairpin RNA molecules and ledRNA molecules), the precursor RNA molecule further comprises a double-stranded region containing at least 23 consecutive base pairs and lacking protrusions. In one embodiment, 5% to 40% of the at least 23 consecutive base pairs are G:U base pairs. Alternatively, the at least 23 consecutive base pairs are all typical base pairs. The precursor RNA molecule (A) of these embodiments thus provides a mixture of symmetrical and asymmetric product RNA molecules (P). In one embodiment, when cleaved by Dicer, the precursor RNA molecule provides a more asymmetric product RNA molecule than the symmetrical product RNA molecule (P).
[0707] In one embodiment, the length of the double-stranded region lacking protrusions is 30-200 consecutive base pairs, preferably at least 100 base pairs, and more preferably 100-200, 100-300, 100-400, 100-500, or 100-600 base pairs.
[0708] In one embodiment, applicable to each embodiment of the first, second, third, fourth, or fifth aspect, or to an embodiment of the asymmetric precursor RNA molecule (including ledRNA structures), the one or more RNases are type III ribonucleases, preferably Dicer or Dicer-like (DCL) proteins, more preferably DCL2 and / or DCL4 proteins or homologs. In one embodiment, the eukaryotic cells that produce the precursor RNA are plant cells in which the genes encoding DCL2 and / or DCL4 proteins are wild-type (unmodified).
[0709] In one embodiment, for each embodiment applicable to the first, second, third, fourth, or fifth aspects, or for embodiments of the asymmetric precursor RNA molecules (including precursor hairpin RNA molecules and ledRNA molecules), one, two, three, four, five, or six base pairs in at least some of the one or more double-stranded product RNA molecules (P) are atypical base pairs, preferably G:U base pairs. Preferably, most of the double-stranded product RNA molecules (P) generated from the precursor RNA molecule independently contain one, two, three, four, five, or six G:U base pairs, for example, at least 60%, at least 70%, at least 80%, or at least 90% of the product RNA molecules generated from the precursor RNA molecule contain the stated number of G:U base pairs.
[0710] In one embodiment, in each embodiment applicable to the first, second, third, fourth, or fifth aspect, or in an embodiment of the asymmetric precursor RNA molecule (including the ledRNA structure), the dsRNA region (B) and / or the portion (C) of the double-stranded RNA region and / or at least some of the product RNA molecules (P) form an atypical base pair or are not base-paired, preferably forming a G:U base pair, and / or 5% to 40% of the ribonucleotides in the dsRNA region (B) and / or the portion (C) of the double-stranded RNA region and / or at least some of the product RNA molecules (P) form an atypical base pair or are not base-paired, preferably forming a G:U base pair. Preferably, most of the double-stranded product RNA molecules (P) generated from the precursor RNA molecule independently have an average of about one-quarter to one-sixth of G:U base pairs. Preferably, at least 60%, at least 70%, at least 80%, or at least 90% of the typical base-paired ribonucleotides in the dsRNA region are located in subregions of 4-6 typical base pairs. In one embodiment, a plurality of the G:U base pairs in the population of the double-stranded product RNA molecules (P) generated from the precursor RNA molecule have G ribonucleotides in the sense RNA sequence (H) and U ribonucleotides in the antisense RNA sequence (J).
[0711] In one embodiment, 10% to 40%, 10% to 35%, 10% to 30%, or 10% to 25% of the ribonucleotides in the total of the dsRNA region (B) and / or in the total of the portion (C) of the double-stranded RNA region and / or in at least some of the product RNA molecules (P) form G:U base pairs. In another embodiment, 15% to 40%, 15% to 35%, 15% to 30%, or 15% to 25% of the ribonucleotides in the total of the dsRNA region (B) and / or in the total of the portion (C) of the double-stranded RNA region and / or in at least some of the product RNA molecules (P) form G:U base pairs. In one embodiment, 17% to 40%, 17% to 35%, 17% to 30%, or 17% to 25% of the ribonucleotides in the total of the dsRNA region (B) and / or the total of the portion (C) of the double-stranded RNA region and / or at least some of the product RNA molecules (P) form G:U base pairs. In another embodiment, about 10%, about 15%, about 20%, about 25%, about 30%, or about 35% of the ribonucleotides in the total of the dsRNA region (B) and / or the total of the portion (C) of the double-stranded RNA region and / or at least some of the product RNA molecules (P) form G:U base pairs.
[0712] In one embodiment, applicable to each embodiment of the first, second, third, fourth, or fifth aspect, or to embodiments of the asymmetric precursor RNA molecule (including precursor hairpin RNA molecules and ledRNA molecules), the at least one double-stranded RNA region (B) in the precursor RNA molecule, preferably all double-stranded RNA regions (B), lacks 8 consecutive typical base pairs. This can be readily achieved, in addition to the protrusions in the double-stranded RNA regions, by introducing appropriately distributed G:U base pairs.
[0713] In one embodiment, applicable to each embodiment of the first, second, third, fourth, or fifth aspect, or the embodiment of the asymmetric precursor RNA molecule (including precursor hairpin RNA molecules and ledRNA molecules), the precursor RNA molecule, upon cleavage by the one or more RNases, produces at least two, at least three, at least four, at least five, at least six, at least seven, at least eight, at least nine, at least 10, at least 15, at least 20, at least 30, at least 40, at least 50, or at least 100 different product RNA molecules (P). In one embodiment, the precursor RNA molecule, upon cleavage by the one or more RNases, produces at least two, at least three, at least four, at least five, at least six, at least seven, at least eight, at least nine, at least 10, at least 11, at least 12, at least 13, at least 14, at least 15, at least 20, at least 25, at least 30, at least 40, and at most about 50 non-overlapping different product RNA molecules (P).
[0714] In one embodiment, applicable to each embodiment of the first, second, third, fourth, or fifth aspect, or the embodiment of the asymmetric precursor RNA molecule (including precursor hairpin RNA molecules and ledRNA molecules), the first RNA strand (D) and / or the second RNA strand (F), preferably both, comprise at least 50, at least 100, at least 200, at least 300, at least 400, at least 500, at least 600, at least 700, at least 800, at least 900, at least 1,000, or 100 to 1,000, or 50 to 1,000 nucleotides, or 50 to 500, or 100 to 500 ribonucleotides. In a preferred embodiment, the first RNA strand (D) is shorter than the second RNA strand (F).
[0715] In one embodiment, applicable to each embodiment of the first, second, third, fourth, or fifth aspect, or to an embodiment of the asymmetric precursor RNA molecule (including precursor hairpin RNA molecules and ledRNA molecules), the precursor RNA molecule having a single double-stranded RNA region (B) and a single portion (C) extending to cover the entire double-stranded RNA region (B), i.e., the single portion (C) corresponding to the entire double-stranded RNA region (B).
[0716] In one embodiment, both the RNA strands (D) and (F) of the double-stranded region (B) are 23 to 33 ribonucleotides in length, and the double-stranded region (B) contains at least 18 base pairs, preferably at least 19 or at least 20 base pairs. This is preferred when the eukaryotic cell is a vertebrate cell, particularly a mammalian cell. In this embodiment, preferably, one, two, three, four, five, or six base pairs in at least some of the one or more double-stranded product RNA molecules (P) produced from the precursor RNA molecule are atypical base pairs, preferably G:U base pairs.
[0717] In one embodiment, each embodiment applicable to the first, second, and third aspects includes the ledRNA molecule.
[0718] (i) The lengths of the RNA strands (D) and (F) in the double-stranded region (B) are each between 34 and 200 ribonucleotides.
[0719] (ii) In the RNA strands (D) and (F), a total of at least 80%, preferably at least 90%, of the ribonucleotides are base-paired, thereby forming the double-stranded region (B) of the precursor RNA molecule, and
[0720] (iii) A total of 5% to 40% of the ribonucleotides in the dsRNA region (B) are base-paired with atypical base pairs or not base-paired, preferably with G:U base pairs. In this context, preferably 10% to 40%, 10% to 35%, 10% to 30%, or 10% to 25% of the ribonucleotides in the total of the dsRNA region (B) and / or in the total of the portion (C) of the double-stranded RNA region and / or in at least some of the product RNA molecules (P) form G:U base pairs. More preferably, 15% to 40%, 15% to 35%, 15% to 30%, or 15% to 25% of the ribonucleotides in the total of the dsRNA region (B) and / or in the total of the portion (C) of the double-stranded RNA region and / or in at least some of the product RNA molecules (P) form G:U base pairs. Even more preferably, 17% to 40%, 17% to 35%, 17% to 30%, or 17% to 25% of the ribonucleotides in the total of the dsRNA region (B) and / or in the total of the portion (C) of the double-stranded RNA region and / or in at least some of the product RNA molecules (P) form G:U base pairs. In one embodiment, about 10%, about 15%, about 20%, about 25%, about 30%, or about 35% of the ribonucleotides in the total of the dsRNA region (B) and / or in the total of the portion (C) of the double-stranded RNA region and / or in at least some of the product RNA molecules (P) form G:U base pairs. Such molecules are particularly useful in vertebrate cells such as mammalian cells.
[0721] In one embodiment, each embodiment applicable to the first, second, third, fourth, or fifth aspect, or the embodiment of the asymmetric precursor RNA molecule (including ledRNA molecule), is derived from at least one product RNA molecule (P) of the product RNA molecule (P) produced by the precursor RNA molecule. Preferably, the antisense RNA sequence (J) of a plurality of different product RNA molecules is capable of hybridizing with the region (R) of the target RNA molecule in a eukaryotic cell by all at least 2 to 8 ribonucleotides of the antisense RNA sequence (J) that pair with the ribonucleotide bases in the region (R) of the target RNA molecule, preferably all at least 2-10 or 2-11 ribonucleotides of the antisense RNA sequence (J).
[0722] In one embodiment, at least 50%, at least 75%, at least 90%, or at least 95% of the ribonucleotides of the antisense RNA sequence (J) are capable of pairing with ribonucleotide bases in the region (R) of the target RNA molecule in the eukaryotic cell.
[0723] In one embodiment, all ribonucleotides of the antisense RNA sequence (J), preferably all ribonucleotides of multiple different antisense RNA sequences (J), are capable of pairing with ribonucleotide bases in region (R) of the target RNA molecule in the eukaryotic cell. In a preferred embodiment, all ribonucleotides of the antisense RNA sequence (J), preferably all ribonucleotides of multiple different antisense RNA sequences (J), are capable of base pairing with ribonucleotides in region (R) of the target RNA molecule in the eukaryotic cell (particularly plant cells, fungal cells, nematode cells, or arthropod cells such as insect cells) via typical base pairs.
[0724] In one embodiment, applicable to each embodiment of the first, second, and third aspects, or to embodiments of the asymmetric precursor RNA molecules (including precursor hairpin RNA molecules and ledRNA molecules), the eukaryotic cell containing the target RNA molecule is a vertebrate cell, preferably a mammalian cell, more preferably a human cell, or a non-mammal vertebrate cell such as a bird cell or a fish cell. The vertebrate cell may be a companion animal or livestock cell.
[0725] In one embodiment, each embodiment applicable to the embodiments of the first, second, third, fourth, or fifth aspects, or the embodiment of the asymmetric precursor RNA molecule (including precursor hairpin RNA molecules and ledRNA molecules),
[0726] (i) The first RNA sequence (E) differs from the corresponding wild-type RNA sequence in the target RNA molecule in that one or more ribonucleotides are deleted from the corresponding wild-type RNA sequence to prepare the first RNA sequence, preferably by deleting multiple ribonucleotides in the Δ22, Δ23, or Δ24 patterns, and / or
[0727] (ii) The second RNA sequence (G) differs from the perfectly complementary sequence of the corresponding wild-type RNA sequence in the target RNA molecule in that one or more ribonucleotides are inserted into the perfectly complementary sequence to prepare the second RNA sequence or the sequence, preferably (i). In a preferred embodiment, the second RNA chain (F) is identical in sequence along its entire length to the complementary sequence of the wild-type RNA sequence in the target RNA molecule, particularly for target RNA molecules in plant, arthropod, arachnid, or decapod, nematode, or fungal cells.
[0728] In one embodiment, for each embodiment of the first, second, third, fourth, or fifth aspect, or for the embodiment of the asymmetric precursor RNA molecule (including precursor hairpin RNA molecules and ledRNA molecules), the deletion of ribonucleotides from the corresponding wild-type RNA sequence occurs at one or more ribonucleotide positions corresponding to the non-base-paired ribonucleotides in the second RNA sequence (G) as defined herein.
[0729] In one embodiment, each embodiment applicable to the first, second, third, fourth, or fifth aspect includes a precursor hairpin RNA molecule and an ledRNA molecule, wherein the second RNA sequence (G) is identical in length to the perfectly complementary sequence of the corresponding wild-type RNA sequence in the target RNA molecule. That is, the second RNA sequence (G) does not have any ribonucleotide insertions or deletions relative to the complementary sequence of the region in the target RNA molecule.
[0730] In one embodiment, each embodiment applicable to the embodiments of the first, second, third, fourth, or fifth aspects, or the embodiment of the asymmetric precursor RNA molecule (including precursor hairpin RNA molecules and ledRNA molecules),
[0731] (i) The first RNA sequence (E) differs from the corresponding wild-type RNA sequence in the target RNA molecule in that one or more A or C ribonucleotides in the corresponding wild-type RNA sequence are replaced with G or U ribonucleotides, thereby producing the first RNA sequence, wherein the G or U ribonucleotides participate in the G:U base pair with the ribonucleotides of the second RNA sequence (G), and / or
[0732] (ii) The second RNA sequence (G) differs from the fully complementary sequence in that one or more A or C ribonucleotides in the fully complementary sequence are replaced with G or U ribonucleotides, thereby producing the second RNA sequence, wherein the G or U ribonucleotides participate in the G:U base pair with the ribonucleotides of the first RNA sequence (E), preferably (i).
[0733] In another aspect, the present invention provides a precursor RNA molecule comprising:
[0734] i) The first double-stranded RNA region (B) of the first aspect of the present invention and the second double-stranded RNA region (B) of the second aspect of the present invention.
[0735] ii) The first double-stranded RNA region (B) of the first aspect of the present invention and the second double-stranded RNA region (B) of the third aspect of the present invention.
[0736] iii) The first double-stranded RNA region (B) of the second aspect of the present invention and the second double-stranded RNA region (B) of the third aspect of the present invention.
[0737] iv) The first double-stranded RNA region (B) of the first aspect of the present invention, the second double-stranded RNA region (B) of the second aspect of the present invention, and the third double-stranded RNA region (B) of the third aspect of the present invention.
[0738] v) The first double-stranded RNA region (B) of the first aspect of the present invention and the second double-stranded RNA region (B) of the first aspect of the present invention.
[0739] vi) The first double-stranded RNA region (B) of the second aspect of the present invention and the second double-stranded RNA region (B) of the second aspect of the present invention.
[0740] vii) The first double-stranded RNA region (B) of the third aspect of the present invention and the second double-stranded RNA region (B) of the third aspect of the present invention, or
[0741] viii)i) to vii) any combination. All combinations of embodiments of the first, second, and third aspects are considered herein.
[0742] In one embodiment, the precursor RNA molecule comprises two, three, four, five, ten, fifteen, twenty or more double-stranded RNA regions according to the first aspect of the present invention, two, three, four, five, ten, fifteen, twenty or more double-stranded RNA regions according to the second aspect of the present invention, two, three, four, five, ten, fifteen, twenty or more double-stranded RNA regions according to the third aspect of the present invention, or any combination thereof.
[0743] Each embodiment of the precursor RNA molecules described in the first, second, third, fourth, and fifth aspects above, as well as precursor RNA molecules lacking the linker RNA sequence, can be used to reduce the expression and / or activity of target RNA molecules in eukaryotic cells (preferably plant cells, fungal cells, or nematode cells, or arthropod cells such as insect cells or decapod cells). It can also be used to reduce the expression and / or activity of viral target RNA molecules (such as plant viruses, including specific plant viruses mentioned herein). It can also be used to reduce the expression and / or activity of target RNA molecules in other invertebrate cells (such as arthropod or insect cells, nematode cells) or non-mammalian vertebrate cells. A single precursor RNA molecule or a combination of precursor RNA molecules can also be used to reduce the expression and / or activity of multiple target RNA molecules, for example, produced by multiple genes. The precursor RNA molecule is useful through processing to produce the product RNA molecule (P), wherein the antisense sequence (J) works in conjunction with the Argonaute protein in RISC, a mechanism well known in the art. It can also be useful by enhancing the production of secondary antisense sRNA molecules relative to the corresponding conventional RNA molecule. The precursor RNA molecule can be produced in plant cells to reduce insect target RNA molecules, fungal pathogens, or nematode target RNA molecules upon ingestion, or applied locally to plants or insects to reduce target RNA molecules.
[0744] On one hand, the present invention provides a double-stranded RNA molecule (P) comprising a sense RNA sequence (H) of 21 consecutive ribonucleotides, an antisense RNA sequence (J) of 22 consecutive ribonucleotides, and one, two, or three protrusions.
[0745] In the sense RNA sequence (H), 18 or 19 of ribonucleotides 1 to 19 are each paired with ribonucleotide bases 1 to 20 of the antisense RNA sequence (J).
[0746] Each of the one, two, or three protrusions is immediately followed by a ribonucleotide, which is base-paired in the double-stranded RNA molecule.
[0747] The sense RNA sequence contains ribonucleotides 20 and 21 forming an unpaired 3' overhang consisting of two ribonucleotides, and the antisense RNA sequence contains ribonucleotides 21 and 22 forming an unpaired 3' overhang consisting of two ribonucleotides.
[0748] The sense RNA sequence contains ribonucleotides 1 and 2 that pair with ribonucleotides 19 and 20 of the antisense RNA sequence, respectively.
[0749] The sense RNA sequence contains ribonucleotides 18 and 19 that are paired with ribonucleotides 1 and 2 of the antisense RNA sequence, respectively.
[0750] In one embodiment,
[0751] (i) Ribonucleotides 1, 2, and 3 of the sense RNA sequence (H) are paired with ribonucleotides 18, 19, and 20 of the antisense RNA sequence (J), respectively, or
[0752] (ii) Ribonucleotides 17, 18, and 19 of the sense RNA sequence (H) are paired with ribonucleotides 1, 2, and 3 of the antisense RNA sequence (J), respectively.
[0753] Or preferably both (i) and (ii). In additional features of these embodiments, the product RNA molecule may have at least four, at least five, or at least six consecutive base pairs at one or both ends of the double-stranded molecule before any protrusion. In these embodiments, any one of those base pairs may be a G:U base pair, preferably one or more ribonucleotides of ribonucleotides 1, 2, and 3 of the antisense sequence (J) participating in the G:U base pair, more preferably one or two ribonucleotides of ribonucleotides 1 and 2 of the antisense sequence (J) participating in the G:U base pair, and even more preferably ribonucleotide 1 of the antisense sequence (J) participating in the G:U base pair. Most preferably, one or more ribonucleotides of ribonucleotides 1, 2, and 3 of the antisense sequence (J) are U ribonucleotides, or one or two ribonucleotides of ribonucleotides 1 and 2 are U ribonucleotides, or ribonucleotide 1 is a U ribonucleotide.
[0754] On one hand, the present invention provides a double-stranded RNA molecule (P) comprising a sense RNA sequence (H) of 21 consecutive ribonucleotides, an antisense RNA sequence (J) of 23 consecutive ribonucleotides, and one, two, three, or four protrusions.
[0755] In the sense RNA sequence (H), 18 or 19 of ribonucleotides 1 to 19 are each paired with ribonucleotide bases 1 to 21 of the antisense RNA sequence (J).
[0756] Each of the one, two, three, or four protrusions is immediately followed by a ribonucleotide, which is base-paired in the double-stranded RNA molecule.
[0757] The sense RNA sequence contains ribonucleotides 20 and 21 forming an unpaired 3' overhang of two ribonucleotides, and the antisense RNA sequence contains ribonucleotides 22 and 23 forming an unpaired 3' overhang of two ribonucleotides.
[0758] The sense RNA sequence contains ribonucleotides 1 and 2 that pair with ribonucleotides 20 and 21 of the antisense RNA sequence, respectively.
[0759] The sense RNA sequence contains ribonucleotides 18 and 19 that are paired with ribonucleotides 1 and 2 of the antisense RNA sequence, respectively.
[0760] In one embodiment,
[0761] (i) Ribonucleotides 1, 2, and 3 of the sense RNA sequence (H) are paired with ribonucleotides 19, 20, and 21 of the antisense RNA sequence (J), respectively, or
[0762] (ii) Ribonucleotides 17, 18, and 19 of the sense RNA sequence (H) are paired with ribonucleotides 1, 2, and 3 of the antisense RNA sequence (J), respectively.
[0763] Or preferably both (i) and (ii). In additional features of these embodiments, the product RNA molecule may have at least four, at least five, or at least six consecutive base pairs at one or both ends of the double-stranded molecule before any protrusion. In these embodiments, any one of those base pairs may be a G:U base pair, preferably one or more ribonucleotides of ribonucleotides 1, 2, and 3 of the antisense sequence (J) participating in the G:U base pair, more preferably one or two ribonucleotides of ribonucleotides 1 and 2 of the antisense sequence (J) participating in the G:U base pair, and even more preferably ribonucleotide 1 of the antisense sequence (J) participating in the G:U base pair. Most preferably, one or more ribonucleotides of ribonucleotides 1, 2, and 3 of the antisense sequence (J) are U ribonucleotides, or one or two ribonucleotides of ribonucleotides 1 and 2 are U ribonucleotides, or ribonucleotide 1 is a U ribonucleotide.
[0764] On one hand, the present invention provides a double-stranded RNA molecule (P) comprising a sense RNA sequence (H) of 21 consecutive ribonucleotides and an antisense RNA sequence (J) of 24 consecutive ribonucleotides, and one, two, three, four, or five protrusions.
[0765] In the sense RNA sequence, 18 or 19 of ribonucleotides 1 to 19 are each paired with ribonucleotide bases 1 to 22 of the antisense RNA sequence (J).
[0766] Each of the one, two, three, four, or five protrusions is immediately followed by a ribonucleotide, which is base-paired in the double-stranded RNA molecule.
[0767] The sense RNA sequence contains ribonucleotides 20 and 21 forming an unpaired 3' overhang of two ribonucleotides, and the antisense RNA sequence contains ribonucleotides 23 and 24 forming an unpaired 3' overhang of two ribonucleotides.
[0768] The sense RNA sequence contains ribonucleotides 1 and 2 that pair with ribonucleotides 21 and 22 of the antisense RNA sequence, respectively.
[0769] The sense RNA sequence contains ribonucleotides 18 and 19 that are paired with ribonucleotides 1 and 2 of the antisense RNA sequence, respectively.
[0770] In one embodiment,
[0771] (i) Ribonucleotides 1, 2, and 3 of the sense RNA sequence (H) are paired with ribonucleotides 20, 21, and 22 of the antisense RNA sequence (J), respectively, or
[0772] (ii) Ribonucleotides 17, 18, and 19 of the sense RNA sequence (H) are paired with ribonucleotides 1, 2, and 3 of the antisense RNA sequence (J), respectively.
[0773] Or preferably both (i) and (ii). In additional features of these embodiments, the product RNA molecule may have at least four, at least five, or at least six consecutive base pairs at one or both ends of the double-stranded molecule before any protrusion. In these embodiments, any one of those base pairs may be a G:U base pair, preferably one or more ribonucleotides of ribonucleotides 1, 2, and 3 of the antisense sequence (J) participating in the G:U base pair, more preferably one or two ribonucleotides of ribonucleotides 1 and 2 of the antisense sequence (J) participating in the G:U base pair, and even more preferably ribonucleotide 1 of the antisense sequence (J) participating in the G:U base pair. Most preferably, one or more ribonucleotides of ribonucleotides 1, 2, and 3 of the antisense sequence (J) are U ribonucleotides, or one or two ribonucleotides of ribonucleotides 1 and 2 are U ribonucleotides, or ribonucleotide 1 is a U ribonucleotide.
[0774] In one embodiment, applicable to each of these aspects, the base pairing between the ribonucleotides of the sense RNA sequence (H) and the ribonucleotides of the antisense RNA sequence (J) comprises one, two, three, four, five, or six G:U base pairs. Preferably, all G:U base pairs have the G ribonucleotide in the sense RNA sequence (H) and the U ribonucleotide in the antisense RNA sequence (J).
[0775] In one embodiment, applicable to each of these aspects, the base pairing between the ribonucleotides of the sense RNA sequence (H) and the ribonucleotides of the antisense RNA sequence (J) lacks a G:U base pair, preferably lacking atypical base pairs.
[0776] In one embodiment, applicable to all the above aspects, the ribonucleotide 1 of the antisense RNA sequence (J) in at least some of the product RNA molecules (P) is a U ribonucleotide. In one embodiment, the ribonucleotide 1 of the antisense RNA sequence (J) in at least some of the product RNA molecules (P) is a U ribonucleotide that pairs with a G ribonucleotide base in the sense RNA sequence (H).
[0777] In one embodiment, applicable to all the above aspects, all at least 2-8, 2-10, or 2-11 ribonucleotides of the antisense RNA sequence (J) are paired with ribonucleotide bases in region (R) of the target RNA molecule in a eukaryotic cell, preferably all ribonucleotides of the antisense RNA sequence are paired with ribonucleotide bases in region (R) of the target RNA molecule. In a preferred embodiment, all ribonucleotides of the antisense RNA sequence (J) are paired with ribonucleotide bases in region (R) of the target RNA molecule via typical base pairs.
[0778] In an embodiment of the fourth or fifth aspect, or in an embodiment of the asymmetric precursor RNA molecule described in the first, second, third, fourth, or fifth aspect, the double-stranded RNA molecule comprises a sense RNA sequence of 21 consecutive ribonucleotides, an antisense RNA sequence of 22 consecutive ribonucleotides, and one, two, or three protrusions.
[0779] In the sense RNA sequence, 18 or 19 of ribonucleotides 1 to 19 are each paired with ribonucleotide bases 1 to 20 of the antisense RNA sequence.
[0780] In each of the double-stranded RNA product molecules, the base pair between the sense RNA sequence and the antisense RNA sequence independently comprises 2, 3, 4, 5, or 6 G:U base pairs.
[0781] Each of the one, two, or three protrusions is immediately followed by a ribonucleotide, which is base-paired in the double-stranded RNA molecule.
[0782] The sense RNA sequence contains ribonucleotides 20 and 21 forming an unpaired 3' overhang consisting of two ribonucleotides, and the antisense RNA sequence contains ribonucleotides 21 and 22 forming an unpaired 3' overhang consisting of two ribonucleotides.
[0783] The sense RNA sequence contains ribonucleotides 1 and 2 that pair with ribonucleotides 19 and 20 of the antisense RNA sequence, respectively.
[0784] The sense RNA sequence contains ribonucleotides 18 and 19 that are paired with ribonucleotides 1 and 2 of the antisense RNA sequence, respectively.
[0785] In one embodiment, (i) ribonucleotides 1, 2, and 3 of the sense RNA sequence are paired with ribonucleotides 18, 19, and 20 of the antisense RNA sequence, respectively, or (ii) ribonucleotides 17, 18, and 19 of the sense RNA sequence are paired with ribonucleotides 1, 2, and 3 of the antisense RNA sequence, respectively, or preferably both (i) and (ii).
[0786] In an embodiment of the fourth or fifth aspect, or in an embodiment of the asymmetric precursor RNA molecule described in the first, second, third, fourth, or fifth aspect, the double-stranded RNA molecule comprises a sense RNA sequence of 21 consecutive ribonucleotides, an antisense RNA sequence of 23 consecutive ribonucleotides, and one, two, three, or four protrusions.
[0787] In the sense RNA sequence, 18 or 19 of ribonucleotides 1 to 19 are each paired with ribonucleotide bases 1 to 21 of the antisense RNA sequence.
[0788] In each of the double-stranded RNA product molecules, the base pair between the sense RNA sequence and the antisense RNA sequence independently comprises 2, 3, 4, 5, or 6 G:U base pairs.
[0789] Each of the one, two, three, or four protrusions is immediately followed by a ribonucleotide, which is base-paired in the double-stranded RNA molecule.
[0790] The sense RNA sequence contains ribonucleotides 20 and 21 forming an unpaired 3' overhang of two ribonucleotides, and the antisense RNA sequence contains ribonucleotides 22 and 23 forming an unpaired 3' overhang of two ribonucleotides.
[0791] The sense RNA sequence contains ribonucleotides 1 and 2 that pair with ribonucleotides 20 and 21 of the antisense RNA sequence, respectively.
[0792] The sense RNA sequence contains ribonucleotides 18 and 19 that are paired with ribonucleotides 1 and 2 of the antisense RNA sequence, respectively.
[0793] In one embodiment, (i) ribonucleotides 1, 2, and 3 of the sense RNA sequence are paired with ribonucleotides 19, 20, and 21 of the antisense RNA sequence, respectively, or (ii) ribonucleotides 17, 18, and 19 of the sense RNA sequence are paired with ribonucleotides 1, 2, and 3 of the antisense RNA sequence, respectively, or preferably both (i) and (ii).
[0794] In an embodiment of the fourth or fifth aspect, or in an embodiment of the asymmetric precursor RNA molecule described in the first, second, third, fourth, or fifth aspect, the double-stranded RNA molecule comprises a sense RNA sequence of 21 consecutive ribonucleotides, an antisense RNA sequence of 24 consecutive ribonucleotides, and one, two, three, four, or five protrusions.
[0795] In the sense RNA sequence, 18 or 19 of ribonucleotides 1 to 19 are each paired with ribonucleotide bases 1 to 22 of the antisense RNA sequence.
[0796] In each of the double-stranded RNA product molecules, the base pair between the sense RNA sequence and the antisense RNA sequence independently comprises 2, 3, 4, 5, or 6 G:U base pairs.
[0797] Each of the one, two, three, four, or five protrusions is immediately followed by a ribonucleotide, which is base-paired in the double-stranded RNA molecule.
[0798] The sense RNA sequence contains ribonucleotides 20 and 21 forming an unpaired 3' overhang of two ribonucleotides, and the antisense RNA sequence contains ribonucleotides 23 and 24 forming an unpaired 3' overhang of two ribonucleotides.
[0799] The sense RNA sequence contains ribonucleotides 1 and 2 that pair with ribonucleotides 21 and 22 of the antisense RNA sequence, respectively.
[0800] The sense RNA sequence contains ribonucleotides 18 and 19 that are paired with ribonucleotides 1 and 2 of the antisense RNA sequence, respectively.
[0801] In one embodiment, (i) ribonucleotides 1, 2 and 3 of the sense RNA sequence are paired with ribonucleotides 20, 21 and 22 of the antisense RNA sequence, respectively, or (ii) ribonucleotides 17, 18 and 19 of the sense RNA sequence are paired with ribonucleotides 1, 2 and 3 of the antisense RNA sequence, respectively, or preferably both (i) and (ii).
[0802] In one embodiment, the ribonucleotide 1 of the antisense RNA sequence is a U ribonucleotide. In another embodiment, the ribonucleotide 1 of the antisense RNA sequence is a U ribonucleotide that pairs with a G ribonucleotide base in the sense RNA sequence.
[0803] In one embodiment, the double-stranded RNA molecule (P) has one or more of the features defined herein.
[0804] As illustrated herein, the number of eukaryotic siRNA molecules comprising antisense RNA sequences (J) of 22, 23, or 24 ribonucleotides relative to 21 ribonucleotides can be altered by Δ22, Δ23, or Δ24 modifications in the precursor RNA molecule, relative to the unmodified corresponding conventional precursor RNA molecule, particularly along the full length of the double-stranded region (B) containing the second RNA strand (F) of at least 100 ribonucleotides. Therefore, on one hand, the present invention provides a population of multiple different double-stranded RNA molecules (P) of the present invention. On the other hand, the present invention provides a population of multiple different double-stranded RNA molecules comprising the double-stranded RNA molecule of the present invention or any combination thereof.
[0805] In one embodiment, the population of the plurality of different double-stranded RNA molecules (P) comprises at least two, at least three, at least four, at least five, at least six, at least seven, at least eight, at least nine, at least 10, at least 15, at least 20, at least 30, at least 40, at least 50, or at least 100 different product RNA molecules (P), each of the different product RNA molecules (P) independently comprising:
[0806] (i) A 22-continuous antisense RNA sequence (J) with one, two, or three protrusions,
[0807] (ii) A 23-continuous antisense RNA sequence (J) with one, two, three, or four protrusions,
[0808] (iii) A 24-continuous antisense RNA sequence (J) with one, two, three, four, or five protrusions, or
[0809] (iv) Any combination of (i), (ii) and (iii).
[0810] In one embodiment, the population of the plurality of different double-stranded RNA molecules (P) includes (i) or (ii) above.
[0811] In one embodiment,
[0812] (i) The population contains more antisense RNA sequences (J) consisting of 22 ribonucleotides than antisense RNA sequences (J) consisting of 21 ribonucleotides.
[0813] (ii) The population contains more antisense RNA sequences (J) consisting of 23 ribonucleotides than antisense RNA sequences (J) consisting of 21 ribonucleotides.
[0814] (iii) The population contains more antisense RNA sequences (J) consisting of 24 ribonucleotides than antisense RNA sequences (J) consisting of 21 ribonucleotides, or
[0815] (iv) Any combination of (i), (ii) and (iii).
[0816] In an embodiment of the first, second, third, fourth, or fifth aspect, or in an embodiment of the asymmetric precursor RNA molecule, the present invention provides a population of multiple different double-stranded RNA molecules. In one embodiment, the population of multiple different double-stranded RNA molecules comprises at least two, at least three, at least four, at least five, at least six, at least seven, at least eight, at least nine, at least 10, at least 15, at least 20, at least 30, at least 40, at least 50, or at least 100 different product RNA molecules, each of the different product RNA molecules independently comprising:
[0817] (i) A 22-continuous antisense RNA sequence with one, two, or three protrusions,
[0818] (ii) A 23-string antisense RNA sequence with one, two, three, or four protrusions.
[0819] (iii) A 24-continuous antisense RNA sequence of ribonucleotides and one, two, three, four, or five protrusions, or
[0820] (iv) Any combination of (i), (ii) and (iii).
[0821] In one embodiment, the population of the plurality of different double-stranded RNA molecules includes the following characteristics:
[0822] (i) The population contains more antisense RNA sequences consisting of 22 ribonucleotides than antisense RNA sequences consisting of 21 ribonucleotides.
[0823] (ii) The population contains more antisense RNA sequences consisting of 23 ribonucleotides than antisense RNA sequences consisting of 21 ribonucleotides.
[0824] (iii) The population contains more antisense RNA sequences consisting of 24 ribonucleotides than antisense RNA sequences consisting of 21 ribonucleotides, or
[0825] (iv) Any combination of (i), (ii) and (iii).
[0826] In an embodiment of the first, second, third, fourth, or fifth aspect, or in an embodiment of the asymmetric precursor RNA molecule, the present invention provides a method for increasing the amount of small interfering RNA (sRNA) of 22, 23, or 24 ribonucleotides in length in insect cells or insect or fungal cells or fungi, or for increasing the ratio of the amount of sRNA of 22, 23, or 24 ribonucleotides in length to the amount of sRNA of 21 ribonucleotides in length, the method comprising delivering to the eukaryotic cells (such as plant cells, nematode cells, insect cells, or fungal cells), insects, or fungi one or more of the following of the present invention: precursor RNA molecules, double-stranded RNA molecules, populations of multiple different double-stranded RNA molecules, polynucleotides, vectors, cells, non-human objects or portions thereof, extracts, and compositions.
[0827] On one hand, the present invention provides a eukaryotic cell containing the double-stranded RNA molecule (P) of the present invention.
[0828] On the one hand, the present invention provides a population of eukaryotic cells comprising a plurality of different double-stranded RNA molecules (P) of the present invention.
[0829] In an embodiment of the first, second, third, fourth, or fifth aspect or in an embodiment of the asymmetric precursor RNA molecule, the present invention provides a eukaryotic cell (such as a plant cell, nematode cell, insect cell, or fungal cell) comprising one or more of the following: the precursor RNA molecule of the present invention, a double-stranded RNA molecule, and a group of multiple different double-stranded RNA molecules, wherein the eukaryotic cell is preferably a plant cell, insect cell, or fungal cell such as a yeast cell.
[0830] In one embodiment, the eukaryotic cell comprises one or two of a group of precursor RNA molecules of the present invention and multiple different double-stranded RNA molecules.
[0831] On one hand, the present invention provides a double-stranded RNA molecule (P) which can be obtained by cleaving a precursor RNA molecule of the present invention or from a precursor RNA molecule of the present invention, wherein the double-stranded RNA molecule has one or more of any of the features defined herein.
[0832] On one hand, the present invention provides a double-stranded RNA molecule (P) which can be obtained by cleaving the precursor RNA molecule of the present invention or from the precursor RNA molecule of the present invention.
[0833] On one hand, the present invention provides a method for identifying a double-stranded RNA molecule (P) or a precursor RNA molecule (A) used to reduce the amount and / or activity of a target RNA molecule of interest, the method comprising:
[0834] i) To generate the precursor RNA molecule (A) and / or double-stranded RNA molecule of the present invention, or a group of multiple different precursor RNA molecules (A) and / or multiple different double-stranded RNA molecules of the present invention.
[0835] ii) Determine the ability of the precursor RNA molecule, the double-stranded RNA molecule, or a group of multiple different precursor RNA molecules or multiple different double-stranded RNA molecules to reduce the amount and / or activity of the target RNA molecule of interest. Thus, the RNA molecules of the present invention can be used for screening assays to identify suitable precursor RNA molecules that downregulate known target RNA molecules, or to identify target RNA molecules associated with a suitable phenotype or function in the eukaryotic cells.
[0836] In one embodiment, step i) includes expressing the precursor RNA molecule (A) of the present invention in the eukaryotic cell, wherein the precursor RNA molecule is cleaved in the eukaryotic cell by one or more ribonucleases (RNases) to produce the double-stranded RNA molecule or a population of the plurality of different double-stranded RNA molecules.
[0837] In one embodiment, the method further comprises designing the double-stranded RNA molecule based on a region (R) of the ribonucleotide sequence of the target RNA molecule of interest, preferably using features defined herein.
[0838] In one embodiment, the method further includes a step of generating one or more of the double-stranded RNA molecules or the precursor RNA molecules after step ii), for example, in a kit for commercial use containing the double-stranded RNA molecules or the precursor RNA molecules.
[0839] In an embodiment of the precursor RNA molecule described in the fourth or fifth aspect, or in an embodiment of the asymmetric precursor RNA molecule, the present invention provides a method for identifying a double-stranded RNA molecule or precursor RNA molecule for reducing the amount and / or activity of a target RNA molecule of interest in insect or fungal cells, the method comprising:
[0840] i) To generate the precursor RNA molecule of the present invention, and / or double-stranded RNA molecule, or a group of multiple different precursor RNA molecules, and
[0841] ii) Determine the ability of the precursor RNA molecule, or the double-stranded RNA molecule, or a member of a group of multiple different precursor RNA molecules, or a group of multiple different double-stranded RNA molecules to reduce the amount and / or activity of the target RNA molecule of interest in the insect or fungal cell.
[0842] In one embodiment, step i) comprises introducing the precursor RNA molecule of the present invention into: (i) insect cells, preferably by ingestion, soaking, dusting, spraying or injecting an insect containing the insect cells; and / or (ii) fungal cells, preferably by local application, such as soaking, dusting, spraying or administering a composition containing the precursor RNA molecule to the fungal cells; wherein the precursor RNA molecule is cleaved by Dicer in the insect cells or the fungal cells to produce the double-stranded RNA molecule or a population of the plurality of different double-stranded RNA molecules.
[0843] In one embodiment, step i) comprises introducing the precursor RNA molecule of the present invention into a plant cell or microbial cell, such as a bacterial cell or a yeast cell, and step ii) comprises delivering the plant cell or microbial cell of step (i) to the insect cell or the fungal cell, preferably by ingestion of the plant cell or the microbial cell, wherein the precursor RNA molecule is cleaved by Dicer in the insect cell or the fungal cell to produce the double-stranded RNA molecule or a population of the plurality of different double-stranded RNA molecules. In one embodiment, the method further comprises a step of producing the double-stranded RNA molecule or a plurality of the precursor RNA molecules after step ii).
[0844] The invention also provides methods for identifying or generating double-stranded RNA molecules (P) or precursor RNA molecules (A) using the methods of the present invention.
[0845] On the one hand, the present invention provides an isolated and / or exogenous polynucleotide that encodes the precursor RNA molecule of the present invention.
[0846] In one embodiment, the polynucleotide is a DNA construct such as a chimeric DNA construct. Alternatively, the polynucleotide is an RNA construct, such as an RNA construct based on a viral RNA genome.
[0847] In one embodiment, the polynucleotide is operatively linked to a promoter capable of guiding the expression of the precursor RNA molecule in a host cell, preferably a eukaryotic cell such as a plant cell, and optionally to a polyadenylated region / transcription terminator or transcription termination sequence. In one embodiment, the promoter is heterologous to the target RNA molecule.
[0848] In one embodiment, the promoter is an RNA polymerase III promoter, an RNA polymerase II promoter, or a promoter that functions in an in vitro transcription reaction.
[0849] On the one hand, the present invention provides a carrier containing the polynucleotide of the present invention.
[0850] In one embodiment, the vector is a viral vector, such as a DNA viral vector, an RNA viral vector, or a plasmid.
[0851] On one hand, the present invention provides a host cell comprising one or more of the following: the precursor RNA molecule of the present invention, the double-stranded RNA molecule of the present invention, a population of multiple different double-stranded RNA molecules of the present invention, the polynucleotide of the present invention, or the vector of the present invention.
[0852] In one embodiment, the host cell comprises a population of two, three, four, five, 10, 15, 20, 50, 100 or more different double-stranded RNA molecules of the present invention.
[0853] In one embodiment, the host cell is a eukaryotic cell. In one embodiment, the host cell is a microorganism, such as bacterial cells like *E. coli* cells, or yeast cells like *Saccharomyces cerevisiae*. In one embodiment, the microorganism has been modified to reduce the catabolism of double-stranded RNA molecules or enhance their accumulation. In one embodiment, the host cell is a non-human host cell, or a cell in a cell culture or in vitro, or a cell from a non-human organism.
[0854] In another aspect, the present invention provides eukaryotic cells comprising one or more of the following: the precursor RNA molecule of the present invention, a polynucleotide encoding the precursor RNA molecule, a double-stranded RNA molecule (P) of the present invention, and a population of a plurality of different double-stranded RNA molecules (P) of the present invention, preferably wherein the cell is a non-human cell or an in vitro eukaryotic cell.
[0855] In one embodiment, the host cell is a plant cell, fungal cell, or animal cell, preferably a plant cell, arthropod cell such as an insect cell, arachnid cell, decapod cell, nematode cell, or fungal cell. In one embodiment, the plant cell is wild-type for the gene encoding the DCL4 protein and / or the gene encoding the DCL2 protein. In one embodiment, the plant cell is not a Nicotiana benthamiana cell or a Nicotiana tabacum cell. In one embodiment, the host cell is a fungal cell or animal cell that is wild-type for the Dicer protein.
[0856] In one embodiment, applicable to all embodiments of the above aspects, the double-stranded RNA molecule and / or the precursor RNA molecule and / or the population of the plurality of different double-stranded RNA molecules are not naturally present in the cell.
[0857] In one embodiment, applicable to all embodiments described above, the host cell is dead and / or unable to reproduce. For example, the dead or inactivated host cell is a microbial cell. Alternatively, the dead or inactivated cell is a plant cell or a pest cell.
[0858] On the one hand, the present invention provides a non-human object or a portion thereof comprising the cells of the present invention.
[0859] In one embodiment, the non-human organism or a portion thereof is a genetically modified non-human organism or a portion thereof, which is genetically modified for the polynucleotides of the present invention, preferably a genetically modified plant or a portion thereof.
[0860] In one embodiment, the polynucleotide is stably integrated into the genome of the organism or a portion thereof, preferably into the nuclear genome of the organism or a portion thereof, such as in non-human eukaryotic organisms like plants or yeast. Alternatively, the polynucleotide may not be integrated into the genome of the organism or a portion thereof, but may be expressed in the organism or a portion thereof, for example, transiently.
[0861] In one embodiment, the plant is transgenic for the polynucleotide stably integrated into the plant's genome, wherein the polynucleotide encodes a first, second, third, fourth, or fifth aspect precursor RNA molecule or an embodiment of the asymmetric RNA molecule, wherein at least some of the antisense RNA sequences in the precursor RNA molecule and / or the double-stranded product RNA molecule generated from the precursor RNA molecule are capable of reducing the expression and / or activity of the target RNA molecule upon ingestion by insects (e.g., lepidopteran insects) or in fungal pathogens. In one embodiment, the transgenic plant has increased resistance to the insect or the fungal pathogen relative to a corresponding plant lacking the polynucleotide. For example, at least some insect larvae are killed after ingesting some transgenic plant cells expressing the precursor RNA molecule. In one embodiment, the transgenic plant is a cotton plant and the insect is a genus *Helicoverpa*, or a corn, sorghum, or rice plant and the insect is a genus *Helicoverpa*. In one embodiment, the fungal pathogen is a genus *Fusarium* or *Verticillium*.
[0862] In an embodiment of the fourth or fifth aspect or of the asymmetric precursor RNA molecule, the present invention provides a non-human organism or a portion thereof, preferably a plant or a portion thereof, or an insect or a portion thereof, or a fungus or a portion thereof, said non-human organism or portion thereof comprising one or more of the following: precursor RNA molecule, double-stranded RNA molecule, population of multiple different double-stranded RNA molecules, polynucleotide, vector, or host cell. In one embodiment, said non-human organism or portion thereof is a transgenic plant or portion thereof for which the polynucleotide of the present invention is transgenic, preferably said polynucleotide is stably integrated into the genome of said plant or portion thereof.
[0863] On one hand, the present invention provides a method for generating the host cell of the present invention, the method comprising introducing one or more of the following into the cell: a precursor RNA molecule of the present invention, a double-stranded RNA molecule of the present invention, a population of multiple different double-stranded RNA molecules of the present invention, a polynucleotide of the present invention, or a vector of the present invention. In a preferred embodiment, if the host cell is an animal cell, the step of introducing the molecule occurs in vitro. For example, the introduction step occurs in vitro. The introduction step may be followed by a step of culturing or propagating the molecule in which it has been introduced, which may include selecting transformed cells and / or identifying cells or progeny cells containing the molecule. Progeny cells may be measured to identify cells with a suitable phenotype.
[0864] On one hand, the present invention provides a method for producing a non-human organism of the present invention, the method comprising introducing one or more of the following into a cell and producing the non-human organism from the cell: a precursor RNA molecule of the present invention, a double-stranded RNA molecule of the present invention, a population of a plurality of different double-stranded RNA molecules of the present invention, a polynucleotide of the present invention, or a vector of the present invention. In one embodiment, when the non-human organism is a plant, the step of producing the non-human organism from the cell comprises regenerating a transgenic plant from the cell. Following the step of introducing the polynucleotide of the present invention may be a step of selecting or identifying cells or progeny cells containing the polynucleotide.
[0865] In one embodiment, the polynucleotides of the present invention are stably integrated into the genome of the cell or the organism, preferably into the organism or a portion thereof, preferably into the nuclear genome of a plant.
[0866] On one hand, the present invention provides a method for generating the precursor RNA molecule of the present invention, the double-stranded RNA molecule of the present invention, and / or a population of multiple different double-stranded RNA molecules of the present invention, the method comprising expressing the polynucleotide of the present invention in a host cell or a cell-free expression system. In one embodiment, the host cell is a eukaryotic cell, preferably a plant cell or a yeast cell. In one embodiment, the host cell is a cell modified to reduce dsRNA degradation, for example by removing type III ribonuclease.
[0867] In one embodiment, the method further comprises extracting and / or at least partially purifying some of the following: the precursor RNA molecule of the present invention, or the double-stranded RNA molecule of the present invention, or a group of multiple different double-stranded RNA molecules of the present invention. In one embodiment, the method does not include the step of extracting the RNA molecule from the host cell. In one embodiment, after the precursor RNA is generated, the host cell is inactivated or killed, for example, by heat treatment.
[0868] On one hand, the present invention provides an extract of cells according to the present invention, wherein the extract comprises one or more of the following: a precursor RNA molecule of the present invention, a double-stranded RNA molecule of the present invention, a group of multiple diff...
Claims
1. A precursor RNA molecule comprising at least one double-stranded RNA region, wherein: (i) The double-stranded RNA region comprises: (a) A first RNA strand of at least 46 consecutive ribonucleotides, the first RNA strand comprising a first RNA sequence of at least 44 consecutive ribonucleotides, and (b) A second RNA strand of at least 46 consecutive ribonucleotides, the second RNA strand comprising a second RNA sequence of at least 44 consecutive ribonucleotides. The first RNA sequence hybridizes with the second RNA sequence through base pairing between at least 44 consecutive ribonucleotides of the first RNA sequence and at least 44 consecutive ribonucleotides of the second RNA sequence, thereby forming at least a portion of the double-stranded RNA region. The total 10% to 35% of the ribonucleotides in the first and second RNA sequences are paired with G:U base pairs. The second RNA sequence is at least 80% identical to the sequence of at least 44 consecutive ribonucleotides, the sequence of which is completely complementary to the first region of the target RNA molecule in the fungal cell; and (ii) The precursor RNA molecule can be cleaved in the fungal cell by one or more Dicers to produce double-stranded product RNA molecules, each of which independently consists of a sense RNA sequence of 21 consecutive ribonucleotides from the first RNA sequence and an antisense RNA sequence of 21 consecutive ribonucleotides from the second RNA sequence. In each of the double-stranded RNA product molecules, ribonucleotides 1 to 19 of the sense RNA sequence are base-paired with ribonucleotides 1 to 19 of the antisense RNA sequence. In each of the double-stranded RNA product molecules, the 19 base pairs between the sense RNA sequence and the antisense RNA sequence independently contain 2, 3, 4, 5, or 6 G:U base pairs. In each of the double-stranded product RNA molecules, ribonucleotides 20 and 21 of the sense RNA sequence form an unpaired 3' overhang consisting of two ribonucleotides, and in each of the double-stranded product RNA molecules, ribonucleotides 20 and 21 of the antisense RNA sequence form an unpaired 3' overhang consisting of two ribonucleotides. Wherein (c) at least some of the antisense RNA sequences in the double-stranded product RNA molecule are capable of reducing the expression and / or activity of the target RNA molecule in the fungal cells, or (d) The antisense RNA sequences in the double-stranded product RNA molecule are each independently identical in sequence to the corresponding regions of the complementary sequences of the target RNA molecule by at least 80%, or (e), (c), and (d) are both.
2. A precursor RNA molecule comprising at least one double-stranded RNA region, wherein: (i) The double-stranded RNA region comprises: (a) A first RNA strand of at least 46 consecutive ribonucleotides, the first RNA strand comprising a first RNA sequence of at least 44 consecutive ribonucleotides, and (b) A second RNA strand of at least 48 consecutive ribonucleotides, the second RNA strand comprising a second RNA sequence of at least 46 consecutive ribonucleotides. The first RNA sequence hybridizes with the second RNA sequence through base pairing between at least 42 ribonucleotides from the at least 44 consecutive ribonucleotides of the first RNA sequence and at least 42 ribonucleotides from the at least 46 consecutive ribonucleotides of the second RNA sequence, thereby forming at least a portion of the double-stranded RNA region. In the portion of the double-stranded RNA region, two, three, or four ribonucleotides of the at least 46 consecutive ribonucleotides of the second RNA sequence are non-base-paired, and zero, one, or two ribonucleotides of the at least 44 consecutive ribonucleotides of the first RNA sequence are non-base-paired, thereby forming a protrusion in the portion of the double-stranded RNA region. Each of the protrusions is immediately followed by a ribonucleotide, which is base-paired in the specified portion of the double-stranded RNA region. The total 10% to 35% of the ribonucleotides in the first and second RNA sequences are paired with G:U base pairs. The second RNA sequence is at least 80% identical to the sequence of at least 46 consecutive ribonucleotides, the sequence of which is completely complementary to the first region of the target RNA molecule in the fungal cell; and (ii) The precursor RNA molecule can be cleaved in the fungal cell by one or more Dicer sequences to produce double-stranded product RNA molecules, each of which independently consists of a sense RNA sequence of 21 consecutive ribonucleotides from the first RNA sequence and an antisense RNA sequence of 22 consecutive ribonucleotides from the second RNA sequence. The antisense RNA sequence of the double-stranded product RNA molecule each includes at least one of the protrusions. In each of the double-stranded RNA product molecules, the base pair between the sense RNA sequence and the antisense RNA sequence independently comprises 2, 3, 4, 5, or 6 G:U base pairs. In each of the double-stranded product RNA molecules, ribonucleotides 20 and 21 of the sense RNA sequence form an unpaired 3' overhang consisting of two ribonucleotides. In each of the double-stranded product RNA molecules, ribonucleotides 21 and 22 of the antisense RNA sequence form an unpaired 3' overhang consisting of two ribonucleotides. Wherein (c) at least some of the antisense RNA sequences in the double-stranded product RNA molecule are capable of reducing the expression and / or activity of the target RNA molecule in the fungal cells, or (d) The antisense RNA sequences in the double-stranded product RNA molecule are each independently identical in sequence to the corresponding regions of the complementary sequences of the target RNA molecule by at least 80%, or (e), (c), and (d) are both.
3. A precursor RNA molecule comprising at least one double-stranded RNA region, wherein: (i) The double-stranded RNA region comprises: (a) A first RNA strand of at least 46 consecutive ribonucleotides, the first RNA strand comprising a first RNA sequence of at least 44 consecutive ribonucleotides, and (b) A second RNA strand of at least 50 consecutive ribonucleotides, the second RNA strand comprising a second RNA sequence of at least 48 consecutive ribonucleotides. The first RNA sequence hybridizes with the second RNA sequence through base pairing between at least 42 ribonucleotides from the at least 44 consecutive ribonucleotides of the first RNA sequence and at least 42 ribonucleotides from the at least 48 consecutive ribonucleotides of the second RNA sequence, thereby forming at least a portion of the double-stranded RNA region. In the portion of the double-stranded RNA region, 4, 5, or 6 of the at least 48 consecutive ribonucleotides of the second RNA sequence are non-base-paired, and 0, 1, or 2 of the at least 44 consecutive ribonucleotides of the first RNA sequence are non-base-paired, thereby forming a protrusion in the portion of the double-stranded RNA region. Each of the protrusions is immediately followed by a ribonucleotide, which is base-paired in the specified portion of the double-stranded RNA region. The total 10% to 35% of the ribonucleotides in the first and second RNA sequences are paired with G:U base pairs. The second RNA sequence is at least 80% identical to the sequence of at least 48 consecutive ribonucleotides, and the sequence of said at least 48 consecutive ribonucleotides is completely complementary to the first region of the target RNA molecule in the fungal cell; and (ii) The precursor RNA molecule can be cleaved in the fungal cell by one or more Dicer sequences to produce double-stranded product RNA molecules, each of which independently consists of a sense RNA sequence of 21 consecutive ribonucleotides from the first RNA sequence and an antisense RNA sequence of 23 consecutive ribonucleotides from the second RNA sequence. The antisense RNA sequence of the double-stranded product RNA molecule each includes at least one of the protrusions. In each of the double-stranded RNA product molecules, the base pair between the sense RNA sequence and the antisense RNA sequence independently comprises 2, 3, 4, 5, or 6 G:U base pairs. In each of the double-stranded product RNA molecules, ribonucleotides 20 and 21 of the sense RNA sequence form an unpaired 3' overhang consisting of two ribonucleotides. In each of the double-stranded product RNA molecules, ribonucleotides 22 and 23 of the antisense RNA sequence form an unpaired 3' overhang consisting of two ribonucleotides, and Wherein (c) at least some of the antisense RNA sequences in the double-stranded product RNA molecule are capable of reducing the expression and / or activity of the target RNA molecule in the fungal cells, or (d) The antisense RNA sequences in the double-stranded product RNA molecule are each independently identical in sequence to the corresponding regions of the complementary sequences of the target RNA molecule by at least 80%, or (e), (c), and (d) are both.
4. A precursor RNA molecule comprising at least one double-stranded RNA region, wherein: (i) The double-stranded RNA region comprises: (a) A first RNA strand of at least 46 consecutive ribonucleotides, the first RNA strand comprising a first RNA sequence of at least 44 consecutive ribonucleotides, and (b) A second RNA strand of at least 52 consecutive ribonucleotides, the second RNA strand comprising a second RNA sequence of at least 50 consecutive ribonucleotides. The first RNA sequence hybridizes with the second RNA sequence through base pairing between at least 42 ribonucleotides from the at least 44 consecutive ribonucleotides of the first RNA sequence and at least 42 ribonucleotides from the at least 50 consecutive ribonucleotides of the second RNA sequence, thereby forming at least a portion of the double-stranded RNA region. In the portion of the double-stranded RNA region, 6, 7, or 8 of the at least 50 consecutive ribonucleotides of the second RNA sequence are non-base-paired, and 0, 1, or 2 of the at least 44 consecutive ribonucleotides of the first RNA sequence are non-base-paired, thereby forming a protrusion in the portion of the double-stranded RNA region. Each of the protrusions is immediately followed by a ribonucleotide, which is base-paired in the specified portion of the double-stranded RNA region. The total 10% to 35% of the ribonucleotides in the first and second RNA sequences are paired with G:U base pairs. The second RNA sequence is at least 80% identical to the sequence of at least 50 consecutive ribonucleotides, and the sequence of said at least 50 consecutive ribonucleotides is completely complementary to the first region of the target RNA molecule in the fungal cell; and (ii) The precursor RNA molecule can be cleaved in the fungal cell by one or more Dicers to produce double-stranded product RNA molecules, each of which independently consists of a sense RNA sequence of 21 consecutive ribonucleotides from the first RNA sequence and an antisense RNA sequence of 24 consecutive ribonucleotides from the second RNA sequence. The antisense RNA sequence of the double-stranded product RNA molecule each includes at least one of the protrusions. In each of the double-stranded RNA product molecules, the base pair between the sense RNA sequence and the antisense RNA sequence independently comprises 2, 3, 4, 5, or 6 G:U base pairs. In each of the double-stranded product RNA molecules, ribonucleotides 20 and 21 of the sense RNA sequence form an unpaired 3' overhang consisting of two ribonucleotides. In each of the double-stranded product RNA molecules, ribonucleotides 23 and 24 of the antisense RNA sequence form an unpaired 3' overhang consisting of two ribonucleotides. Wherein (c) at least some of the antisense RNA sequences in the double-stranded product RNA molecule are capable of reducing the expression and / or activity of the target RNA molecule in the fungal cells, or (d) The antisense RNA sequences in the double-stranded product RNA molecule are each independently identical in sequence to the corresponding regions of the complementary sequences of the target RNA molecule by at least 80%, or (e), (c), and (d) are both.
5. The precursor RNA molecule according to any one of claims 1 to 4, comprising a linker RNA sequence, wherein the linker RNA sequence links the 3' end of the first RNA strand to the 5' end of the second RNA strand, or links the 5' end of the first RNA strand to the 3' end of the second RNA strand.
6. The precursor RNA molecule according to claim 5, wherein the precursor RNA molecule comprises a second double-stranded RNA region and a second linker RNA sequence forming an ledRNA structure, preferably wherein a total of 10% to 35% of the ribonucleotides in the second double-stranded RNA region are base-paired in G:U base pairs.
7. The precursor RNA molecule according to any one of claims 1 to 6, wherein one or more of the following are applicable: (i) The linker RNA sequence comprises at least 50 consecutive ribonucleotides that are at least 90% identical to the second region of the target RNA molecule in the fungal cell, and / or the linker RNA sequence comprises at least 50 consecutive ribonucleotides that are at least 90% identical to the complementary sequence of the second region of the target RNA molecule in the fungal cell. (ii) The precursor RNA molecule further comprises at least 50 consecutive ribonucleotides of a sequence at least 90% identical to the second region of the target RNA molecule in the fungal cell, the sequence being covalently linked to the 5' or 3' end of the first RNA strand or to the 5' or 3' end of the second RNA strand, and / or at least 50 consecutive ribonucleotides of a sequence at least 90% identical to the complementary sequence of the second region of the target RNA molecule in the fungal cell, the sequence being covalently linked to the 5' or 3' end of the first RNA strand or to the 5' or 3' end of the second RNA strand. (iii) The linker RNA sequence comprises a single-stranded RNA sequence of at least 44 consecutive ribonucleotides identical to a region of the first RNA sequence or the second RNA sequence. (iv) The precursor RNA molecule contains the linker RNA sequence and is encoded by a polynucleotide lacking an intron in the region encoding the linker RNA sequence. (v) The first RNA sequence and the second RNA sequence have the same length across the entire length of the double-stranded RNA region. (vi) The first RNA sequence and the second RNA sequence have different lengths across the entire length of the double-stranded RNA region, wherein the first RNA sequence is longer than the second RNA sequence, or preferably, the first RNA sequence is shorter than the second RNA sequence. (vii) The first RNA sequence differs from the first region of the target RNA molecule only in that at least some A ribonucleotides are replaced by G ribonucleotides, or at least some C ribonucleotides are replaced by U ribonucleotides, or a combination of at least some A ribonucleotides being replaced by G ribonucleotides and at least some C ribonucleotides being replaced by U ribonucleotides, or some but not all A ribonucleotides being replaced by G ribonucleotides, or some but not all C ribonucleotides being replaced by U ribonucleotides, or a combination of some but not all A ribonucleotides being replaced by G ribonucleotides and some but not all C ribonucleotides being replaced by U ribonucleotides, and optionally wherein the second RNA sequence is sequence-complementary to the first region of the target RNA molecule. (viii) The second RNA sequence differs from the complementary sequence of the first region of the target RNA molecule only in that A ribonucleotides are replaced by G ribonucleotides, or C ribonucleotides are replaced by U ribonucleotides, or a combination of A ribonucleotides being replaced by G ribonucleotides and C ribonucleotides being replaced by U ribonucleotides, or some but not all A ribonucleotides being replaced by G ribonucleotides, or some but not all C ribonucleotides being replaced by U ribonucleotides, or a combination of some but not all A ribonucleotides being replaced by G ribonucleotides and some but not all C ribonucleotides being replaced by U ribonucleotides, and optionally wherein the first RNA sequence is sequence-identical to the first region of the target RNA molecule. (ix) Relative to the target RNA molecule, at least some of the double-stranded product RNA molecules have non-overlapping antisense RNA sequences, preferably adjacent to non-overlapping antisense RNA sequences. (x) The sense RNA sequence of each double-stranded product RNA molecule differs from its corresponding sequence in the first region of the target RNA molecule only in that at least some A ribonucleotides are replaced by G ribonucleotides, or at least some C ribonucleotides are replaced by U ribonucleotides, or a combination of at least some A ribonucleotides being replaced by G ribonucleotides and at least some C ribonucleotides being replaced by U ribonucleotides, or some but not all A ribonucleotides being replaced by G ribonucleotides, or some but not all C ribonucleotides being replaced by U ribonucleotides, or a combination of some but not all A ribonucleotides being replaced by G ribonucleotides and some but not all C ribonucleotides being replaced by U ribonucleotides. (xi) The difference between the antisense RNA sequence of each double-stranded product RNA molecule and the corresponding sequence in the complementary sequence of the first region of the target RNA molecule is only that A ribonucleotide is replaced by G ribonucleotide, or C ribonucleotide is replaced by U ribonucleotide, or a combination of A ribonucleotide being replaced by G ribonucleotide and C ribonucleotide being replaced by U ribonucleotide, or some but not all of A ribonucleotides being replaced by G ribonucleotide, or some but not all of C ribonucleotides being replaced by U ribonucleotide, or a combination of some but not all of A ribonucleotides being replaced by G ribonucleotide and some but not all of C ribonucleotides being replaced by U ribonucleotide. (xii) The percentage of G ribonucleotides in the first RNA sequence is between 26% and 40% of the total number of ribonucleotides in the first RNA sequence, and / or the percentage of G ribonucleotides in the second RNA sequence is between 26% and 40% of the total number of ribonucleotides in the second RNA sequence. (xiii) The percentage of U ribonucleotides in the first RNA sequence is between 26% and 40% of the total number of ribonucleotides in the first RNA sequence, and / or the percentage of U ribonucleotides in the second RNA sequence is between 26% and 40% of the total number of ribonucleotides in the second RNA sequence. The double-stranded RNA region described in (xiv) has at most 18 consecutive typical base pairs, and (xv) The precursor RNA molecule can be prepared by transcriptional enzymatic reaction in vitro or in cells or both.
8. The precursor RNA molecule according to any one of claims 1 to 6, wherein one or more of the following are applicable: (i) The precursor RNA molecule comprises a linker RNA sequence comprising a single-stranded RNA sequence of at least 44, at least 50, or at least 100 consecutive ribonucleotides, wherein the single-stranded RNA sequence is identical to the region of the first RNA sequence or the second RNA sequence of the double-stranded RNA region. (ii) The percentage of G ribonucleotides in the first RNA sequence increases by substitution of A for G relative to the corresponding sequence in the region of the target RNA molecule, and / or the percentage of G ribonucleotides in the second RNA sequence increases by substitution of A for G relative to the corresponding sequence in the complementary sequence of the region of the target RNA molecule. (iii) The percentage of U ribonucleotides in the first RNA sequence increases by a C-to-U substitution relative to the corresponding sequence in the region of the target RNA molecule, and / or the percentage of U ribonucleotides in the second RNA sequence increases by a C-to-U substitution relative to the corresponding sequence in the complementary sequence of the region of the target RNA molecule. (iv) At least some of the antisense RNA sequences in the antisense RNA sequence of the double-stranded product RNA molecule generated from the precursor RNA molecule pair with the bases of the region of the target RNA molecule along the full length of the antisense RNA sequence, preferably by typical base pairing along the full length. (v) At least some of the antisense RNA sequences in the double-stranded product RNA molecule generated from the precursor RNA molecule are capable of reducing the expression and / or activity of the target RNA molecule in the fungal cell, or the antisense RNA sequences in the double-stranded product RNA molecule generated from the precursor RNA molecule are capable of reducing the expression and / or activity of multiple different target RNA molecules in the fungal cell, wherein the different target RNA molecules are sequence-independent. (vi) Compared to the use of antisense RNA sequences generated from corresponding precursor RNA molecules having only typical base pairings, the reduction in the expression and / or activity of the target RNA molecule in the fungal cells leads to a reduction in fungal infection symptoms or fungal growth. (vii) The sense RNA sequences of the two double-stranded RNA regions are consecutive with respect to the target RNA molecule, or the antisense RNA sequences of the two double-stranded RNA regions are consecutive with respect to the complementary sequences of the target RNA molecule. (viii) The two double-stranded RNA regions can be cleaved by Dicer to produce double-stranded product RNA molecules, the double-stranded product RNA molecules containing antisense RNA sequences that hybridize to one region of the target RNA molecule or to different discontinuous regions of the target RNA molecule. (ix) The two double-stranded RNA regions can be cleaved by Dicer to produce double-stranded product RNA molecules, the double-stranded product RNA molecules comprising antisense RNA sequences that hybridize to regions of different target RNA molecules or to corresponding regions within a family of target RNA molecules, and (x) The second double-stranded region lacks non-base-paired ribonucleotide protrusions.
9. The precursor RNA molecule according to any one of claims 1 to 8, comprising a second double-stranded region, wherein the second double-stranded region comprises a third RNA sequence of at least 23 consecutive ribonucleotides and a fourth RNA sequence of at least 26 consecutive ribonucleotides, wherein the third RNA sequence hybridizes with the fourth RNA sequence through base pairing between at least 20 ribonucleotides of the at least 23 consecutive ribonucleotides of the third RNA sequence and at least 20 ribonucleotides of the at least 26 consecutive ribonucleotides of the fourth RNA sequence, thereby forming at least a portion of the second double-stranded RNA region. In the portion of the double-stranded RNA region, one, two, three, four, five, or six ribonucleotides of the at least 26 consecutive ribonucleotides of the fourth RNA sequence are non-base-paired, and zero, one, two, or three ribonucleotides of the at least 23 consecutive ribonucleotides of the first RNA sequence are non-base-paired, thereby forming a protrusion in the portion of the second double-stranded RNA region. Each of the protrusions is immediately followed by a ribonucleotide, which is base-paired within the portion of the second double-stranded RNA region. The fourth RNA sequence is at least 80% identical to the sequence of at least 26 consecutive ribonucleotides, and the sequence of at least 26 consecutive ribonucleotides is completely complementary to the region of the target RNA molecule in the fungal cell.
10. The precursor molecule according to claim 9, wherein... (i) The first RNA sequence and / or the third RNA sequence differs from the corresponding wild-type RNA sequence in the target RNA molecule in that one or more ribonucleotides are deleted from the corresponding wild-type RNA sequence to prepare the first RNA sequence or the third RNA sequence, and / or (ii) The second RNA sequence and / or the fourth RNA sequence differs from the fully complementary sequence of the corresponding wild-type RNA sequence in the target RNA molecule in that one or more ribonucleotides are inserted into the fully complementary sequence to prepare the second RNA sequence or the fourth RNA sequence, preferably (i).
11. The precursor RNA molecule according to any one of claims 1 to 10, wherein all ribonucleotides of the antisense RNA sequence are capable of pairing with ribonucleotide bases in the region of the target RNA molecule.
12. A double-stranded RNA molecule comprising a sense RNA sequence of 21 consecutive ribonucleotides, an antisense RNA sequence of 22 consecutive ribonucleotides, and one, two, or three protrusions. In the sense RNA sequence, 18 or 19 of ribonucleotides 1 to 19 are each paired with ribonucleotide bases 1 to 20 of the antisense RNA sequence. In each of the double-stranded RNA product molecules, the base pair between the sense RNA sequence and the antisense RNA sequence independently comprises 2, 3, 4, 5, or 6 G:U base pairs. Each of the one, two, or three protrusions is immediately followed by a ribonucleotide, which is base-paired in the double-stranded RNA molecule. The sense RNA sequence contains ribonucleotides 20 and 21 forming an unpaired 3' overhang consisting of two ribonucleotides, and the antisense RNA sequence contains ribonucleotides 21 and 22 forming an unpaired 3' overhang consisting of two ribonucleotides. The sense RNA sequence contains ribonucleotides 1 and 2 that pair with ribonucleotides 19 and 20 of the antisense RNA sequence, respectively. The sense RNA sequence contains ribonucleotides 18 and 19 that are paired with ribonucleotides 1 and 2 of the antisense RNA sequence, respectively.
13. A double-stranded RNA molecule comprising a sense RNA sequence of 21 consecutive ribonucleotides, an antisense RNA sequence of 23 consecutive ribonucleotides, and one, two, three, or four protrusions. In the sense RNA sequence, 18 or 19 of ribonucleotides 1 to 19 are each paired with ribonucleotide bases 1 to 21 of the antisense RNA sequence. In each of the double-stranded RNA product molecules, the base pair between the sense RNA sequence and the antisense RNA sequence independently comprises 2, 3, 4, 5, or 6 G:U base pairs. Each of the one, two, three, or four protrusions is immediately followed by a ribonucleotide, which is base-paired in the double-stranded RNA molecule. The sense RNA sequence contains ribonucleotides 20 and 21 forming an unpaired 3' overhang of two ribonucleotides, and the antisense RNA sequence contains ribonucleotides 22 and 23 forming an unpaired 3' overhang of two ribonucleotides. The sense RNA sequence contains ribonucleotides 1 and 2 that pair with ribonucleotides 20 and 21 of the antisense RNA sequence, respectively. The sense RNA sequence contains ribonucleotides 18 and 19 that are paired with ribonucleotides 1 and 2 of the antisense RNA sequence, respectively.
14. A double-stranded RNA molecule comprising a sense RNA sequence of 21 consecutive ribonucleotides, an antisense RNA sequence of 24 consecutive ribonucleotides, and one, two, three, four, or five protrusions. In the sense RNA sequence, 18 or 19 of ribonucleotides 1 to 19 are each paired with ribonucleotide bases 1 to 22 of the antisense RNA sequence. In each of the double-stranded RNA product molecules, the base pair between the sense RNA sequence and the antisense RNA sequence independently comprises 2, 3, 4, 5, or 6 G:U base pairs. Each of the one, two, three, four, or five protrusions is immediately followed by a ribonucleotide, which is base-paired in the double-stranded RNA molecule. The sense RNA sequence contains ribonucleotides 20 and 21 forming an unpaired 3' overhang of two ribonucleotides, and the antisense RNA sequence contains ribonucleotides 23 and 24 forming an unpaired 3' overhang of two ribonucleotides. The sense RNA sequence contains ribonucleotides 1 and 2 that pair with ribonucleotides 21 and 22 of the antisense RNA sequence, respectively. The sense RNA sequence contains ribonucleotides 18 and 19 that are paired with ribonucleotides 1 and 2 of the antisense RNA sequence, respectively.
15. A population of a plurality of different double-stranded RNA molecules, said population comprising the double-stranded RNA molecules according to any one of claims 12 to 14 or any combination thereof.
16. The population of multiple different double-stranded RNA molecules according to claim 15, wherein (i) The population contains more antisense RNA sequences consisting of 22 ribonucleotides than antisense RNA sequences consisting of 21 ribonucleotides. (ii) The population contains more antisense RNA sequences consisting of 23 ribonucleotides than antisense RNA sequences consisting of 21 ribonucleotides. (iii) The population contains more antisense RNA sequences consisting of 24 ribonucleotides than antisense RNA sequences consisting of 21 ribonucleotides, or (iv) Any combination of (i), (ii) and (iii), preferably (i) and (ii).
17. A eukaryotic cell comprising one or more of the following: a precursor RNA molecule according to any one of claims 1 to 11, a double-stranded RNA molecule according to any one of claims 12 to 14, or a group of multiple and different double-stranded RNA molecules according to claim 15 or 16, wherein the eukaryotic cell is preferably a plant cell, a fungal cell such as a yeast cell, or a microorganism.
18. A method for identifying a double-stranded RNA molecule or precursor RNA molecule for reducing the amount and / or activity of a target RNA molecule of interest in fungal cells, the method comprising... i) to generate a precursor RNA molecule according to any one of claims 1 to 11, and / or a double-stranded RNA molecule according to any one of claims 12 to 14, or a population of multiple different precursor RNA molecules according to claim 15 or claim 16. ii) Determining the ability of the precursor RNA molecule, or the double-stranded RNA molecule, or a member of a population of the plurality of different precursor RNA molecules, or a population of the plurality of different double-stranded RNA molecules to reduce the amount and / or activity of the target RNA molecule of interest in the fungal cell, optionally wherein step i) comprises introducing the precursor RNA molecule according to any one of claims 1 to 11 into the fungal cell, preferably by local application, such as soaking, dusting, spraying, or applying a composition comprising the precursor RNA molecule to the fungal cell, wherein the precursor RNA molecule is cleaved in the fungal cell by Dicer to produce the double-stranded RNA molecule or a population of the plurality of different double-stranded RNA molecules.
19. An isolated and / or exogenous polynucleotide or a vector containing said polynucleotide, said isolated and / or exogenous polynucleotide or said vector encoding a precursor RNA molecule according to any one of claims 1 to 11, optionally said polynucleotide being operatively linked to a promoter capable of guiding said precursor RNA molecule to expression in a host cell, preferably a plant cell, fungal cell or other microbial cell or in vitro, and optionally containing a polyadenylated region / transcription terminator or transcription termination sequence.
20. A host cell comprising one or more of the following: a precursor RNA molecule according to any one of claims 1 to 11, a double-stranded RNA molecule according to any one of claims 12 to 14, a group of a plurality of different double-stranded RNA molecules according to claim 15 or claim 16, and a polynucleotide or vector according to claim 19, wherein the host cell is preferably a plant cell or a fungal cell.
21. A non-human organism or part thereof, preferably a plant or part thereof or a fungus, said non-human organism or part thereof comprising one or more of the following: a precursor RNA molecule according to any one of claims 1 to 11, a double-stranded RNA molecule according to any one of claims 12 to 14, a group of a plurality of different double-stranded RNA molecules according to claim 15 or claim 16, a polynucleotide or vector according to claim 19, or a cell according to claim 17 or 20, preferably said non-human organism or part thereof is a transgenic plant or part thereof, said transgenic plant or part thereof being transgenic for the polynucleotide according to claim 19, preferably said polynucleotide being stably integrated into the genome of said plant or part thereof.
22. A method of producing a cell according to claim 17 or claim 20, the method comprising introducing one or more of the following into the cell: a precursor RNA molecule according to any one of claims 1 to 11, a double-stranded RNA molecule according to any one of claims 12 to 14, a group of a plurality of different double-stranded RNA molecules according to claim 15 or claim 16, or a polynucleotide or vector according to claim 19.
23. A method for producing a non-human object according to claim 21, the method comprising introducing one or more of the following into a cell and producing the non-human object from the cell: a precursor RNA molecule according to any one of claims 1 to 11, a double-stranded RNA molecule according to any one of claims 12 to 14, a group of a plurality of different double-stranded RNA molecules according to claim 15 or claim 16, or a polynucleotide or vector according to claim 19.
24. A method for producing one or more of the following: a precursor RNA molecule according to any one of claims 1 to 11, a double-stranded RNA molecule according to any one of claims 12 to 14, or a group of a plurality of different double-stranded RNA molecules according to claim 15 or claim 16, said method comprising expressing the polynucleotide or vector according to claim 19 in a host cell or cell-free expression system.
25. An extract of a cell according to claim 17 or claim 20, wherein the extract comprises one or more of the following: a precursor RNA molecule according to any one of claims 1 to 11, a double-stranded RNA molecule according to any one of claims 12 to 14, a group of a plurality of different double-stranded RNA molecules according to claim 15 or claim 16, or a polynucleotide or vector according to claim 19.
26. A composition comprising one or more of the following: a precursor RNA molecule according to any one of claims 1 to 11, a double-stranded RNA molecule according to any one of claims 12 to 14, a group of a plurality of different double-stranded RNA molecules according to claim 15 or claim 16, a polynucleotide or carrier according to claim 19, a cell according to claim 17 or claim 20, a non-human object or a portion thereof according to claim 21, or an extract according to claim 25.
27. A method for increasing the quantity of double-stranded RNA molecules according to any one of claims 12 to 14 in fungal cells or fungi, the method comprising expressing a polynucleotide or vector according to claim 19 in the fungal cells or fungi, or contacting the fungal cells or fungi with a population of precursor RNA molecules according to any one of claims 1 to 11, or double-stranded RNA molecules according to any one of claims 12 to 14, or double-stranded RNA molecules according to claim 15 or claim 16.
28. A method for reducing or downregulating the level and / or activity of a target RNA molecule in a fungal cell or fungus, the method comprising delivering to the fungal cell or fungus one or more of the following: a precursor RNA molecule according to any one of claims 1 to 11, a double-stranded RNA molecule according to any one of claims 12 to 14, a group of a plurality of different double-stranded RNA molecules according to claim 15 or claim 16, a polynucleotide or vector according to claim 19, a cell according to claim 17 or claim 20, a non-human object or part thereof according to claim 21, an extract according to claim 25, and a composition according to claim 26.
29. The method of claim 28, wherein one or more of the following are applied topically to the fungal cells or the fungus, such as by spraying, dusting, soaking, or applying a composition comprising the precursor RNA molecule, the double-stranded RNA molecule, a population of the double-stranded RNA molecule, the polynucleotide, the carrier, or the extract, thereby contacting the fungal cells or the fungus: the precursor RNA molecule, the double-stranded RNA molecule, a population of the double-stranded RNA molecule, the polynucleotide, the carrier, or the extract.
30. A method for identifying a function or phenotype associated with a target RNA molecule in a fungal cell or fungus, the method comprising (i) delivering to the fungal cell or fungus one or more of the following: a precursor RNA molecule according to any one of claims 1 to 11, a double-stranded RNA molecule according to any one of claims 12 to 14, a population of a plurality of different double-stranded RNA molecules according to claim 15 or claim 16, a polynucleotide or vector according to claim 19, a cell according to claim 17 or claim 20, a non-human organism or part thereof according to claim 21, an extract according to claim 25, and a composition according to claim 26; and (ii) determining the function or phenotype of the fungal cell or organism or its progeny fungal cells or progeny fungi, or measuring molecules associated with the function or phenotype of the fungal cell or fungus or its progeny fungal cells or fungi, thereby identifying a function or phenotype associated with a target RNA.
31. A method for identifying regions of a target RNA molecule in a fungal cell or fungus that are susceptible to RNAi downregulation, the method comprising (i) delivering to the cell or organism one or more of the following: a plurality of precursor RNA molecules according to any one of claims 1 to 11, a plurality of double-stranded RNA molecules according to any one of claims 12 to 14, a population of a plurality of different double-stranded RNA molecules according to claim 15 or claim 16, a polynucleotide or vector according to claim 19, an extract according to claim 25, and a composition according to claim 26, wherein the plurality of precursor RNA molecules, the plurality of double-stranded RNA molecules, or the population of the plurality of double-stranded RNA molecules targets different regions of the target RNA molecule; and (ii) determining one or more of the following in the fungal cell or the fungus or its progeny fungal cells or fungi: the amount of the target RNA molecule, the amount of protein encoded by the target RNA molecule, and / or the function or phenotype associated with the target RNA molecule; and (iii) selecting regions of the target RNA molecule based on the determination results from step (ii), thereby identifying the regions.
32. A method for identifying RNA molecules capable of influencing fungal pathogens, the method comprising (i) delivering to the fungal pathogen one or more of the following: a precursor RNA molecule according to any one of claims 1 to 11, a double-stranded RNA molecule according to any one of claims 12 to 14, a population of a plurality of different double-stranded RNA molecules according to claim 15 or claim 16, a polynucleotide or vector according to claim 19, a cell according to claim 17 or claim 20, a non-human object or part thereof according to claim 21, an extract according to claim 25, and a composition according to claim 26; and (ii) determining whether the precursor RNA molecule, the double-stranded RNA molecule, or the population of the different double-stranded RNA molecules has an influence on the fungal pathogen; and optionally (iii) selecting RNA molecules based on the results from step (ii) if the precursor RNA molecule, the double-stranded RNA molecule, or the population of the different double-stranded RNA molecules has a desired influence on the fungal pathogen, thereby identifying the RNA molecule.
33. A method for reducing or downregulating the level and / or activity of a target RNA molecule in a fungus, the method comprising delivering to the fungus one or more of the following: a precursor RNA molecule according to any one of claims 1 to 11, a double-stranded RNA molecule according to any one of claims 12 to 14, a population of a plurality of different double-stranded RNA molecules according to claim 15 or claim 16, a polynucleotide or vector according to claim 19, a cell according to claim 17 or 20, a non-human object or part thereof according to claim 21, an extract according to claim 25, and a composition according to claim 26.
34. A method for reducing or preventing harm to humans or non-human objects caused by fungi, the method comprising delivering to the fungi one or more of the following or contacting the fungi with one or more of the following: a precursor RNA molecule according to any one of claims 1 to 11, a double-stranded RNA molecule according to any one of claims 12 to 14, a group of a plurality of different double-stranded RNA molecules according to claim 15 or claim 16, a polynucleotide or vector according to claim 19, a cell according to claim 17 or claim 20, a non-human object or part thereof according to claim 21, an extract according to claim 25, and a composition according to claim 26.
35. A method for controlling fungi, the method comprising delivering to the fungi one or more of the following: a precursor RNA molecule according to any one of claims 1 to 11, a double-stranded RNA molecule according to any one of claims 12 to 14, a population of a plurality of different double-stranded RNA molecules according to claim 15 or claim 16, a polynucleotide or vector according to claim 19, a cell according to claim 17 or 20, a non-human object or part thereof according to claim 21, an extract according to claim 25, and a composition according to claim 26, wherein the precursor RNA molecule, the double-stranded RNA molecule, or the population of the double-stranded RNA molecules has a detrimental effect on the fungi, preferably wherein the precursor RNA molecule is produced in a plant, and the fungi infect the plant.
36. A method for increasing the amount of small interfering RNA (sRNA) of 22, 23, or 24 ribonucleotides in length in fungal cells or fungi, or for increasing the ratio of the amount of sRNA of 22, 23, or 24 ribonucleotides in length to the amount of sRNA of 21 ribonucleotides in length, the method comprising delivering to the fungal cells or fungi one or more of the following: a precursor RNA molecule according to any one of claims 1 to 11, a double-stranded RNA molecule according to any one of claims 12 to 14, a population of a plurality of different double-stranded RNA molecules according to claim 15 or claim 16, a polynucleotide or vector according to claim 19, a cell according to claim 17 or claim 20, a non-human object or part thereof according to claim 21, an extract according to claim 25, and a composition according to claim 26.
37. A method of treating a disease in an organism, the method comprising administering to a fungal pathogen of the organism one or more of the following: a precursor RNA molecule according to any one of claims 1 to 11, a double-stranded RNA molecule according to any one of claims 12 to 14, a group of a plurality of different double-stranded RNA molecules according to claim 15 or 16, a polynucleotide or carrier according to claim 19, a cell according to claim 17 or 20, a non-human object or part thereof according to claim 21, an extract according to claim 25, and a composition according to claim 26, preferably wherein the organism is a plant.
38. The method according to any one of claims 22 to 24 or 27 to 37, wherein the sense RNA sequence of the double-stranded RNA region of the precursor RNA molecule or the product RNA molecule is shorter than the antisense RNA sequence, preferably wherein the sense RNA sequence is completely shorter than the antisense RNA sequence because non-base-paired ribonucleotides protruding from the double-stranded RNA region or the product RNA molecule are present in the antisense RNA sequence, more preferably wherein the length of the sense RNA sequence is between 87% and 97%, or 87% and 96%, or 91% and 97%, or 91% and 96%, or more preferably between 94% and 97% or 94% and 96%, or the length of the sense RNA sequence is about 21 / 22, 21 / 23, or 21 / 24 of the length of the antisense RNA sequence, calculated as a fraction.
39. One or more of the following: a precursor RNA molecule according to any one of claims 1 to 11; a double-stranded RNA molecule according to any one of claims 12 to 14; a group of a plurality of different double-stranded RNA molecules according to claim 15 or 16; a polynucleotide or vector according to claim 19; a cell according to claim 17 or 20; a non-human object or part thereof according to claim 21; an extract according to claim 25; and a composition according to claim 26, for the treatment of a disease caused by a fungal pathogen, wherein the double-stranded RNA molecule or the group of said double-stranded RNA molecules has a beneficial effect on at least one symptom of said disease or controls said fungal pathogen.
40. Use of one or more of the following: a precursor RNA molecule according to any one of claims 1 to 11; a double-stranded RNA molecule according to any one of claims 12 to 14; a group of a plurality of different double-stranded RNA molecules according to claim 15 or 16; a polynucleotide or carrier according to claim 19; a cell according to claim 17 or 20; a non-human object or part thereof according to claim 21; an extract according to claim 25; and a composition according to claim 26, for the preparation of a medicament for treating diseases caused by fungal pathogens.
41. A kit comprising one or more of the following: a precursor RNA molecule according to any one of claims 1 to 11, a double-stranded RNA molecule according to any one of claims 12 to 14, a group of a plurality of different double-stranded RNA molecules according to claim 15 or claim 16, a polynucleotide or vector according to claim 19, a cell according to claim 17 or 20, a non-human object or part thereof according to claim 21, an extract according to claim 25, and a composition according to claim 26.
Citation Information
Patent Citations
Asymmetric RNA Molecules
AU2023904203
Asymmetric RNA Molecules
AU2024900066
Asymmetric RNA Molecules
AU2024901860
Asymmetric RNA Molecules
AU2024902006
RNA Molecules for treating insects
AU2024902008
